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51.  Einleitende Zusammenfassung
1.1 Hintergrund
Die	offene	und	endovaskuläre	thorakale	Aortenchirurgie	stellt	einen	bedeutenden	Teil-
bereich	der	beiden	Fachgebiete	Herz-	und	Gefäßchirurgie	dar.	Die	offen-konventionelle	
Aortenchirurgie	mit	Anwendung	der	Herz-Lungen-Maschine	ist	nach	wie	vor	der	Gold-
standard	zur	Behandlung	von	Pathologien	der	aufsteigenden	Aorta	(Aorta	ascendens)	
und	des	Aortenbogens	[1].	Im	Bereich	der	absteigenden	Aorta	(Aorta	descendens)	hat	
sich	hingegen	die	sogenannte	„Thoracic	endovascular	aortic	repair“-Technik	(TEVAR)	–	ur-
sprünglich	als	Notfall-Therapieverfahren	–	mittlerweile	als	Standardtherapie,	insbeson-
dere	bei	akuten	und	traumatisch-bedingten	Pathologien,	durchgesetzt	[2].	Komplexe	
Pathologien	der	 thorakalen	Aorta,	welche	 eine	offen-chirurgische	Behandlung	 erfor-
dern,	umfassen	 im	Wesentlichen	die	akute	Typ	A	Dissektion,	Pathologien	mit	Beteili-
gung	des	Aortenbogens	sowie	Wiederholungseingriffe	nach	stattgehabter	offener	oder	
endovaskulärer	Aortenoperation.	Letztere	sind	oft	mit	einem	besonders	hohen	Mor-
biditäts-	und	Letalitätsrisiko	vergesellschaftet,	da	es	 sich	hierbei	 zumeist	um	Notfall-
operationen	bei	drohender	oder	akuter	Aortenruptur,	anhaltenden	Blutungen,	media-
stinalen	Infektionen	oder	Malperfusion	von	nachgeschalteten	Organsystemen	handelt.	
Trotz	modernster	Bildgebungsverfahren	und	Kathetertechniken	ist	die	rein	endovasku-
läre	Therapie	von	diesen	komplexen	Notfällen,	insbesondere	bei	Infektionen	von	ein-
gebrachten	Aortenprothesen,	oft	nur	in	Ausnahmefällen	oder	übergangsweise	(als	sog.	
„Bridge-to-surgery“)	möglich	 und	mit	 einem	 deutlich	 erhöhten	 perioperativen	 Risiko	
vergesellschaftet	[3].
Durch	die	kontinuierliche	Entwicklung	von	neuen	chirurgischen	Techniken	und	Behand-
lungsstrategien	konnte	die	klassische	thorakale	Aortenchirurgie	als	Therapie	der	Wahl	
von	komplexen	Aortenpathologien	weiter	verbessert	und	die	postoperativen	Morbidi-
täts-	und	Letalitätsraten	weiter	gesenkt	werden	 [4].	Die	 intraoperativen	Neuerungen	
der	modernen	thorakalen	Aortenchirurgie	betreffen	vor	allem	verschiedene	Kannülie-
rungstechniken	zum	Anschluss	an	die	Herz-Lungen-Maschine	sowie	Perfusions-	und	
6Temperaturstrategien	für	die	Organprotektion,	welche	nunmehr	besondere	Anforde-
rungen	an	das	perioperative	Management	stellen	[5,6].	
Die	vorliegende	kumulative	Habilitationsschrift	soll	neue	Einblicke	in	die	Therapie,	ins-
besondere	im	Hinblick	auf	postoperative	Ergebnisse,	aktueller	Behandlungsstrategien	
und	das	perioperative	Management,	von	komplexen	thorakalen	Aortenpathologien	im	
Bereich	des	Aortenbogens	und	der	Aorta	descendens	aus	herzchirurgischer	Sicht	zu-
sammentragen.
71.2 Pathologien der thorakalen Aorta
Anatomisch	und	therapeutisch	kann	die	thorakale	Aorta	in	vier	verschiedene	Abschnitte	
unterteilt	werden.	Diese	umfassen	die	Aortenwurzel	(Bulbus	aortae),	die	aufsteigende	
Aorta	(Aorta	ascendens),	den	Aortenbogen	und	die	absteigende	Aorta	(Aorta	descen-
dens).	Pathologien	des	Aortenbogens	können	je	nach	ihrer	Lokalisation	als	proximal,	
distal,	oder	total	beschrieben	werden	(Abbildung 1).
  
Abbildung 1: 
Anatomische	Einteilung	der 
Aorta	 (aus	 Lühr	 [7]	 mit	
freundlicher	 Genehmigung	
der	 Albert-Ludwigs-Univer-
sität	Freiburg	i.	Br.).
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81.2.1 Akute thorakale Aortenpathologien 
Akute	 Aortenpathologien	 sind	 potentiell	 lebensbedrohlich	 (Ruptur	 der	 Hauptschlag-
ader)	und	können	alle	Abschnitte	der	 thorakalen	Aorta	betreffen.	Allgemein	werden	
diese	Erkrankungen,	aufgrund	der	Ähnlichkeit	der	klinischen	Leitsymptome,	unter	dem	
Begriff	 „akutes	 thorakales	 Aortensyndrom“	 zusammengefasst	 [8].	 Klassischer	 Weise	
geht	das	akute	thorakale	Aortensyndrom	initial	mit	einem	akuten	und	reißenden	tho-
rakalen	„Vernichtungsschmerz“	einher,	welcher	im	weiteren	klinischen	Verlauf	persis-
tieren	oder	nachlassen	kann.	Zusätzlich	können	weitere	klinische	Symptome	durch	die	
resultierende	 Veränderung	 des	 Blutstroms	 in	 der	 Aorta—beispielsweise	 Pulsdefizite	
zwischen	den	oberen	und	unteren	Extremitäten,	neurologische	Ausfälle	(transitorische	
ischämische	Attacke,	Schlaganfall,	Paraplegie,	etc.)	und	Durchblutungsstörungen	nach-
geschalteter	Organsysteme—auftreten.	
Die	Dissektion	stellt	mit	einer	Inzidenz	von	2	bis	3,5	Fälle/100.000	Einwohner	die	häu-
figste	und	prognostisch	ungünstigste	akute	thorakale	Aortenpathologie	dar	[9].	Bei	der	
Dissektion	 kommt	 es—meist	 im	 Zusammenhang	mit	 einer	 hypertensiven	 Krise—zu	
einem	lokalen	Einriss	der	innersten	Schicht	der	Aorta	(Intima)	und	in	der	Folge	zu	einer	
Einblutung	mit	Aufspaltung	der	mittleren	Gefäßmuskelschicht	(Media)	[10].	Je	nach	Lo-
kalisation	kann	sich	die	Einblutung	innerhalb	der	aortalen	Gefäßschichten	nach	anteg-
rad	oder	retrograd	ausdehnen,	während	diese	nur	noch	durch	die	bindegewebige	äu-
ßerste	Gefäßschicht	(Adventitia)	begrenzt	wird.	Dissektionen	werden	hinsichtlich	ihres	
Entstehungsortes	(sog.	„Entry“)	und	der	 jeweiligen	Ausdehnung	nach	Stanford	(Typ	A	
und	B)	oder	DeBakey	(Typ	I-III)	klassifiziert	(Abbildung 2).	Im	klinischen	Alltag	hat	sich	
jedoch	die	Einteilung	nach	Stanford	weitestgehend	durchgesetzt.	Aufgrund	der	hohen	
Rupturgefahr	bei	Patienten	mit	akuter	Stanford	Typ	A	Dissektion	ist	bis	heute	stets	die	
notfallmäßige	offene	Operation	indiziert,	während	bei	der	akuten	(unkomplizierten)	Typ	
B	Dissektion	zunächst	konservative	Therapieansätze	(Schmerzlinderung,	Blutdrucksen-
kung,	 etc.)	 im	Vordergrund	 stehen	 [9].	 Im	Falle	 von	drohenden	Komplikationen	 (z.B.	
Ruptur	oder	Organmalperfusion)	ist	jedoch	auch	bei	der	akuten	Typ	B	Dissektion	eine	
offene	oder	endovaskuläre	Operation	der	Aorta	descendens	indiziert	[2].
Das	intramurale	Hämatom	(IMH)	und	das	penetrierende	Aortenulkus	(PAU)	sind	eben-
9falls	unter	dem	Begriff	akutes	Aortensyndrom	subsumiert,	treten	aber	deutlich	seltener	
als	die	Aortendissektion	auf.	Während	bei	der	Entstehung	eines	IMH	am	ehesten	eine	
Einblutung	aus	den	Vasa	vasorum	innerhalb	der	Aortenmedia	vermutet	wird	(welche	
sich	ebenfalls	zirkulär	innerhalb	der	Aorta	im	Sinne	einer	Dissektion	ausbreiten	kann),	
so	liegt	dem	PAU	ursächlich	eine	Ulzeration	auf	dem	Boden	einer	fokalen	Arterioskle-
rose	zu	Grunde	[8,9,11].	Beide	Pathologien	zeichnen	sich	durch	ein	hohes	Ruptur-	und	
Dissektionsrisiko	aus,	welches	insbesondere	bei	einer	Lokalisation	im	Bereich	der	Aorta	
ascendens	und	des	Aortenbogens	stark	erhöht	 ist	 (IMH	bis	35%;	PAU	bis	40%),	und	
stellen	somit	 je	nach	Befund	ebenfalls	dringliche	bis	notfallmäßige	Operationsindika-
tionen	dar	[12].	Die	traumatische	(loco	typico,	meist	nach	Dezelerationstrauma)	oder	
iatrogene	Verletzung	(z.B.	im	Rahmen	einer	Herzkatheteruntersuchung)	der	Aorta	kann	
ebenfalls	zum	akuten	Aortensyndrom	gezählt	werden.
I II IIIa IIIb
A B  
Abbildung 2:	Klassifikationen	der	akuten	Aortendissektion	nach	Stanford	(A	und	B)	und	DeBa-
key	(I-III)	(aus	Lühr	[7]	mit	freundlicher	Genehmigung	der	Albert-Ludwigs-Universität	Freiburg	i.	Br.).
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1.2.2 Chronisch-degenerative Aortenpathologien
Chronisch-degenerative	Aortenpathologien	sind	in	der	Regel	mit	einer	Erweiterung	aller	
Wandschichten	der	Aorta	(Intima,	Media,	Adventitia)	assoziiert,	welche	ab	entsprechen-
der	Größe	(>150%	des	erwarteten	geschlechts-,	alters-	und	körpergrößenabhängigen	
Durchmessers)	als	Aneurysma	bezeichnet	werden	[13].	Thorakale	Aortenaneurysmen	
treten	mit	verschiedenen	Häufigkeiten	in	den	jeweiligen	Abschnitten	auf:	Aorta	ascen-
dens	(60%),	Aorta	descendens	(40%)	und	Aortenbogen	(10%)	[14].	Das	durchschnitt-
liche	Wachstum	beträgt	 je	nach	Lokalisation	zwischen	0,1	cm	(Aorta	ascendens)	und	
0,29	cm	(Aorta	descendens)	pro	Jahr	[15].	Ursächlich	können	Aneursymen	der	thora-
kalen	Aorta	degenerativ	(Atherosklerose),	syndromal	(Marfan	Syndrom,	Ehlers-Danlos	
Syndrom,	Loeys-Dietz	Syndrom,	Erdheim-Gsell	Syndrom,	Turner	Syndrom),	genetisch	
(uni-/	 bicuspide	 Aortenklappe,	 nicht-syndromal/	 familiär)	 oder	 inflammatorisch	 (z.B.	
Aortitis,	Riesenzellarteritis,	Takayasu	Arteritis,	Wegner	Granulomatose,	Lues,	etc.)	be-
dingt	sein	[8,13,16,17].	
Die	Entstehung	von	thorakalen	Aneurysmen	verläuft	in	der	Regel	asymptomatisch.	Kli-
nische	Symptome,	bei	entsprechender	Größenzunahme	mit	Kompression	von	umge-
benden	Strukturen	des	Mediastinums,	 sind	meist	unspezifisch	 (Schluck-	und	Stimm-
störung,	obere	Einflussstauung),	so	dass	die	Diagnose	in	der	Regel	erst	spät	oder	als	
Zufallsbefund	gestellt	wird	[8].	Die	jährliche	Inzidenz	thorakaler	Aneurysmen	beträgt	5	
bis	10	Fälle/100.000	Einwohner	mit	steigender	Tendenz	[18].
Die	progediente	Zunahme	der	Wandspannung	bei	gleichzeitiger	Abnahme	der	Dehn-
barkeit	im	Bereich	der	aneurysmatischen	Erweiterung	der	Aorta	erhöht	das	Risiko	einer	
Ruptur	bzw.	das	Auftreten	einer	Dissektion.	Das	jährliche	Risiko	beträgt	demnach	bei	
Aortendurchmessern	von	4,0	bis	4,9	cm	ca.	2%	und	steigt	rapide	auf	6,9%	bei	Aneurys-
men	ab	6	cm	in	der	Aorta	ascendens	bzw.	7	cm	in	der	Aorta	descendens	[8,19].	Dem-
entsprechend	sehen	die	europäischen	und	US-amerikanischen	Leitlinien	eine	chirurgi-
sche	Indikation	bereits	ab	einem	Aortendurchmesser	5,0	cm	bzw.	5,5	cm	vor	[9,20].	Im	
Falle	von	schnell	wachsenden	(>0,5	cm/	Jahr)	Aneurysmen,	syndromalen	Erkrankungen	
(z.B.	Marfan	Syndrom)	oder	elektiven	Eingriffen	an	der	Aortenklappe	kann	die	OP-Indi-
kation	entsprechend	früher	gestellt	werden	(ab	4,5	cm	Aortendurchmesser)	[16].		
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1.3	 Offene	und	endovaskuläre	Aortenchirurgie	
Seit	den	1950er	 Jahren	konnten	die	operativen	Ergebnisse	bei	offenen	Eingriffen	an	
der	thorakalen	Aorta	durch	die	Entwicklung	von	neuen	und	bahnbrechenden	operati-
ven	Techniken	und	Strategien—insbesondere	durch	die	klinische	Einführung	des	tiefen	
hypothermen	Kreislaufstillstands,	der	selektiven	zerebralen	Hirnperfusion	und	der	so-
genannten	Elephant	Trunk-Technik—stetig	verbessert	und	optimiert	werden	[21–25].	
Heutzutage	werden	bei	ausgedehnten	Pathologien	der	thorakalen	Aorta,	insbesondere	
mit	Beteiligung	des	Aortenbogens	und	der	Aorta	descendens,	zwei-zeitige	offene	Ope-
rationsverfahren	oder	Hybridtechniken	favorisiert	[26,27].	Eine	komplette	endovasku-
läre	Versorgung	aortaler	Pathologien	 im	Bereich	der	Aorta	 ascendens	und	des	Aor-
tenbogens	 sind	bislang,	 aufgrund	der	anatomischen	Gegebenheiten	der	proximalen	
thorakalen	Aorta	und	weiterhin	bestehenden	technischen	Limitationen,	auf	wenige	Fall-
berichte	und	kleine	Fallserien	beschränkt	[28,29].	Demzufolge	ist	die	offene	Chirurgie	
nach	wie	vor	als	der	Goldstandard	für	die	Behandlung	von	Pathologien	der	proximalen	
thorakalen	Aorta	(Aortenbulbus,	Aorta	ascendens	und	Aortenbogen)	zu	sehen	[5,8].
Durch	die	erfolgreiche	Entwicklung	und	klinische	Etablierung	von	aortalen	Stentprothe-
sen,	welche	eine	thorakale	endovaskuläre	Aortenreparatur	(TEVAR)	ermöglichten,	hat	
sich	die	chirurgische	Therapie	im	Bereich	der	Aorta	descendens	in	den	vergangenen	
Jahren	jedoch	maßgeblich	verändert	[2,30].	Die	TEVAR	stellt	heutzutage	die	Standard-
therapie	 bei	 Patienten	mit	 traumatischer	Aortenverletzung	und	 akuter	 komplizierter	
Stanford	Typ	B	Dissektion	dar	[2,31].	Im	Vergleich	zum	offenen	Ersatz	der	Aorta	descen-
dens	wurde	bei	der	TEVAR-Methode	zwar	eine	niedrigere	perioperative	Letalität	und	
Morbidität	nachgewiesen,	 jedoch	birgt	diese	Technik	ein	potentielles	Risiko	 für	mehr	
Langzeitkomplikationen	durch	Verletzung	benachbarter	mediastinaler	Strukturen	 (Ri-
gidität	der	aortalen	Stentprothese)	bei	vergleichbarem	Querschnittsrisiko	(Paraplegie)
[2,32,33]	(Abbildung 3).	
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Abbildung 3:	Computertomographische	Darstellung	einer	gedeckten	Ruptur	der	Aorta	descen-
dens	nach	dorsal	mit	Erosion	des	7.	thorakalen	Wirbelkörpers	(rote	Pfeile)	bei	Materialversagen	
einer	endovaskulären	Stentprothese	(aus	Luehr	M	et	al.	[33]	mit	freundlicher	Genehmigung	von	
Wolters	Kluwer	Health,	Inc.).	
13
2.	 Offene	Eingriffe	am	Aortenbogen
Komplexe	Pathologien	der	thorakalen	Aorta	können	heutzutage	erfolgreich	offen	chir-
urgisch,	endovaskulär	oder	als	Hybridprozeduren	behandelt	werden.	Mitte	des	vergan-
genen	 Jahrhunderts	stellte	die	offene	Aortenbogenchirurgie,	wegen	des	hohen	tech-
nischen	 Aufwands,	 der	 limitierten	 Anwendungsindikationen	 und	 einem	 gesteigerten	
Risiko	für	zerebrale	und	postoperative	Komplikationen,	jedoch	eine	chirurgisch	extrem	
anspruchsvolle	und	für	den	Patienten	sehr	gefährliche	Operation	dar	[34].	Die	Erkennt-
nis,	dass	eine	Erniedrigung	der	Körperkerntemperatur	auf	unter	20°C	zumindest	sehr	
kurze	Phasen	eines	Kreislaufstillstandes	ohne	gravierende	neurologische	Schäden	er-
laubt,	bildete	die	Grundlage	der	modernen	Aortenbogenchirurgie.	Die	klinische	Einfüh-
rung	des	tiefen	hypothermen	Kreislaufstillstands		Mitte	der	1970er	Jahre	(Temperatur-
absenkung	auf	unter	20°C;	Erstbeschreibung	durch	Hans	G.	Borst	bereits	im	Jahr	1964	
in	München	[35])	erlaubte	fortan	routinemäßige	Eingriffe	am	Aortenbogen	mit	relativer	
Sicherheit	für	perioperative	Komplikationen	[22].	
Die	 Einführung	 additiver	 zerebraler	 Perfusionsstrategien	 (retrograd	 vs.	 antegrad)	 in	
Kombination	mit	tiefer	Hypothermie	stellte	die	zweite	grundlegende	Neuerung	in	der	
Entwicklung	hin	zur	modernen	Aortenbogenchirurgie	dar	[23,36].	Insbesondere	durch	
die	Einführung	der	antegraden,	selektiven	zerebralen	Perfusion	(„antegrade	selective	
cerebral	 perfusion“,	 ASCP)	 konnte	eine	erhebliche	Reduzierung	perioperativer	 (zent-
raler)	 neurologischer	 Schäden	 bei	 gleichzeitiger	 Anhebung	 der	 Körperkerntempera-
tur	des	Patienten	erreicht	werden.	In	jüngster	Zeit	wurden	neue	Operationsstrategien	
mit	einer	Kombination	aus	ASCP	(18–22°C)	unter	 lediglich	moderaten	(28–32°C)	Kör-
perkerntemperaturen	 zunehmend	 eingesetzt,	 um	 hypothermie-assoziierte	 Kompli-
kationen	(z.B.	Störungen	der	Gerinnungskaskade)	und	prolongierte	Abkühlungs-	und	
Aufwärmzeiten	 beim	 Einsatz	 extrakorporaler	 Zirkulation	 zu	 vermeiden	 [34].	 Bislang	
existiert	 jedoch	hinsichtlich	des	optimalen	Temperatur-,	Kannülierungs-	und	Perfusi-
onsmanagements	 beim	 Aortenbogenersatz	 kein	 einheitlicher	 Konsens—und	 folglich	
eine	große	Anzahl	von	in	der	Fachliteratur	beschriebenen	Strategien	und	empfohlenen	
chirurgischen	Techniken	[5].	
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Die	 Behandlung	 von	 ausgedehnten	 Aortenbogenaneurysmen,	 insbesondere	mit	 Be-
teiligung	der	Aorta	descendens	und	der	Notwendigkeit	 für	eine	Zweitoperation	über	
eine	linkslaterale	Thorakotomie,	war	in	der	Vergangenheit	einem	sehr	hohen	Risiko	für	
perioperative	Letalität	und	 Ischämie	des	Rückenmarks	mit	potentieller	Querschnitts-
lähmung	(Paraplegie)	assoziiert.	Im	Jahre	1983	wurde	jedoch,	ebenfalls	durch	Borst,	ein	
weiterer	Meilenstein	durch	die	sogenannte	„Elephant	Trunk“-Technik	(ET)	gelegt,	wel-
che	die	distale	Anastomose	beim	Aortenbogenersatz	vereinfachte	und	gleichzeitig	als	
potenzieller	proximaler	Anschluss	(offen)	oder	als	Landezone	(endovaskulär)	für	einen	
Zweiteingriff	zur	Versorgung	der	deszendierenden	Aorta	dient	(Reduktion	der	OP-Dau-
er	bzw.	Vermeidung	einer	offenen	Zweitoperation)	[25].	Die	Einführung	endovaskulä-
rer	Stentprothesen	 in	den	1990er	 Jahren	schaffte	die	 technischen	Voraussetzungen,	
um	die	zweitzeitig	konzipierte	konventionelle	ET-Technik	als	sogenannte	„Frozen	Ele-
phant	Trunk“-Technik	(FET)	zu	einem	einzeitigen	Eingriff	weiter	zu	entwickeln	[26,37].	
Die	heutige	FET-Technik	stellt	ein	Hybridverfahren	zwischen	konventioneller	und	endo-
vaskulärer	Technik	dar	und	erlaubt	somit	die	definitive	Behandlung	von	ausgedehnten	
Aortenbogenpathologien	als	einzeitige	Operation	via	Sternotomie	bei	deutlich	kürzeren	
Kreislaufstillstandszeiten	[37,38]	(Abbildung 4).
Abbildung 4:	Computertomographie	der	thorakalen	Aorta:	Aneurysma	der	Aortenwurzel	und	
der	Aorta	descendens	mit	Beteiligung	des	distalen	Bogens	(a	+	b);	postoperative	Erfolgskontrolle	
(c)	(aus	Luehr	M	et	al.	[37]	mit	freundlicher	Genehmigung	von	Springer-Verlag	Berlin	Heidelberg).
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2.1  Multizentrische Analyse von aktuellen Therapiestrategien und 
Ergebnissen	bei	offenen	Eingriffen	am	Aortenbogen	(Original-
arbeit 6.1)
Hintergrund 
Die	chirurgische	Technik	des	offenen	Aortenbogenersatzes	konnte,	ebenso	wie	das		pe-
rioperative	Management,	 in	den	vergangenen	Jahrzehnten	durch	deutliche	Ergebnis-
verbesserungen,	mit	weniger	perioperativen	Komplikationen	und	höheren	Überlebens-
raten,	kontinuierlich	weiterentwickelt	werden.	Allerdings	 ist	die	chirurgische	Therapie	
des	 Aortenbogens—in	 Ermangelung	 klarer	 chirurgischer	 Leitlinien	 bei	 einer	 Vielzahl	
von	 zur	Verfügung	 stehenden	Behandlungsstrategien	und	Operationstechniken—oft	
zentrumsspezifisch	und	(insbesondere	in	nicht-spezialisierten	Kliniken)	auch	weiterhin	
mit	einer	hohen	perioperativen	Morbidität	und	Letalität	vergesellschaftet	[5,6].	
Die	Anwendung	neuer	Techniken	und	Strategien	für	Aortenbogenoperationen	(einher-
gehend	mit	niedrigeren	perioperativen	Komplikations-	und	Letalitätsraten)	sind	in	der	
Fachliteratur	fast	ausschließlich	von	einzelnen	spezialisierten	Kliniken,	als	sog.	„Single	
Center	Experience“,	beschrieben.	Multi-zentrische	Studienansätze,	welche	als	Basis	für	
Empfehlungen	und	zukünftige	fachübergreifende	Leitlinien	dienen	könnten,	sind	bis-
lang	jedoch	die	Ausnahme	[39].	
Das	 Ziel	 des	 Forschungsprojektes	 war	 die	 retrospektive	 Analyse	 aktueller	 klinischer	
Ergebnisse,	im	Hinblick	auf	angewandte	chirurgische	Techniken	und	Perfusionsstrate-
gien,	nach	elektivem	kompletten	Aortenbogenersatz	an	verschiedenen	Referenzzent-
ren	in	Europa.			
Methodik
Es	erfolgte	eine	retrospektive	Datenauswertung	 im	Zeitraum	2003	bis	2013	aus	den	
folgenden	elf	europäischen	Aortenzentren:	Ludwig-Maximilians-Universität	München,	
Herz-	und	Gefäßklinik	Bad	Neustadt,	S.	Orsola-Malpighi	Krankenhaus	der	Universität	
Bologna	 (Italien),	 Europa	 Krankenhaus	 Rom	 (Italien),	 Humanitas	 Gavazzeni	 Kranken-
haus	Bergamo	(Italien),	Universität	Birmingham	(UK),	Herzzentrum	–	Universität	Leipzig,	
Ruprecht-Karls-Universität	Heidelberg,	Medizinische	Hochschule	Hannover,	Albert-Lud-
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wigs-Universität	Freiburg,	Westdeutsches	Herzzentrum	–	Universität	Duisburg-Essen,	
Johann-Wolfgang-Goethe	Universität	Frankfurt.	
Alle	Aortenbogenoperationen	mit	drei	(total),	zwei	(subtotal)	oder	einer	(partiell)	zirku-
lären	Anastomose	der	hirnversorgenden	Gefäße	(sog.	supraaortale	Abgänge	der	Aorta)	
wurden	eingeschlossen.	Akute	Aortenpathologien	(z.B.	Dissektionen,	iatrogene	Verlet-
zungen,	Traumata,	Notfälle,	etc.)	wurden	ausgeschlossen.	Als	primäre	Endpunkte	wur-
den	30-Tage-	und	Langzeit-Sterblichkeit	(ursachenunabhängig)	sowie	neuaufgetretene	
postoperative	neurologische	Defizite	(innerhalb	von	7	Tagen	oder	nach	prolongierter	
Aufwachphase)	definiert.
Ergebnisse
Insgesamt	konnten	1232	elektive	Aortenbogenoperationen	für	die	multizentrische	Ana-
lyse	 identifiziert	 und	 eingeschlossen	werden.	 Die	 30-Tage-	 und	 Krankenhausletalität	
der	 gesamten	Studienkohorte	betrug	8,8%	bzw.	11,6%.	 Im	Langzeitverlauf	 (mittlerer	
Nachverfolgungszeitraum:	3,3	±	2,9	Jahre;	entsprechend	4020	Patientenjahren)	zeigte	
sich	eine	Gesamtüberlebensrate	nach	5	und	8	Jahren	von	72,0	±	1,5%	und	64,0	±	2,0%	
(Abbildung 5).	
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Abbildung 5:	Kaplan-Meier-Überlebensschätzung	von	Patienten	nach	elektivem	Aortenbogen-
ersatz	mit	95%-Konfidenzintervall	(aus	Urbanski	PP,	Luehr	M,	et	al.	[39]	mit	freundlicher	Geneh-
migung	von	Oxford	University	Press).
Neuaufgetretene	neurologische	Defizite	wurden	als	zerebral	fokal	permanent	/-tempo-
rär,	Paraplegie	(Querschnittslähmung)	oder	als	temporär-postoperatives	Delir	in	5,7%	
(n=70),	3,3%	(n=40),	1,1%	(n=13)	und	7,9%	(97)	der	Fälle	festgestellt.
In	der	anschließenden	multivariaten	Risikofaktoranalyse	(logistische	Regressionsanaly-
se)	konnten	die	Parameter	hohes	Patientenalter	(p<0.001),	die	Anzahl	vorheriger	Herz-
operationen	 (p=0.016)	und	eine	gleichzeitig	 stattfindende	koronare	Bypassoperation	
(p=0.029)	als	unabhängige	Risikofaktoren	für	30-Tage-Sterblichkeit	identifiziert	werden.	
Zusätzlich	wurden	auch	einzelne	Studienzentren—am	ehesten	bei	stark	variierenden	
Patientenzahlen	(eingeschlossene	Patienten	pro	Zentrum	zwischen	17	und	237)—als	
unabhängige	Risikofaktoren	für	elektive	Aortenbogenoperationen	identifiziert.	
Die	angewandten	Kannülierungstechniken	zur	Etablierung	der	extrakorporalen	Zirkula-
tion	(Herz-Lungen-Maschine)	im	Studienzeitraum	variierten	deutlich	hinsichtlich	der	fa-
vorisierten	Lokalisation	zwischen	den	verschiedenen	Kliniken:	A.	axillaris	dextra	(37,7%),	
Aorta	(24,8%),	A.	carotis	dextra/	sinistra	(13,7%),	Trunkus	brachiocephalicus	(12,1%),	A.	
femoralis	(10,6%)	und	andere	Lokalisationen	(1,1%).	Als	Perfusionsstrategie	wurde	vor-
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nehmlich	die	antegrade	Hirnperfusion	(ASCP)	angewendet	(96,7%),	während	der	tiefe	
hypotherme	Kreislaufstillstand	ohne	(6,0%)	oder	mit	retrograder	Hirnperfusion	(0,1%)	
äußerst	 selten	herangezogen	wurde.	Auf	die	 geplante	Risikoanalyse	 von	perfusions-
spezifischen	 Parametern	 der	 selektiven	 Hirnperfusion—u.a.	 Temperatur	 (°C),	 Druck	
(mmHg)	und	Fluss	(ml/min)—hinsichtlich	des	Auftretens	von	postoperativen	neurolo-
gischen	Komplikationen	musste	jedoch	bei	lückenhafter	Datenlage	einzelner	Zentren	
verzichtet	werden.		
  
Diskussion
Diese	multi-zentrische	Analyse	konnte	zeigen,	dass	die	perioperative	Letalität	und	Mor-
bidität	bei	offenen	Eingriffen	am	Aortenbogen	zwar	 im	Vergleich	zu	den	Ergebnissen	
aus	den	vergangenen	Jahrzehnten	(tiefer	Kreislaufstillstand	ohne	Hirnperfusion)	heut-
zutage	deutlich	niedriger	liegt,	jedoch	mit	über	10%	weiterhin	als		substanziell	zu	be-
zeichnen	ist.	Die	perioperative	Letaliät	ist	insbesondere	bei	älteren,	bereits	voroperier-
ten	Patienten	oder	bei	notwendigen	Kombinationseingriffen	 (z.B.	Aortenbogenersatz	
mit	notwendiger	Bypassoperation)	erhöht.	Ebenso	sind	temporäre	oder	permanente	
neurologische	Defizite	durch	die	notwendige	Manipulation	an	den	hirnversorgenden	
Gefäßen	(Anastomosierung,	Kreislaufstillstand,	selektive	Perfusion,	etc.)	nicht	unwahr-
scheinlich,	wenngleich	auch	hier	das	Risiko	im	Vergleich	zu	früheren	Ergebnissen	ins-
gesamt	weiter	gesunken	ist.
Im	Gegensatz	zu	den	in	der	Studienkohorte	sehr	unterschiedlich	angewendeten	Kan-
nülierungstechniken	für	den	elektiven	Aortenbogenersatz,	konnte	bei	den	intraoperati-
ven	Perfusionsstrategien	zur	zerebralen	Protektion	ein	eindeutiger	Paradigmenwechsel	
hin	zur	antegraden	Hirnperfusion	(96,7%;	ASCP)	registriert	werden,	während	der	tiefe	
hypotherme	Kreislaufstillstand	ohne	(6,0%)	oder	mit	retrograder	Hirnperfusion	(0,1%)	
bei	den	teilnehmenden	Studienzentren	seinen	Stellenwert	weitestgehend	verloren	hat.
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2.2  Aortale Ereignisse und Reoperationen nach elektivem Aorten-
bogenersatz: Inzidenz, chirurgische Strategien und Ergebnisse 
	 (Originalarbeit	6.2)
Hintergrund
Offene	 elektive	 Eingriffe	 am	Aortenbogen	werden	 seit	 Jahrzehnten	 routinemäßig	 an	
spezialisierten	 Zentren	weltweit	mit	 guten	 Ergebnissen	durchgeführt,	wobei	 heutzu-
tage—insbesondere	 bei	 ausgedehnten	 Aortenbogenpathologien—zunehmend	 Hyb-
ridverfahren	 (z.B.	 FET-Technik)	 zum	Einsatz	 kommen.	Nach	 stattgehabtem	elektivem	
Aortenbogenersatz	bleibt	 jedoch	oftmals	 ungeklärt,	 ob	die	 Primäroperation	den	Pa-
tienten	tatsächlich	geheilt	hat,	oder	ob	es	im	postoperativen	Kurz-	und	Langzeitverlauf	
im	Bereich	des	Aortenersatzes	oder	den	angrenzenden	Aortensegmenten	verstärkt	zu	
neuen	Pathologien	oder	Komplikationen	(sog.	„aortale	Ereignisse“)	mit	der	Notwendig-
keit	zur	Re-Operation	kommt.
Das	Ziel	der	Studie	war	die	 retrospektive	Analyse	 im	Kurz-	und	Langzeitverlauf	nach	
elektivem	komplettem	Aortenbogenersatz	hinsichtlich	der	Inzidenz	neuer	aortaler	Er-
eignisse	(mit	oder	ohne	Re-Operationsindikation)	und	postoperativer	Ergebnisse	nach	
Sekundäreingriff.			
Methoden
Die	bereits	bestehende	Datenbank	mit	1232	elektiven	Aortenbogenoperationen	von	elf	
europäischen	Aortenzentren	(s. Kapitel 2.1)	wurde	für	die	Datenauswertung	herange-
zogen	[39].	Retrospektiv	wurden	alle	Patienten	mit	einem	aortalen	Ereignis	im	Kurz-	bis	
Langzeitverlauf	nach	elektivem	Aortenbogenersatz	eingeschlossen.	Es	erfolgte	eine	de-
skriptive	Analyse	zur	Bestimmung	der	Inzidenz	von	aortalen	Ereignissen,	notwendigen	
Re-Operationen,	angewandten	OP-Techniken	und	potentiellen	Risikofaktoren	für	Kran-
kenhausmortalität	bei	Sekundäreingriff.	Die	Patienten	ohne	aortales	Ereignis	wurden	
ausgeschlossen.
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Ergebnisse
Insgesamt	konnten	155	Patienten	(mittleres	Alter	64,9	Jahre;	66,5%	Männer)	mit	einem	
aortalen	Ereignis	nach	elektivem	Aortenbogenersatz	identifiziert	werden.	Das	mittlere	
Intervall	von	Primäroperation	zu	aortalem	Ereignis	betrug	11,3	Monate	(IQR:	4,2	-	38,4).	
Am	häufigsten	war	die	Aorta	descendens	(79,4%)	betroffen,	gefolgt	von	Aorta	abdomi-
nalis	(10,3%)	und	Aorta	ascendens/	Bogen	(9,0%).	
Re-Operationen	wurden	bei	insgesamt	133	Patienten	(85,8%),	entweder	offen	(43,6%)	
oder	endovaskulär	(56,4%),	durchgeführt.	In	den	verbliebenen	22	Fällen	bestand	ent-
weder	eine	Kontraindikation	 für	einen	Sekundäreingriff	oder	die	Operation/Interven-
tion	konnte	nicht	rechtzeitig	durchgeführt	werden.	
Insgesamt	 lag	 die	 Krankenhaus-	 und	 die	 Langzeitletalität	 nach	 Re-Operation	 an	 der	
Aorta	bei	17,3%	bzw.	8,3%.	Nach	einem,	drei	und	fünf	Jahren	lagen	die	Überlebensraten	
bei	81,2%,	79,0%	und	76,7%	(Abbildung 6).	Postoperative	permanente	neurologische	
Komplikationen	traten	als	Paraplegie	und	Schlaganfall	in	jeweils	6,0%	und	1,5%	der	Fälle	
auf. 
Abbildung 6: Kaplan-Meier-Überlebensschätzung:	Re-Operation	nach	stattgehabtem	primären	
Aortenbogenersatz	inkl.	95%-Konfidenzintervall	(aus	Luehr	M,	et	al.	[40]	mit	freundlicher	Geneh-
migung	von	Oxford	University	Press).
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In	der	multivariaten	Analyse	konnte	einzig	das	Alter	der	operierten	Patienten	als	un-
abhängiger	Risikofaktor	 identifiziert	werden	 (p=0,008;	95%-CI:	1,005	 -	1,176).	Die	Ka-
plan-Meier-Überlebensschätzung	 lieferte	 keinen	 statistisch	 signifikanten	Unterschied	
zwischen	 offen	 operierten	 Patienten	 hinsichtlich	 der	 Lokalisation	 (Aorta	 ascendens/	
Bogen	vs.	A.	descendens;	p=0,613)	(Abbildung 7).	
Abbildung 7:	 Kaplan-Meier-Überlebensschätzung:	Offene	 Re-Operation	 nach	 stattgehabtem	
primären	Aortenbogenersatz	im	Bereich	der	Aorta	ascendens/	Bogen	vs.	Aorta	descendens	mit	
95%-Konfidenzintervall	(aus	Luehr	M,	et	al.	[40]	mit	freundlicher	Genehmigung	von	Oxford	Uni-
versity	Press).
Auch	der	direkte	Vergleich	von	offener	und	endovaskulärer	Therapie	 im	Bereich	der	
Aorta	descendens	lieferte	keinen	statistisch	signifikanten	Überlebensvorteil	für	die	en-
dovaskuläre	Therapie	(p=0,059)	(Abbildung 8).
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Abbildung 8: Kaplan-Meier-Überlebensschätzung:	Offene	vs.	endovaskuläre	Re-Operation	nach	
stattgehabtem	primären	Aortenbogenersatz	 im	Bereich	der	Aorta	descendens	mit	95%-Kon-
fidenzintervall	 (aus	Luehr	M,	et	al.	 [40]	mit	 freundlicher	Genehmigung	von	Oxford	University	
Press).
Diskussion
Aus	 der	 Studienkohorte	 von	 1232	 elektiven	 Aortenbogenoperationen	 entwickelten	
insgesamt	12,6%	ein	aortales	Ereignis	 im	Zeitraum	2003	bis	2013.	 Im	voroperierten	
Bereich	des	 	Primäreingriffs	 (Aorta	ascendens/	Aortenbogen)	waren	Re-Operationen	
jedoch	in	nur	0,7%	der	Fälle	notwendig.	Dieses	Ergebnis	bestätigt	den	elektiven	konven-
tionellen	Aortenbogenersatz	weiterhin	als	Goldstandard,	 insbesondere	da	die	Mehr-
zahl	der	neuen	aortalen	Ereignisse	in	den	unbehandelten	distalen	Aortenabschnitten	
(Aorta	 descendens	 und	 abdominalis)	 auftraten.	 Bei	 den	 endovaskulären	 Sekundär-
eingriffen	 im	Bereich	der	Aorta	descendens	zeichnete	sich	ein	Trend—hin	zu	einem	
früh-postoperativen	Überlebensvorteil	 (p=0,059)—ab,	so	dass	die	Vorbereitung	einer	
TEVAR-Landungszone	im	Rahmen	des	offenen	Primäreingriffs	am	Aortenbogen,	im	Sin-
ne	eines	ET	oder	FET,	gerechtfertigt	erscheint.	
Trotz	der	insgesamt	niedrigen	Anzahl	von	aortalen	Ereignissen	sollten	Patienten,	nach	
stattgehabter	Aortenbogenchirurgie,	idealerweise	an	eine	Aortensprechstunde	mit	re-
gelmäßigen	Verlaufskontrollen	der	gesamten	Aorta	angebunden	werden.
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2.3  Extra-anatomische Revaskularisation bei distalem Verschluss 
der Arteria carotis und resultierender zerebraler Malperfusion 
bei	der	akuten	Typ	A	Dissektion	(Originalarbeit	6.3)
Hintergrund
Im	 Rahmen	 der	 akuten	 Typ	 A	 Dissektion	 kann	 es	 (entsprechend	 der	 Ausdehnung)	
durch	 eine	 Verlegung	 (falsches	 Lumen)	 bzw.	 Involvierung	 von	 aortalen	Gefäßabgän-
gen	(periphere	Dissektion)	zu	einer	Malperfusion	mit	 Ischämie	von	nachgeschalteten	
Organsystemen	kommen	[41].	Eine	Beteiligung	der	supraaortalen	Äste	(Trunkus	brachi-
ocephalicus,	A.	carotis	communis	links	und	A.	subclavia	links)	wird	aufgrund	des	poten-
tiellen	Schlaganfallrisikos	als	besonders	kritisch	bewertet	und	in	der	Literatur	mit	einer	
variablen	Inzidenz	von	5	bis	43%	der	Fälle	beschrieben	[42].	Das	Risiko	ist	insbesondere	
bei	präoperativ	bereits	nachgewiesenen	(hämorrhagischen)	Schlaganfällen	oder	koma-
tösen	Patienten	mit	unklarem	neurologischen	Status	erhöht	[43,44]	(Abbildung 9).
Primäres	Ziel	der	offenen	Operation	 ist	die	schnellstmögliche	Wiederherstellung	des	
Blutflusses	durch	den	Ersatz	der	disseziierten	thorakalen	Aorta	mit	Anschluss	des	rich-
tigen	Gefäßlumens	(sog.	„wahres	Lumen“).	Die	Erfolgsaussichten	für	die	Wiederherstel-
lung	 einer	 vollständigen	 zerebralen	 Durchblutung	 können	 jedoch	 bei	 langstreckiger	
Dissektion	mit	 distaler	 Verlegung	der	Carotiden,	 z.B.	 durch	Kollaps	des	 falschen	 Lu-
mens	mit	oder	ohne	Thrombusbildung,	limitiert	oder	schlichtweg	nicht	mehr	gegeben	
sein.	 In	Einzelfällen	wurde	hier	die	Möglichkeit	einer	Revaskularisierung	mittels	eines	
uni-	 oder	 bilateralen	 extra-anatomischen	Bypasses—u.a.	 zur	 Frühzeitigen	 Initiierung	
der	selektiven	antegraden	Hirnperfusion—beschrieben	[45–47].		
Das	Ziel	dieser	retrospektiven	Untersuchung	war	die	Identifikation	und	deskriptive	Ana-
lyse	der	postoperativen	Ergebnisse	von	Patienten	mit	akuter	Typ	A	Dissektion	und	einer	
präoperativen	Okklusion	der	linken	und/oder	rechten	A.	carotis	communis,	welche	zu-
sätzlich	mittels	extra-anatomischem	Bypass	behandelt	wurden.
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Abbildung 9:	Präoperatives	CT:	Dissektion	aller	drei	supraaortalen	Äste	(A),	Malperfusion	des	
Tr.	brachiocephalicus	und	Dissektion	der	linken	A.	carotis	communis	(B),	präoperativer	Schlag-
anfall	(C)	und	postoperative	links-zerebrale	Einblutung	im	präoperativen	Ischämiegebiet	(D)	(aus	
Luehr	M,	et	al.	[48]	mit	freundlicher	Genehmigung	von	Oxford	University	Press).
Methodik
Im	Zeitraum	2005	bis	2013	wurden	insgesamt	354	Patienten	mit	akuter	Typ	A	Dissek-
tion	am	Herzzentrum	Leipzig	–	Universität	Leipzig	operiert.	Ausschließlich	Patienten	mit	
einer	präoperativen	Okklusion	der	linken	oder	rechten	A.	carotis	communis	und	nach-
gewiesener	zerebraler	Malperfusion	(Klinik	und	Bildgebung)	wurden	in	die	Analyse	mit	
eingeschlossen	 (Abbildung 10).	 Die	 perioperativen	Daten	der	 eingeschlossenen	Pa-
tienten	wurden	retrospektiv	aus	den	Krankenakten	und	OP-Berichten	zusammengetra-
gen	und	anschließend	ausgewertet.	Für	die	Überlebensschätzung	nach	Kaplan-Meier	
wurde	ein	aktuelles	Follow-up	durchgeführt.	Patienten	mit	einer	Dissektion	der	supra-
aortalen	Äste	ohne	Carotisokklusion	wurden	ausgeschlossen.
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Abbildung 10:	Präoperative	Computertomographie	(CT):	Verschluss	der	rechten	A.	carotis	com-
munis	auf	Höhe	der	Bifurkation	und	retrograder	Füllung	(A),	kompletter	Kollaps	des	wahren	Lu-
mens	bei	unilateraler	(B	and	C)	und	bilateraler	Okklusion	der	A.	carotis	communis	(D)	(aus	Luehr	
M,	et	al.	[48]	mit	freundlicher	Genehmigung	von	Oxford	University	Press).
Ergebnisse
Insgesamt	 konnten	 23	 Hochrisiko-Patienten	 (Inzidenz:	 6,5%	 von	 354	 Patienten)	 mit	
einer	distalen	Okklusion	der	A.	carotis	communis	 links	 (n=11)	oder	rechts	 (n=13)	bei	
Typ	A	Dissektion	identifiziert	und	analysiert	werden	(mittleres	Alter	66,3	Jahre;	78,3%	
männlich).	Ein	Patient	wurde	präoperativ	mit	einem	bilateralen	Verschluss	der	A.	carotis	
communis	aufgenommen.	
Drei	Patienten	mit	ausgeprägtem	präoperativen	Schlaganfall	entwickelten	postopera-
tiv	eine	intrazerebrale	Blutung	(n=2)	bzw.	ein	Multi-Organ-Versagen	(n=1).	Die	resultie-
rende	Krankenhausletalität	betrug	13,0%.	Nach	einem	mittleren	postoperativen	Zeit-
raum	von	15,2	Monaten	(IQR:	4,8–34,1)	lag	die	Überlebensrate	der	Studiengruppe	bei	
69,6%.	Im	Vergleich	zu	Patienten	ohne	Carotisokklusion,	die	im	selben	Zeitraum	wegen	
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einer	akuten	Typ	A	Dissektion	am	Herzzentrum	Leipzig	operiert	wurden	(Überlebens-
rate	72,5%),	zeigte	die	Kaplan-Meier-Überlebensschätzung—nach	Entlassung	aus	dem	
Krankenhaus—über	einen	Zeitraum	von	36	Monaten	 keinen	 statistisch	 signifikanten	
Unterschied	(p=0,90)	(Abbildung 11).	
Die	 registrierte	 postoperative	 Schlaganfallrate	 in	 der	 Studienkohorte	 betrug	 34,8%.	
Neue	permanente	bzw.	fatale	neurologische	Komplikationen	traten	in	26,1%	(n=6)	der	
Fälle	 auf,	 wohin	 gegen	 sich	 acht	 Patienten	 (34,8%)	 von	 neuaufgetretenen,	 temporä-
ren	 neurologischen	Defiziten	 im	 postoperativen	 Verlauf	 vollständig	 erholten.	 In	 den	
verbleibenden	neun	Fällen	(39,1%)	wurden	bei	unauffälligem	Verlauf	keine	relevanten	
neurologischen	Komplikationen	registriert.	Die	Intensivstations-	und	Krankenhausver-
weildauer	lag	im	Mittel	bei	7	(IQR:	2,0–16,5)	bzw.	16	(12,5–26,0)	Tagen.
Abbildung 11: Kaplan-Meier-Überlebensschätzung	bei	Patienten	mit	Typ	A	Dissektion	 (intra-
operativ	verstorbene	Fälle	ausgeschlossen):	präoperative	Carotisokklusion	(Gruppe	1)	vs.	keine	
Carotisokklusion	(Gruppe	2)	(aus	Luehr	M,	et	al.	[48]	mit	freundlicher	Genehmigung	von	Oxford	
University	Press).
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Diskussion
Patienten	mit	Carotisokklusion	und	einer	präoperativen	zerebralen	Malperfusion	bei	
akuter	Typ	A	Dissektion	stellen	eine	Hochrisikogruppe	mit	deutlich	erhöhter	Kranken-
hausletalität	 (14,6%	bis	 30,5%)	 dar	 und	haben	postoperativ,	 im	Vergleich	 zu	 Patien-
ten	ohne	Endorganischämie,	eine	signifikant	erhöhte	Langzeitsterblichkeit	[41,49,50].	
Dennoch	konnte	in	der	Studie	gezeigt	werden,	dass	eine	frühzeitige	offene	Operation	
mit	einem	extra-anatomischen	Bypass	(zur	schnellen	Wiederherstellung	der	zerebra-
len	Perfusion	über	die	Herz-Lungen-Maschine)	im	Vergleich	mit	Patienten	ohne	dista-
le	 Carotisokklusion	nicht	 zwangsläufig	mit	 einer	 signifikant	 erhöhten	Verlaufsletalität	
einhergeht.	Vielmehr	ist	davon	auszugehen,	dass	in	der	untersuchten	Patientengrup-
pe—ohne	die	angewandte	OP-Technik—ein	zusätzlicher	Anstieg	der	Krankenhaus-	und	
Verlaufsletalität	sowie	eine	signifikant	höhere	Rate	von	permanenten	und	fatalen	neu-
rologischen	Komplikationen	aufgetreten	wäre.	
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2.4  Schlussfolgerungen
	 1)		 	Bei	elektiven	offenen	Eingriffen	am	Aortenbogen	ist	die	perioperative	Leta-
lität	und	Morbidität	mit	über	10%	weiterhin	als	substanziell	zu	bezeichnen	
und,	insbesondere	bei	älteren,	bereits	voroperierten	Patienten	oder	Kom-
binationseingriffen,	signifikant	erhöht.
	 2)	 	In	den	vergangenen	Jahren	hat	ein	Paradigmenwechsel	hinsichtlich	der	ze-
rebralen	Protektion	hin	zur	antegraden	Hirnperfusion	stattgefunden.	Der	
tiefe	hypotherme	Kreislaufstillstand	und	die	retrograde	Hirnperfusion	ha-
ben	ihren	Stellenwert	in	Europa	weitestgehend	verloren.
	 3)	 	Nach	 stattgehabtem	 elektivem	 Aortenbogenersatz	 liegt	 die	 Inzidenz	 von	
Re-Operationen	 im	Bereich	 der	 Primäroperation	 bei	 unter	 1%	der	 Fälle.	
Dieses	Ergebnis	bestätigt	den	konventionellen	Aortenbogenersatz	weiter-
hin	als	Goldstandard.
	 4)	 	Im	postoperativen	Verlauf	nach	elektivem	Aortenbogenersatz	ist	die	Aorta	
descendens	am	häufigsten	von	aortalen	Ereignissen	und	Re-Operationen	
betroffen.	 Insbesondere	 bei	 ausgedehnten	 Aneurysmen	 des	 Aortenbo-
gens	mit	Beteiligung	der	Aorta	descendens	sollte	deshalb	eine	Landungs-
zone	zur	endovaskulären	Weiterbehandlung,	im	Sinne	eines	ET	oder	FET,	in	
Erwägung	gezogen	werden.
	 5)	 	Patienten	mit	 akuter	 Typ	A	Dissektion	und	 zerebraler	Malperfusion	 stel-
len	eine	Hochrisikogruppe	mit	erhöhter	Letalität	und	Morbidität	dar.	Die	
konsequente	Behandlung	der	distalen	Carotisokklusion	mittels	extra-ana-
tomischem	 Bypass,	 zur	 frühzeitigen	 Wiederherstellung	 der	 antegraden	
zerebralen	Perfusion,	 ist	mit	akzeptablen	postoperativen	Ergebnissen	bei	
vergleichbaren	Überlebensraten	im	mittelfristigen	Verlauf	assoziiert.
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3.	 	Endovaskuläre	Eingriffe	im	distalen	Aortenbogen	
und in der Aorta descendens
Die	endovaskuläre	Chirurgie	mittels	Stentgraftprothese	 (TEVAR)	 stellt	heutzutage	die	
Therapie	der	Wahl	bei	den	meisten	Pathologien	der	Aorta	descendens	dar	[2,30].	Eine	
offene	Operation	kommt	dementsprechend	nur	bei	Patienten	in	Frage,	die	für	einen	
TEVAR-Eingriff	 aus	 sonstigen	 Gründen	 nicht	 geeignet	 sind.	 Dies	 kann	 insbesondere	
dann	der	Fall	sein,	wenn	die	anatomischen	Gegebenheiten	das	Einbringen	der	endo-
vaskulären	Stentprothese	erschweren	oder	verhindern	(Atherosklerose,	starkes	Abkni-
cken	der	Aorta,	),	die	aortale	Grunderkrankung	infektiösen	Ursprungs	ist	(z.B.	Aortitis,	
aorto-ösophageale	Fistel,	etc.)	oder	eine	Verankerung	des	proximalen	Prothesenanteils	
in	Ermangelung	einer	ausreichenden	Landungszone	von	mindestens	zwei	Zentimetern	
(z.B.	bei	aneurysmatischer	Erweiterung)	schlichtweg	nicht	möglich	ist	[30,51].
Im	letzten	Fall	kann	jedoch	eine	Verlagerung	der	proximalen	Landezone	bis	in	den	dis-
talen	Aortenbogen	(sog.	Ishimaru	Landungszonen	2	und	3)	durchgeführt	werden,	um	
einen	TEVAR-Eingriff	trotzdem	noch	zu	ermöglichen	[52,53]	(Abbildung 12).	
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Abbildung 12: Modifizierte	Ishimaru	Landezonen	(LZ)	im	Bereich	der	thorakalen	(LZ	0-5)	und	
abdominalen	(LZ	6-9)	Aorta	(aus	Czerny	et	al.	[52]	mit	freundlicher	Genehmigung	von	Oxford	
University	Press).
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3.1  Inzidenz von neurologischen Komplikationen nach endo- 
vaskulärem	Verschluss	 der	 linken	 Arteria	 subclavia	 (Original-
arbeit 6.4)
Hintergrund
Eine	Verlagerung	der	TEVAR-Landezone	bis	in	den	Aortenbogen	(Landezone	2	und	3,	
Abbildung 12)	erlaubt	auch	eine	endovaskuläre	Behandlung	von	sehr	proximal	gele-
genen	Pathologien	der	Aorta	descendens	[30].	Diese	Behandlungsmethode	ist	jedoch	
oftmals	 nur	 unter	 Inkaufnahme	 einer	 partiellen	 oder	 vollständigen	 Verlegung	 (sog.	
Überstenten)	der	linken	A.	subklavia	(LSA;	Landezone	2)	möglich,	wobei	das	Risiko	für	
zentrale	neurologischen	Komplikationen	durch	eine	Minderperfusion	der	 linken	obe-
ren	Extremität	mit	einem	Subclavian-Steal-Syndrom	(SSS)	erhöht	zu	sein	scheint	[54].	
Das	Ziel	dieser	frühen	Studie	war	die	deskriptive	Analyse	der	postoperativen	Früh-	und	
Spätergebnisse	hinsichtlich	des	Auftretens	neurologischer	Komplikationen	nach	TEVAR	
mit	partieller	oder	vollständiger	Überstentung	der	LSA.		
Methodik
Im	Zeitraum	Dezember	2001	bis	März	2006	wurden	265	Patienten	mit	TEVAR	an	der	
Albert-Ludwigs-Universität	Freiburg	 i.	Br.	behandelt.	 Insgesamt	konnten	20	Patienten	
(10	Männer,	10	Frauen;	mittleres	Alter:	64.3±12.2	Jahre)	in	die	Studie	eingeschlossen	
werden:	bei	14	Patienten	erfolgte	eine	vollständige	und	 in	6	Patienten	eine	partielle	
Überstentung	der	LSA.	
Die	 primären	 Endpunkte	der	 Studie	waren	das	postoperative	Auftreten	 von	 klinisch	
relevanten	 zentralen	 und	 peripheren	 neurologischen	 Komplikationen	 im	 Früh-	 und	
Langzeitverlauf	sowie	der	positive	Nachweis	eines	SSS	 (Grad	 I-III).	Alle	überlebenden	
Patienten	wurden	postoperativ	 in	 regelmäßigen	Abständen	 (3,	6	und	12	Monate)	ei-
ner	 diagnostischen	 (CT/	MRT)	 sowie	 neurologischen	 Verlaufsuntersuchung	 (inkl.	 Ge-
fäß-Doppler-Untersuchung)	 zugeführt.	Anschließend	erfolgte	die	Auswertung	der	kli-
nischen	Daten.
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Ergebnisse
Alle	Patienten	konnten	erfolgreich	mittels	TEVAR	behandelt	werden.	Das	Follow-up	be-
trug	100%.	Zwei	Patienten	verstarben	 im	Verlauf	 (nicht	OP-assoziiert).	Neue	zentrale	
neurologische	Ereignisse	traten	verspätet	in	zwei	Patienten	(10%)	mit	kompletter	Über-
stentung	der	LSA	auf:	Hirnstamminfarkt	(n=1)	und	transitorische	Ischämische	Attacke	
(TIA)	mit	beidseitiger	Visusminderung	(n=1).	Bei	10	der	14	Patienten	(71%)	mit	vollstän-
diger	Überstentung	der	LSA	wurde	ein	SSS	im	Verlauf	festgestellt:	Grad	I	(n=1),	Grad	II	
(n=2)	und	Grad	III	(n=7).	Fünf	Patienten	mit	vollständiger	Überstentung	der	LSA	und	SSS	
Grad	III	(36%)	entwickelten	periphere	neurologische	Komplikationen	im	Sinne	von	sen-
sorischen	und/oder	motorischen	Defiziten	der	linken	oberen	Extermität.	Mit	Ausnahme	
eines	Patienten,	welcher	mittels	Bypass	zur	LSA	(Ausgehend	von	der	linken	A.	carotis	
communis)	im	Verlauf	behandelt	werden	musste,	waren	diese	Symptome	jedoch	rück-
läufig.	In	den	sechs	Patienten	mit	partieller	Überstentung	der	LSA	wurden	keine	rele-
vanten	neurologischen	Komplikationen	bzw.	ein	SSS	festgestellt.	
Diskussion
Eine	Erweiterung	der	Landungszone	bis	in	den	Aortenbogen	mit	partieller	oder	kom-
pletter	Überstentung	der	LSA	erlaubt	eine	Behandlung	mittels	TEVAR	bei	Hochrisiko-
patienten	mit	Pathologien	der	proximalen	Aorta	descendens	und	des	distalen	Aorten-
bogens.	 Im	Gegensatz	 zur	 partiellen	Überstentung	 der	 LSA	muss	 jedoch	 bei	 einem	
vollständigen	LSA-Verschluss	mit	Durchblutungsstörungen	der	oberen	linken	Extremi-
tät	 (SSS)	 und	 potentiellen	 neurologischen	 Komplikationen—insbesondere	 bei	 einem	
SSS	Grad	III—gerechnet	werden.	Dementsprechend	sollte	präoperativ	bei	TEVAR	mit	
geplanter	LSA-Überstentung	möglichst	immer	eine	bildgebende	Diagnostik	der	supra-
aortalen	und	 zerebralen	Gefäßanatomie	durchgeführt	werden,	 um	anatomische	Va-
riationen	(z.B.	Stenosen/	Unterbrechungen	im	Circulus	arteriosus	cerebri)	oder	supra-
aortale	Gefäßpathologien	 (z.B.	Hypoplasie/	Stenose	der	A.	vertebralis	rechts),	welche	
eine	vorherige	Revaskularisierung	der	LSA	mittels	Bypass	bzw.	Transposition	erfordern,	
sicher	auszuschließen.
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3.2  Postoperative Ergebnisse nach endovaskulärer Stentgraft-The-
rapie der Aorta mit komplettem Verschluss der linken Arteria 
subclavia	(Originalarbeit	6.5)
Hintergrund 
Die	komplette	Überstentung	der	LSA	mittels	TEVAR	ermöglicht	bekanntermaßen	die	
Behandlung	von	Patienten	mit	ausgedehnten	Aortenpathologien	der	proximalen	Aorta	
descendens	bis	in	den	distalen	Aortenbogen	hinein.	Allerdings	birgt	dieses	Therapie-
konzept	ein	nicht	zu	unterschätzendes	Risiko	für	das	Auftreten	von	perioperativen	neu-
rologischen	Komplikationen	[30,55,56].	Eine	prophylaktische	Revaskularisation	der	LSA	
bei	elektiven	Fällen,	wie	von	einigen	Klinikern	gefordert,	ist	jedoch	nicht	ohne	Risiko	und	
wird	in	der	Literatur	mit	einer	postoperativen	Sterblichkeit	von	1,2%	bis	5%	beschrie-
ben	 [57–59].	 Aus	 diesem	 Grund	 befürworten	 einige	 Chirurgen	 die	 prophylaktische	
LSA-Revaskularisation	nur	 in	Ausnahmefällen	mit	 nachweislich	 erhöhtem	Risikoprofil	
des	Patienten	(atypische/	pathologische	supraaortale	Gefäßanatomie,	Ausdehnung	der	
Aortenpathologie,	etc.)	[60,61].	Die	bislang	veröffentlichten	Studien	einzelner	Zentren	
zu	diesem	Thema	sind	jedoch	widersprüchlich,	so	dass	ein	gemeinsamer	Konsens	in-
nerhalb	 der	 wissenschaftlichen	 Fachgesellschaften	 hinsichtlich	 der	 prophylaktischen	
Revaskularisation	der	LSA	weiterhin	aussteht.	
Das	Ziel	der	vorliegenden	multi-zentrischen	Studie	war	die	statistische	Analyse	aktueller	
Patientendaten	und	chirurgischer	Ergebnisse	nach	TEVAR	mit	kompletter	Überstentung	
der	LSA,	mit	besonderem	Fokus	auf	den	Einfluss	der	prophylaktischen	LSA-Revasku-
larisation,	zur	Identifikation	möglicher	perioperativer	Risikofaktoren	für	neurologische	
Komplikationen.
Methodik 
Es	erfolgte	eine	retrospektive	Datenauswertung	an	der	Ludwig-Maximilians-Universität	
München,	der	Albert-Ludwigs-Universität	Freiburg	i.	Br.	und	am	Herzentrum	Leipzig	–	
Universität	Leipzig.	Einschlusskriterien	waren	alle	konsekutiv	behandelten	Patienten	mit	
einem	kompletten	Verschluss	der	LSA	mittels	TEVAR	(Landezone	2;	Abbildung 12)	im	
Zeitraum	2001	bis	2016.	Patienten	mit	einer	partiellen	Überstentung	der	LSA	(Landezo-
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ne	2)	oder	mit	Landungszonen	0,	1	und	3	wurden	ausgeschlossen.	Für	die	statistische	
Auswertung	wurden	vorab	zwei	Gruppen	definiert:	„LSA-Revaskularisation“	(Gruppe	1)	
und	„Keine	LSA-Revaskularisation“	(Gruppe	2).	
Neben	der	Krankenhausletalität	wurde	das	einzelne	oder	kombinierte	Auftreten	von	
prozedurspezifischen	 Komplikationen	 nach	 TEVAR	 mit	 LSA-Verschluss	 als	 primärer	
Endpunkt	 festgelegt:	 	 (1)	 linksseitiger	 Schlaganfall,	 (2)	 permanente	 Querschnittsläh-
mung	sowie	(3)	klinisch-relevante	Malperfusion	der	linken	oberen	Extremität.
Ergebnisse 
An	den	drei	Studienzentren	konnten	zwischen	den	Jahren	2001	und	2016	insgesamt	
176	Patienten	(mittleres	Alter:	61,3	Jahre)	in	die	Studie	eingeschlossen	werden.	In	55	
(31,3%)	Fällen	erfolgte	eine	Revaskularisation	mittels	LSA-Bypass	bzw.	 -Transposition	
vor	der	TEVAR-Prozedur	(Gruppe	1),	während	bei	den	verbliebenen	121	(68,7%)	Patien-
ten	die	LSA	ohne	Revaskularisation	komplett	überstentet	wurde	(Gruppe	2).
Die	Krankenhausletalität	 für	die	gesamte	Studienkohorte	 lag	bei	8,5%	 (einschließlich	
Notfalleingriffen)	und	war	zwischen	beiden	Gruppen	nicht	signifikant	unterschiedlich	
(p=0,779).	In	elektiven	Fällen	lag	die	postoperative	Letalität	bei	4,5%.	In	der	Kaplan-Mei-
er-Überlebensschätzung	über	einen	postoperativen	Zeitraum	von	sieben	Jahren	zeigte	
sich	ebenfalls	kein	statistisch	signifikanter	Unterschied	zwischen	beiden	Studiengrup-
pen	(p=0,570;	Abbildung 13).
Postoperativ	lag	die	Schlaganfall-	und	Paraplegierate	für	alle	Studienpatienten	bei	ins-
gesamt	 6,8%	 bzw.	 6,3%,	 ohne	 signifikante	Unterschiede	 zwischen	 revaskularisierten	
(Gruppe	1)	und	nicht-revaskularisierten	(Gruppe	2)	Patienten.	Im	Gegensatz	dazu	traten	
Malperfusionen	der	linken	oberen	Extremität	mit	einer	Inzidenz	von	9,9%	ausschließ-
lich	in	Gruppe	2	auf	(p=0,018).	In	diesen	Patienten	mit	klinisch-relevanter	Malperfusion	
wurde	zudem	eine	vierfach	häufigere	Inzidenz	von	Schlaganfällen	der	linken	Hemisphä-
re	festgestellt	(16,7%	vs.	3,7%;	p=0,095).	
In	der	multivariaten	Analyse	konnten	die	Nicht-Revaskularisation	der	LSA	 (OR:	3,779;	
95%-CI:	1,096	 -	13,029;	p=0,035),	die	Platzierung	von	mehr	als	 zwei	endovaskulären	
Stentprothesen	 (OR:	 3,814;	 95%-CI:	 1,557	 -	 9,343;	p=0,003)	 und	das	Vorhandensein	
einer	koronaren	Herzerkrankung	(OR:	3,276;	95%-CI:	1,262	-	8,507;	p=0,015)	als	unab-
35
hängige	Risikofaktoren	für	eine	prozedurspezifische	Komplikation	(linksseitiger	Schlag-
anfall,	permanente	Querschnittslähmung	oder	klinisch-relevante	Malperfusion	der	lin-
ken	oberen	Extremität)	identifiziert	werden.	
Abbildung 13:	Kaplan-Meier-Überlebensschätzung	von	Patienten	nach	TEVAR	mit	(blaue	Linie)	
oder	ohne	(rote	Linie)	prophylaktische	LSA-Revaskularisation	 inkl.	95%-Konfidenzintervall	 (aus	
Luehr	M,	et	al.	[62]	mit	freundlicher	Genehmigung	von	Elsevier).
Diskussion 
In	dieser	multi-zentrischen	Studie	konnte	erfolgreich	gezeigt	werden,	dass	eine	pro-
phylaktische	Revaskularisation	der	LSA	(im	Vergleich	zur	Nicht-Revaskularisation)	nicht	
zwangsläufig	 mit	 einer	 erhöhten	 Krankenhausletalität	 einhergeht.	 Vielmehr	 zeigte	
sich,	 dass	 die	Nicht-Revaskularisation	 der	 LSA	 bei	 TEVAR-Patienten	mit	 einem	 signi-
fikant	erhöhten	Risiko	 für	die	Entwicklung	einer	klinisch-relevanten	Malperfusion	der	
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linken	oberen	Extremität	(mit	gesteigertem	Risiko	für	einen	linksseitigen	Schlaganfall)	
vergesellschaftet	ist.	Die	Tatsache,	dass	die	o.g.		prozedurspezifischen	Komplikationen	
(Schlaganfall	 und	Querschnittslähmung)	 signifikant	 gehäuft	 bei	 Patienten	mit	 ausge-
prägten	Gefäßverkalkungen	(koronare	Herzerkrankung)	und	nach	der	Implantation	von	
mehreren	Stentprothesen	auftreten,	unterstreicht	die	Notwendigkeit	der	präoperati-
ven	bildgebenden	Diagnostik	und	interdisziplinären	OP-Planung.	
In	der	Konsequenz	sollte	die	prophylaktische	Revaskularisation	der	LSA,	insbesondere	
bei	Patienten	mit	koronarer	Herzerkrankung	sowie	ausgedehnten	Aortenpathologien	
(welche	mehrere	Stentprothesen	zur	Behandlung	erfordern),	vor	der	TEVAR-Prozedur	
erfolgen,	um	assoziierte	 links-zerebrale	neurologische	Komplikationen	 zu	 vermeiden	
und	eine	Perfusion	der	linken	oberen	Extremität	sicher	zu	stellen.		
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3.3  Schlussfolgerungen
	 1)	 	Im	Vergleich	zu	Patienten	mit	einer	partiellen	Überstentung	der	LSA	(anteg-
rade	Perfusion	ist	weiterhin	gegeben)	ist	das	perioperative	Risiko	für	peri-
phere	und	zentrale	neurologische	Komplikationen	bei	einem	vollständigen	
LSA-Verschluss	nach	TEVAR	erhöht.	Dies	trifft	insbesondere	auf	Patienten	
mit	einem	ausgeprägten	postoperativen	Subclavian-Steal-Syndrom	 (Grad	
III)	zu.			
	 2)	 	Die	 Überstentung	 der	 LSA	 ohne	 prophylaktische	 Revaskularisation,	 die	
Platzierung	von	mehr	als	einer	endovaskulären	Stentprothese	und	das	Vor-
handensein	einer	koronaren	Herzerkrankung	stellen	unabhängige	Risiko-
faktoren	für	prozedurspezifische	Komplikationen	bei	TEVAR-Patienten	mit	
einer	Landungszone	2	dar.
	 3)	 	Bei	 einer	 geplanten	 Überstentung	 der	 LSA	 sollte	 eine	 prophylaktische	
Revaskularisierung	mittels	Bypass/	 Transposition	angestrebt	werden,	um	
links-zerebrale	neurologische	Komplikationen	zu	vermeiden	und	eine	Per-
fusion	der	linken	oberen	Extremität	sicher	zu	stellen.
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4.	 	Sekundäreingriffe	 im	 Bereich	 des	 Aortenbogens	
und der Aorta descendens nach stattgehabter 
endovaskulärer Therapie 
Während	die	endovaskuläre	Therapie	von	Pathologien	im	Bereich	der	Aorta	thorako- 
abdominalis	oftmals	eine	mehrwöchige	Vorlaufzeit	erfordert	(Maßanfertigung	einer	in-
dividuellen	Stentprothese),	können	akute	und	chronische	Erkrankungen	mit	Beschrän-
kung	auf	die	Aorta	descendens	meist	schnell	und	erfolgreich	mittels	TEVAR	behandelt	
werden	[2,30].	Zudem	bietet	die	endovaskuläre	Therapie	der	Aorta	descendens	im	Ver-
gleich	zur	offenen	Chirurgie	Vorteile	hinsichtlich	der	frühpostoperativen	Mortalität	und	
Letalität	[20].	Dementsprechend	hat	die	Anzahl	von	TEVAR-Eingriffen	in	den	vergange-
nen Jahren stetig zugenommen. 
Allerdings	ist	die	Inzidenz	von	TEVAR-assoziierten	Komplikationen	im	Mittel-	und	Lang-
zeitverlauf	und	deren	Behandlung	als	Sekundäreingriff—mit	besonderer	Relevanz	für	
jüngeren	Patienten—bislang	jedoch	nur	unzureichend	untersucht	worden.		
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4.1	 	Ergebnisse	von	Sekundäreingriffen	nach	primär	endovaskulä-
rer	Stentgraft-Therapie	der	Aorta	(Originalarbeit	6.6)
Hintergrund 
Durch	die	klinische	Etablierung	von	TEVAR	hat	sich	die	Behandlung	von	Pathologien	
der	Aorta	descendens,	weg	 von	einer	 reinen	Notfallprozedur	und	hin	 zur	Standard-
therapie	entwickelt	[2,30,52].	Durch	die	starke	Zunahme	von	TEVAR	ist	jedoch	auch	das	
Risiko	für	mögliche	Verlaufskomplikationen	im	Bereich	der	Aorta	descendens	sowie	der	
angrenzenden	Aortenabschnitte	(Aortenbogen,	Aorta	abdominalis)	weiter	angestiegen,	
welche	ggf.	mittels	offenem	oder	endovaskulären	Sekundäreingriff	behandelt	werden	
müssen	[63].	Erfahrungen	mit	TEVAR-Komplikationen	sind	jedoch	begrenzt	und	post-
operative	Ergebnisse	von	Sekundäroperationen	wurden	in	der	Fachliteratur	bisher	nur	
einzeln	(z.B.	als	Fallberichte)	oder	in	kleineren	Fallserien	veröffentlicht.	
Das	Ziel	der	Forschungsarbeit	war	daher	die	Bestimmung	der	 Inzidenz	von	 relevan-
ten	Verlaufskomplikationen	nach	stattgehabter	primärer	TEVAR,	die	Beschreibung	der	
durchgeführten	Sekundäreingriffe	sowie	die	Analyse	der	postoperativen	Ergebnisse	an	
einem	großen	aortenchirurgischen	Referenzzentrum.	
Methodik 
Die	Datenbank	des	Herzzentrum	Leipzig	–	Universität	Leipzig	wurde	retrospektiv	aus-
gewertet	und	alle	Patienten	mit	Sekundäreingriff	bei	Komplikation	nach	primärer	TEVAR	
evaluiert.	Als	Sekundäreingriffe	wurden	alle	offenen,	endovaskulären	oder	Hybrid-Ope-
rationen	 im	 klinischen	 Verlauf	 nach	 Primäreingriff	 definiert.	 Zum	 direkten	 Vergleich	
wurden	zwei	Gruppen	hinsichtlich	der	Art	von	Sekundäreingriff	gebildet:	Reintervention	
(endovaskulär)	und	Operation	(offen	konventionell).	Alle	Patienten	mit	bereits	zum	Zeit-
punkt	des	Primäreingriffs	geplanten	Operationen	oder	Reinterventionen	als	Zweitein-
griff	(sog.	„staged	repair“)	wurden	ausgeschlossen.
Ergebnisse 
Insgesamt	konnten	56	(15,1%)	von	371	Patienten	(mittleres	Alter:	61,3	Jahre)	mit	einem	
ungeplanten	Sekundäreingriff	nach	TEVAR	im	Zeitraum	2002	bis	2013	identifiziert	und	
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eingeschlossen	werden.	Es	wurden	25	Operationen	(44,6%)	und	31	Reinterventionen	
(55,4%)	nach	einem	mittleren	Zeitraum	von	3,8	bzw.	1,6	Monaten	durchgeführt.	Die	In-
dikationen	für	Sekundäreingriffe	in	der	gesamten	Studienkohorte	umfassten	relevante	
Undichtigkeiten	(Endoleaks;	n=28;	7,5%),	Zunahme	des	Aneurysmadurchmessers	(n=3;	
0,8%),	Malperfusionssyndrome	(n=9;	2,4%),	retrograde	Typ	A	Dissektionen	(n=2;	0,5%),	
aorto-bronchiale/	 -ösophageale	 Fistelbildungen	 (n=9;	 2,4%),	 Stentprotheseninfekte	
(n=4;	 1,1%)	 sowie	 einen	 Fall	mit	 iatrogener	 Aortenklappeninsuffizienz	 (katheterindu-
ziert;	n=1;	0,3%).	
Die	Krankenhausletalität	betrug	insgesamt	10,7%.	Allerdings	konnte	kein	signifikanter	
Unterschied	zwischen	Patienten	mit	Operation	oder	Reintervention	gefunden	werden	
(4%	vs.	16%;	p=0,14).	Auch	zeigten	sich	keine	signifikanten	Unterschiede—mit	Ausnah-
me	 der	 respiratorischen	 Insuffizienz—im	Hinblick	 auf	 postoperative	 Komplikationen	
(siehe	Tabelle 1).	
Im	postoperativen	Verlauf	über	einen	Zeitraum	von	36	Monaten	konnte	mittels	Über-
lebensschätzung	nach	Kaplan-Meier	ebenfalls	kein	statistisch	signifikanter	Unterschied	
zwischen	offen	operierten	oder	reintervenierten	Patienten	gefunden	werden	(p=0,60;	
Abbildung 14).
Tabelle 1:	Postoperative	Ergebnisse	nach	Sekundäreingriff	(n=56):	Operation	vs.	Reintervention
Komplikation,	n	(%)	 Operation		(n=25)	 Reintervention	(n=31)	 p-Wert
Krankenhausletalität	 1	(4)	 5	(16)	 	 0.14
Paraplegie	 	 1	(4)	 2	(6)	 	 0.68
Schlaganfall	 2	(8)	 3	(9)	 	 0.82
Niereninsuffizienz	 4	(16)	 1	(3)	 	 0.09
Respiratorische	
Insuffizienz			 3	(12)	 -	 	 0.04*
Sepsis	 	 4	(16)	 1	(3)	 	 0.09
Malperfusion	 1	(4)	 1	(3)	 	 0.87
*=statistisch	signifikant
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Abbildung 14:	Kaplan-Meier-Überlebensschätzung:	Operation	vs.	Reintervention	nach	TEVAR	
(aus	Nozdrzykowski	M,	Luehr	M	et	al.	[64]	mit	freundlicher	Genehmigung	von	Oxford	University	
Press).
Diskussion 
Sekundäreingriffe	nach	TEVAR	aufgrund	von	früh	oder	spät	auftretenden	Verlaufskom-
plikationen	sind	nicht	selten	und	wurden	in	der	aktuellen	Studienkohorte	in	über	15%	
der	Fälle	notwendig.	Die	am	häufigsten	auftretenden	Verlaufskomplikationen	stellen	En-
doleaks	(insbesondere	vom	Typ	Ia),	Stentprotheseninfektionen,	aorto-bronchiale/-öso-
phageale	 Fisteln	und	Malperfusionen	nachgeschalteter	Organsysteme	dar.	Während	
sich	Endoleaks	und	Malperfusionen	oftmals	gut	mittels	Reintervention	behandeln	las-
sen,	ist	eine	offene	Operation	bei	Infektionen	mit	oder	ohne	Fistelbildung,	drohenden	
Rupturen	oder	retrograden	Typ	A	Dissektionen	unumgänglich,	um	das	Leben	von	be-
troffenen	Patienten	zu	retten.	
Zusammenfassend	 lässt	sich	 feststellen,	dass	Sekundäreingriffe	nach	TEVAR	bei	ent-
sprechender	 individueller	 Planung	 mit	 sehr	 akzeptablen	 Ergebnissen	 durchgeführt	
werden	können.	 Jedoch	sollte	 in	den	behandelnden	Zentren	eine	engmaschige	Ver-
laufskontrolle	 bei	 TEVAR-Patienten	 durchgeführt	 werden,	 um	 drohende	 oder	 akute	
Komplikationen	frühzeitig	diagnostizieren	und	optimal	therapieren	zu	können.		
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4.2  Chirurgische Therapie bei verzögert auftretender retrograder 
Typ A Dissektion nach endovaskulärer Stentgraft-Therapie des 
Aortenbogens mit kompletter supraaortaler Revaskularisie-
rung	(Originalarbeit	6.7)
Hintergrund 
Die	konventionelle	offene	Operation	ist	nach	wie	vor	der	Goldstandard	bei	der	Thera-
pie	des	Aortenbogens.	Aufgrund	von	zunehmender	klinischer	Erfahrung	und	weiteren	
technischen	Verbesserungen	von	TEVAR	kamen	in	der	jüngsten	Vergangenheit	jedoch	
zunehmend	 endovaskuläre	 Techniken	 bei	 Hochrisikopatienten	 zum	 Einsatz,	 welche	
einer	konventionellen	Aortenbogenoperation	nicht	zugeführt	werden	konnten	[65–67].	
Ein	Konzept,	das	 sog.	 „supraaortale	Debranching“,	 generiert	 eine	ausreichende	Lan-
dungszone	im	Aortenbogen	(Landungszonen	0,	1,	2;	Abbildung 12)	durch	eine	Abset-
zung	und	extra-anatomische	Revaskularisierung	von	Truncus	brachiocephalicus,	der	A.	
carotis	communis	sinistra	und	der	A.	subclavia	sinistra	[65].	Anschließend	werden	eine	
oder	mehrere	Stentprothesen	retrograd	über	die	A.	femoralis	in	der	Aorta	ascendens	
bzw.	im	Aortenbogen	platziert.	Diese	Technik	kann	auch	ohne	Herz-Lungen-Maschine	
und	Kreislaufstillstand	durchgeführt	werden.	Allerdings	birgt	diese	Technik	die	Gefahr	
einer	„retrograden“	Typ	A	Dissektion,	welche	entweder	verzögert	oder	akut	auftreten	
kann	und	mit	einer	sehr	hohen		Letalität	von	50%	bis	70%	assoziiert	ist	[68].	
In	dieser	Analyse	wurden	die	ersten	Erfahrungen	mit	dieser	neuen	Hybrid-Technik	in	
Bezug	auf	die	Durchführbarkeit	und	die	postoperativen	Ergebnisse—mit	speziellem	Fo-
kus	auf	die	Behandlung	der	retrograden	Typ	A	Dissektion—hin	untersucht.
Methodik 
Die	Datenbank	des	Herzzentrum	Leipzig	–	Universität	Leipzig	wurde	hinsichtlich	der	
Behandlung	von	Aortenbogenpathologien	retrospektiv	ausgewertet.	Als	Einschlusskri-
terium	wurde	die	Behandlung	mittels	Hybrid-Technik	(supraaortales	Debranching	und	
TEVAR)	herangezogen.	Patienten	mit	einem	konventionellen	Aortenbogenersatz	wur-
den	ausgeschlossen.
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Ergebnisse 
Im	Zeitraum	2010	bis	 2012	wurden	118	Patienten	mit	 Aortenbogenpathologien	be-
handelt.	Insgesamt	konnten	neun	(7,6%)	Hochrisikopatienten	mit	ausgedehnten	Patho-
logien	des	Aortenbogens	und	Beteiligung	der	proximalen	Aorta	descendens	(mittlerer	
logistischer	EUROScore:	26),	welche	mit	einem	komplettem	supraaortalen	Debranching	
(Landungszone	0)	versorgt	worden	waren,	in	die	Studie	eingeschlossen	werden.
Bei	allen	Patienten	konnte	die	Hybrid-Prozedur	erfolgreich	durchgeführt	werden.	Die	
Krankenhausletalität	 lag	 bei	 0%.	 Die	 mittlere	 Intensiv-	 und	 Krankenhausverweildau-
er	 lang	 im	Mittel	bei	11,3	Tagen	und	19,5	Tagen.	Die	postoperativen	Komplikationen	
umfassten	neue	Schlaganfälle	(n=2),	respiratorische	Insuffizienz	(n=5),	Nachblutungen	
(n=3),	Bypassverschluss	(n=1)	und	Sternuminstabilität	(n=1).	Darüber	hinaus	entwickelten	
zwei	Patienten	(22,2%)	während	ihres	weiteren	Krankenhausaufenthalts	verzögert	eine	ret-
rograde	Typ	A	Dissektion,	welche	in	beiden	Fällen	notfallmäßig	mit	einem	totalen	Aorten-
bogenersatz	in	konventioneller	Technik	behandelt	werden	mussten	(Abbildung 15).		
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Abbildung 15:	 Computertomographie	 mit	 Darstellung	 einer	 retrograden	 Typ	 A	 Dissektion	
durch	Perforation	des	proximalen	nicht-bedeckten	Anteils	der	Stentprothese	(A	und	B).	Intra-
operativer	Blick	auf	den	unbedeckten	Anteil	der	Stentprothese	vor	(C)	und	nach	Einnähen	einer	
Aortenprothese	(D)	zur	Versorgung	mittels	totalem	Aortenbogenersatz	in	ET-Technik	(aus	Luehr	
M,	et	al.	[69]	mit	freundlicher	Genehmigung	von	Oxford	University	Press).
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Diskussion 
Im	Hinblick	auf	die	Ergebnisse	dieser	Studie	stellt	sich	die	Frage,	ob	die	angewandte	
Hybrid-Technik	für	jeden	vermeintlichen	Hochrisikopatienten	auch	immer	die	optimale	
Strategie	darstellt.	Dies	wird	insbesondere	durch	die	Tatsache	verdeutlicht,	dass	beide	
Patienten	mit	retrograder	Typ	A	Dissektion	erfolgreich	konventionell	re-operiert	wer-
den	konnten.	Dementsprechend	sollten	für	eine	Therapieentscheidung	präoperativ	im-
mer	alle	zur	Verfügung	stehenden	Behandlungsoptionen	in	Betracht	gezogen	und	stets	
individuell	auf	den	Patienten	angepasst	werden.
Die	retrograde	Typ	A	Dissektion	stellt	eine	neue	und	möglicherweise	in	ihrer	Inzidenz	
stark	unterschätzte	Komplikation	der	neuen	Hybrid-Technik	des	supraaortalen	Debran-
chings	dar.	Insbesondere	Stentprothesen	mit	unbedeckten	proximalen	Anteilen	(Stent-
gerüst)	 sollten,	ebenso	wie	unnötiges	Überdimensionieren	und	Nachballonieren	der	
Stentprothese,	 im	nativen	Aortenbogen	und	der	Aorta	ascendens	keine	Anwendung	
finden.	Ebenso	sollte	ein	elektiver	Ersatz	der	Aorta	ascendens	 (Landungszone	0)	bei	
Patienten	mit	einer	Ektasie	der	Aorta	ascendens	vor	dem	TEVAR-Eingriff	durchgeführt	
werden,	um	eine	 retrograde	Typ	A	Dissektion	sicher	zu	verhindern	und	eine	ausrei-
chende	Landungszone	zu	gewährleisten	[66].	
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4.3	 	Notfallmäßige	 offene	 Chirurgie	 bei	 aorto-ösophagealen	 und	
aorto-bronchialen Fisteln nach endovaskulärer Stentgraft- 
Therapie	der	Aorta	(Originalarbeit	6.8)
Hintergrund 
Sekundäre	aorto-bronchiale	 (ABF)	und	aorto-ösophageale	 (AÖF)	Fisteln	stellen	unge-
wöhnliche	 (Inzidenz	1,7%)	 aber	 fatale	 Komplikationen	nach	offenem	 thorakalen	und	
thorakoabdominellen	Aortenersatz	dar	 [70].	 In	 jüngster	Zeit	wurden	diese	Komplika-
tionen	jedoch	auch	bei	Patienten	nach	TEVAR	mit	einer	steigenden	Inzidenz	von	1,5%	
bis	1,9%	beschrieben	[70].	Eine	aortale	Fistelbildung	kann	mit	zerebralen		Luftembo-
lien	einhergehen	oder	zu	freien	Blutungen	in	die	Speiseröhre	(AÖF)	bzw.	ins	Bronchial-
system	(ABF)	führen.	Zudem	kommt	es	zu	einer	Infektion	der	Stentprothese,	die	eine	
offene	Reoperation	mit	Entfernung	von	Fremdmaterial	 sowie	umgebendem	Gewebe	
erfordert	und	mit	einer	postoperativen	Letalität	von	26%	bis	64%	assoziiert	ist	[51,70].	
Während	 in	den	Fachgesellschaften	übergreifend	Einigkeit	darüber	besteht,	dass	ein	
konservatives	Vorgehen	mit	einer	Letalität	von	100%	einhergeht,	wird	von	einigen	Au-
toren,	zumindest	für	ABF,	alternativ	zur	offenen	Operation	eine	endovaskuläre	Reinter-
vention	kritisch	diskutiert	[67,71].	In	Ermangelung	von	großen	klinischen	Untersuchun-
gen	beschränkt	sich	die	Erfahrung	bei	der	Behandlung	von	ABF	und	AÖF	allerdings	nur	
auf	einige	wenige	Fallberichte	und	kleinere	Fallserien.
Das	Ziel	dieser	Studie	war	die	retrospektive	Analyse	von	Patienten	mit	ABF	und	AÖF	zur	
Bestimmung	der	 Inzidenz,	 Beschreibung	 der	 klinischen	Präsentation	 und	 Evaluation	
von	postoperativen	Ergebnissen.
Methodik 
Es	erfolgte	eine	 retrospektive	Datenbankauswertung	am	Herzzentrum	Leipzig	–	Uni-
versität	Leipzig	im	Zeitraum	2002	bis	2013.	Ausschließlich	Patienten	mit	einer	AÖF	oder	
ABF	nach	stattgehabter	TEVAR	wurden	in	die	Studie	eingeschlossen.	Alle	TEVAR-Patien-
ten	ohne	eine	aortale	Fistel	im	postoperativen	Verlauf	wurden	ausgeschlossen.
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Ergebnisse
Insgesamt	wurden	374	Patienten	(mittleres	Alter:	67,6	Jahre)	mittels	TEVAR	im	Zeitraum	
2002	bis	2013	behandelt.	Postoperativ	entwickelten	10	(2,6%)	Patienten	eine	AÖF	(n=8;	
2,1%)	und	zwei	eine	ABF	(0,5%)	nach	einem	mittleren	Zeitraum	von	18,1	Monaten.	
Die	klinischen	Symptome	bei	Aufnahme	von	Patienten	mit	AÖF	oder	ABF	umfassten	
Hämatemesis	(n=4),	Hämoptysis	(n=4)	oder	Melena	(n=1)	mit	oder	ohne	hämorrhagi-
schem	Schock	(n=4),	neu-aufgetretenes	Fieber	(n=3),	Dysphagie	(n=1),	Dyspnoe	(n=1),	
Brustschmerz	(n=1),	Schwindel	(n=1)	und	Präsynkope	(n=1).	Alle	Patienten	zeigten	zu-
dem	pathologisch	erhöhte	Entzündungswerte	im	präoperativen	Labor	(n=10)	mit	posi-
tiven	Blutkulturen	 in	8	Fällen.	Die	definitive	Diagnosestellung	erfolgte	einzeln	oder	 in	
Kombination	mittels	Endoskopie	 (n=7),	Bronchoskopie	 (n=1),	Ösophagographie	 (n=1)	
oder	Computertomographie	(n=4)	(Abbildung 16 und 17).	
 
Abbildung 16:	Darstellung	einer	aorto-bronchialen	Fistel	(AÖF;	s.	rote	Pfeilspitze)	mittels	Com-
putertomographie	(aus	Luehr	M,	et	al.	[3]	mit	freundlicher	Genehmigung	von	Oxford	University	
Press).
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Abbildung 17: Darstellung	von	aorto-ösophagealen	Fisteln	(AÖF)	mittels	Endoskopie	(A),	Com-
putertomographie	(B)	oder	Ösophagographie	(C)	(aus	Luehr	M,	et	al	[3]	mit	freundlicher	Geneh-
migung	von	Oxford	University	Press).
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Insgesamt	wurden	acht	Patienten	mit	AÖF	(n=7)	und	ABF	(n=1)	offen	operiert.	Die	Ope-
rationstechnik	umfasste	die	vollständige	Entfernung	der	Stentprothese	und	des	umge-
benden	infizierten	Gewebes	(Abbildung 18).	Die	Krankenhaus-	und	Ein-Jahresletalität	
lagen	jeweils	bei	25%	(n=2)	bzw.	37,5%	(n=3).	Postoperative	Komplikationen	umfassten	
Re-Operationen	bei	Nachblutung	(n=4)	sowie	temporär	auftretendes	Nieren-	(n=2)	und	
Lungenversagen	 (n=2).	 Die	 Krankenhausverweildauer	 nach	 stattgehabter	 Operation	
bei	AÖF/ABF	betrug	im	Mittel	30	(±21,4)	Tage.
Zwei	der	zehn	Patienten	wurden	zum	Zeitpunkt	der	Diagnose	als	inoperabel	eingestuft	
und	verstarben	akut	(n=1)	oder	nach	konservativer	Therapie	im	weiteren	Verlauf	(n=1).
 
Abbildung 18: Intraoperativer	Blick	auf	eine	aorto-ösophageale	Fistel	(A)	und	die	explantierte	
Stentprothese	(B)	(aus	Luehr	M,	et	al.	[3]	mit	freundlicher	Genehmigung	von	Oxford	University	
Press).
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Diskussion 
Durch	die	zunehmende	endovaskuläre	Therapie	der	Aorta	descendens	mittels	TEVAR	
wurde	in	der	Literatur	zuletzt	ein	deutlicher	Anstieg	von	zuvor	als	extrem	selten	gelten-
den	Komplikationen	registriert.	Obwohl	in	der	Fachliteratur	die	Inzidenz	von	aortalen	
Fisteln	in	die	Speiseröhre	(AÖF)	bzw.	in	das	Bronchialsystem	(ABF)	nur	mit	1,5%	bis	1,9%	
beschrieben	wird	[70],	lag	die	Inzidenz	in	der	Studienkohorte	mit	2,6%	fast	doppelt	so	
hoch.	
Die	Ergebnisse	der	Studie	legen	nahe,	dass	AÖF	und	ABF	weitaus	häufiger	nach	TEVAR	
auftreten	als	bislang	angenommen.	Zudem	ist	der	initiale	Verlauf	dieser	fatalen	Kom-
plikationen	oft	unspezifisch,	so	dass	eine	sichere	Diagnose	oft	nur	in	Kombination	von	
verschiedenen	Untersuchungstechniken	und	bildgebenden	Verfahren	möglich	ist.	Da	
späte	Diagnosen	oder	rein	medikamentöse	Therapieansätze	oftmals	fatal	enden	und	
eine	 infizierte	 Stentprothese	nicht	dauerhaft	mittels	 erneuter	 TEVAR	 saniert	werden	
kann,	stellt	die	offene	und	radikale	Operationstechnik,	mit	vollständiger	Entfernung	von	
Fremdmaterialen	und	Geweben,	die	derzeit	einzige	kurative	Therapie	von	Patienten	mit	
AÖF	und	ABF	dar.	In	erfahrenen	Zentren	können	bei	der	operativen	Behandlung	von	
AÖF	und	ABF	 jedoch	 sehr	akzeptable	Ergebnisse,	mit	 einer	postoperativer	Kranken-
hausletalität	von	25%	bis	27%	[3,72],	erreicht	werden.
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4.4 Schlussfolgerungen
	 1)	 	Die	 Inzidenz	 von	Sekundäreingriffen	nach	 TEVAR	aufgrund	 von	Verlaufs-
komplikationen	liegt	bei	über	15%.	Häufige	Verlaufskomplikationen	stellten	
Endoleaks	 (insbesondere	 vom	Typ	 Ia),	 Stentprotheseninfektionen,	 Fisteln	
und	Malperfusionen	nachgeschalteter	Organsysteme	dar.	
	 2)	 	Offene	und	endovaskuläre	Sekundäreingriffe	nach	TEVAR	können	mit	ak-
zeptablen	Ergebnissen	durchgeführt	werden.	Engmaschige	Routineunter-
suchungen	sind	jedoch	notwendig,	um	drohende	oder	akute	Komplikatio-
nen	 im	postoperativen	 Verlauf	 frühzeitig	 zu	 diagnostizieren	und	optimal	
behandeln	zu	können.		
	 3)	 	Das	supaaortale	Debranching	stellt	eine	neues	Hybrid-Verfahren	für	Hoch-
risikopatienten	mit	ausgedehnten	Aortenbogenpathologien	dar.	Allerdings	
birgt	diese	Technik	ein	erhöhtes	Risiko	für	das	Auftreten	von	retrograden	
Typ	A	Dissektionen.	
	 4)	 	Um	 das	 Risiko	 einer	 retrograden	 Typ	 A	 Dissektion	 zu	 senken,	 sollte	 bei	 
TEVAR	im	Aortenbogen	bzw.	in	der	Aorta	ascendens	ein	Überdimensionie-
ren	und	Nachballonieren	vermieden	werden,	ebenso	wie	Stentprothesen	
mit	unbedeckten	proximalen	Anteilen.	Bei	Patienten	mit	Ektasie	der	Aorta	
ascendens	sollte	ein	elektiver	Ersatz	Aorta	ascendens	in	Erwägung	gezogen	
werden.
	 5)	 	Aortale	Fisteln	in	die	Speiseröhre	(AÖF)	und	in	das	Bronchialsystem	(ABF)	
treten	mit	steigender	Inzidenz	(bis	2,6%)	nach	TEVAR	auf.	Eine	offene	Ope-
ration—mit	 vollständiger	 Entfernung	 von	 Fremdmaterial	 und	 infiziertem	
Gewebe—stellt	derzeit	die	einzige	kurative	Therapie	von	AÖF	und	ABF	dar	
und	kann	in	spezialisierten	Zentren	mit	akzeptablen	Ergebnissen	durchge-
führt	werden.
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Abstract
OBJECTIVES: The study was conducted to evaluate, on the basis of a multicentre analysis, current results of elective open aortic arch
surgery performed during the last decade.
METHODS: Data of 1232 consecutive patients who underwent aortic arch repair with reimplantation of at least one supra-aortic artery
between 2004 and 2013 were collected from 11 European cardiovascular centres, and retrospective statistical examination was performed
using uni- and multi-variable analyses to identify predictors for 30-day mortality. Acute aortic dissections and arch surgeries not involving
the supra-aortic arteries were not included.
RESULTS: Arch repair involving all 3 arch arteries (total), 2 arch arteries (subtotal) or 1 arch artery (partial) was performed in 956 (77.6%),
155 (12.6%) and 121 (9.8%) patients, respectively. The patients’ characteristics as well as the surgical techniques, including the method of
cannulation, perfusion and protection, varied considerably between the clinics participating in the study. The in-hospital and 30-day mor-
tality rates were 11.4 and 8.8% for the entire cohort, respectively, ranging between 1.7 and 19.0% in the surgical centres. Multivariable
logistic regression analysis identiﬁed surgical centre, patient’s age, number of previous surgeries with sternotomy and concomitant surger-
ies as independent risk factors of 30-day mortality. The follow-up of the study group was 96.5% complete with an overall follow-up
duration of 3.3 ± 2.9 years, resulting in 4020 patient-years. After hospital discharge, 176 (14.3%) patients died, yielding an overall mortality
rate of 25.6%. The actuarial survival after 5 and 8 years was 72.0 ± 1.5% and 64.0 ± 2.0, respectively.
CONCLUSIONS: The surgical risk in elective aortic arch surgery has remained high during the last decade despite the advance in surgical
techniques. However, the patients’ characteristics, numbers of surgeries, the techniques and the results varied considerably among the
centres. The incompleteness of data gathered retrospectively was not effective enough to determine advantages of particular cannulation,
perfusion, protection or surgical techniques; and therefore, we strongly recommend further prospective multicentre studies, preferably
registries, in which all relevant data have to be clearly deﬁned and collected.
Keywords: Aortic arch • Aortic surgery • Cerebral protection
INTRODUCTION
Since Griepp and associates ﬁrst described the use of deep hypo-
thermic circulatory arrest for prosthetic replacement of the aortic
arch in 1975, the number of centres performing these procedures
has continued to grow and it has become a routine surgery in
many units [1]. However, various reports throughout the last
decades demonstrate that aneurysms of the arch still remain a
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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challenging task, requiring thoughtful preoperative and intrao-
perative planning. Changes in operative techniques and technical
progress have led to a substantial improvement in survival and
outcomes [2–5]. On the other hand, there is also a rapid growth in
alternative techniques and evolving technologies, including deb-
ranching of the aortic arch with subsequent thoracic endovascular
aortic repair that should be benchmarked adequately [6–10]. With
novel perfusion methods, improved neuroprotective strategies,
and further technical advances, the success rates should continue
to improve in the future. However, the determination of the
impact of those advanced techniques on surgical outcomes
should be based on the conclusive analysis of data gathered from
several aortic referral sites to build a foundation for future recom-
mendations and guidelines. Taking into account that no or very
limited multicentre trials exist to date, the aim of this study was to
evaluate the operative and clinical outcomes after conventional
total or subtotal aortic arch replacement, using current perfusion
and surgical techniques at several aortic referral centres in Europe.
PATIENTS ANDMETHODS
To assess the surgical and mid-term clinical outcomes after a con-
ventional aortic arch surgery performed in several European aortic
referral centres during the last 10 years, 18 aortic centres from 5
European countries were asked to report on their respective surgi-
cal strategies and postoperative results after elective aortic arch
surgery performed between January 2004 and December 2013.
Eleven centres (Supplementary material, Table S1) responded to
the call and provided their data for a retrospective analysis. To keep
an anonymous character of this analysis, the order of the centres as
provided in tables and Supplementary tables does not correspond
to the alphabetical order in the list of principal investigators and the
centre list describing particular perfusion and protection strategies,
which are provided in Supplementary material, Tables S1 and S4.
Inclusion criteria
The analysis includes all scheduled (elective and urgent) aortic
arch surgeries performed due to any pathology (also including
chronic dissections or re-do surgeries after conventional or thor-
acic endovascular aortic repair—TEVAR) with at least one circular
aortic anastomosis and reimplantation of at least one aortic arch
branch, regardless of the proximal or distal extent of the thoracic
aorta repair. The extent of arch repair was deﬁned as partial,
subtotal or total:
• Arch repair with reimplantation of one arch artery (partial arch
repair)
• Arch repair with reimplantation of two arch arteries (subtotal
arch repair)
• Arch repair with reimplantation of three arch arteries (total arch
repair)
To give an exact overview of the various methods for convention-
al aortic arch replacement, no exclusions were made with regard to
the performed surgical approaches, (which, in addition to median
sternotomy included median sternotomy with lateral extension
[hemi-clamshell], bilateral thoracotomy [clam shell] and postero-
lateral thoracotomy), anastomosing techniques (conventional, ele-
phant trunk [ET] or stented elephant trunk [so-called frozen elephant
trunk—FET]) or any concomitant cardiac or cardiovascular proce-
dures. For supra-aortic reconstruction, all surgical methods of
reimplantation were included (e.g. island technique, singular reim-
plantation, supra-aortic translocation and extra-anatomic bypass).
To analyse the potential impact of neuroprotective strategies, all
participating centres were also asked to give detailed information
on their arterial cannulation techniques and respective cerebral pro-
tection and, if appropriate, cerebral perfusion management.
Accordingly, all available techniques were included and comprised
all forms of antegrade (bilateral or unilateral) cerebral perfusion
(ACP), retrograde cerebral perfusion (RCP) and deep hypothermic
circulatory arrest (DHCA).
Exclusion criteria
The only exclusion criteria were:
• open arch anastomosis (hemiarch) without involvement of any
arch arteries
• acute aortic dissection
• intraoperative aortic injury necessitating unscheduled repair
Altogether, 1232 patients (mean age 64 ± 13 years) were included
in the study group (Table 1). The respective numbers of included
patients varied between single centres from 17 to 237. The sub-
cohorts also varied in regard to age, gender, previous neurological
event and previous surgery (Supplementary material, Table S2).
Aortic aneurysm was the most frequent indication for aortic arch
surgery (70.9%), followed by chronic dissection (22.6%) and other
pathologies (6.5%); however, the incidences of chronic aneurysm,
chronic dissection or aortic valve defect were also signiﬁcantly dif-
ferent among the centres. Previous open cardiac surgery with ster-
notomy had been performed in 340 patients (27.6%), whereas 34
(2.8%) patients were initially treated by TEVAR of the thoracic aorta.
The detailed preoperative patient characteristics and underlying
aortic pathologies are summarized in Table 1 for the entire cohort
Table 1: Preoperative patient characteristics
Characteristics No (%) or mean ± SD
Sex male 778 (63)
Age (years) 64 ± 13
Arch pathology
Aneurysm 874 (70.9)
Chronic dissection 278 (22.6)
False aneurysm 29 (2.4)
Inflammatory/infection 21 (1.7)
Porcelain aorta 14 (1.1)
Others 16 (1.3)
Aortic valve defect
Insufficiency 515 (41.8)
Stenosis 75 (10.0)
Mixed 51 (4.1)
Previous cardiac surgery 340 (27.6)
Previous neurological events 113 (9.2)
With residuals 66 (5.4)
Without residuals 47 (3.8)
Previous TEVAR 34 (2.8)
Creatinine (mg%) 1.1 ± 1.6
TEVAR: thoracic endovascular aortic repair.
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and in Supplementary material, Table S2 for all sub-cohorts;
whereas Supplementary material, Table S3 demonstrates that the
incidences of chronic-obstructive lung disease (COLD), functional
NYHA class, ejection fraction (EF) and aortic aetiology were
reported incompletely limiting the evidence of statistical analysis.
The complete monitoring of operative data, especially perfusion
ﬂow and pressure during cerebral perfusion, was provided by only
2 centres.
Surgical techniques, cannulation and perfusion
Surgical access was achieved via full sternotomy, partial sternot-
omy, bilateral thoracotomy, sternotomy with lateral extension and
postero-lateral thoracotomy in 1134 (92.1%), 54 (4.4%), 14 (1.1%),
5 (0.4%) and 25 (2.0%) cases, respectively. Various techniques of
arterial cannulation were also used in accordance with the prefer-
ences of the respective centre. As presented in Table 2, the right
axillary artery (AxA) was the most frequently used arterial cannula-
tion site (37.7%) followed by direct aortic (24.8%), common
carotid artery (CCA, 13.7%), innominate artery (IA, 12.1%) and
femoral artery (FA, 10.6%); other access routes as double cannula-
tions were documented in only 13 patients (1.1%). The reported
cerebral protection strategies comprised mainly bilateral (63.1%)
or unilateral (30.6%) ACP, and DHCA (6.0%). In 3 cases (0.2%), the
distal arch was performed with beating heart after cross-clamping
the arch between the left CCA and left subclavian artery (LSA), and
in only 1 case (0.1%) RCP was used (Table 2). However, there were
relevant centre-related differences in the execution of these tech-
niques, which could have already been observed in a survey
performed by the vascular domain group of the EACTS [11].
A noverview of cannulation sites used in particular centres is
demonstrated in Supplementary material, Table S4, whereas a
short description of protection and perfusion techniques is pro-
vided below. Here, the order of the centres corresponds to the al-
phabetical list of the principal investigators (Supplementary
material, Table S1), which is different from the anonymous order
of the sub-cohorts in remaining tables and Supplementary tables.
• In Bologna, the preferred cannulation sites were AxA and IA fol-
lowed by FA and aorta (Supplementary material, Table S4).
Bilateral hypothermic ACP (blood temp. 20–24°C) applied by can-
nulation graft and/or, if appropriate, by inﬂatable perfusion cathe-
ters in the IA and left CCA with a constant ﬂow of 15 ml per kg of
body weight was used for cerebral protection. The LSA was
blocked using a Fogarty catheter or, in case of FET, was cannulated
with inﬂatable perfusion catheter and perfused. Near-infrared
spectroscopy (NIRS) was used for neuro-monitoring and moder-
ate hypothermia (24–26°C) for organ protection.
• In Bergamo, the preferred cannulation site was IA, followed in
very rare cases by aorta, AxA or FA (Supplementary material,
Table S4). Unilateral or bilateral moderate hypothermic ACP
(blood temp. 24–26°C) applied by cannulation graft and/or, if ap-
propriate, by inﬂatable perfusion catheters in the IA and left CCA
with a pressure-controlled ﬂow (targeting 40 mmHg) was used
for cerebral protection. During ACP, the LSA was blocked using
a Fogarty catheter. NIRS was used for neuro-monitoring and
moderate hypothermia (26°C) was used for organ protection.
• In Leipzig, the preferred cannulation site was right AxA, followed
by aorta, IA or FA (Supplementary material, Table S4). Mainly bi-
lateral, or less frequently unilateral, hypothermic ACP (blood
temp. 20°C) applied by cannulation graft and/or, if appropriate, by
inﬂatable perfusion catheters in the IA and left CCA, with a ﬂow
(within the range of 8–20 ml of ﬂow per minute/kg body weight)
and pressure according to the surgeons’ preferences. During ACP,
the LSA was blocked using a Fogarty catheter. NIRS was used for
neuro-monitoring and moderate hypothermia (24–28°C) was
used for organ protection.
• In Heidelberg, the preferred cannulation site was the aorta fol-
lowed by FA (Supplementary material, Table S4). Bilateral, mostly
hypothermic ACP (blood temp. about 20°C) applied via 2 inﬂat-
able perfusion catheters in the IA and left CCA with a ﬂow and
pressure according to the surgeons’ preferences was used for
cerebral protection. During ACP, the LSA was blocked using a
Fogarty catheter. NIRS was used for neuro-monitoring and
moderate hypothermia (24–28°C) for organ protection.
• In Munich, until 2011, the preferred cannulation site was an FA
combined with DHCA. Since 2012, a preferred cannulation site has
been aorta followed by right AxA and IA (Supplementary material,
Table S4). Hypothermic ACP (blood temp. 18°C) applied by cannu-
lation graft and/or, if appropriate, by inﬂatable perfusion catheters
in the IA and left CCA with a pressure-controlled ﬂow (60 mmHg)
was used for cerebral protection. During ACP, the LSA was blocked
using a Fogarty catheter. NIRS was used for neuro-monitoring and
moderate hypothermia (24–28°C) for organ protection.
• In Rome, IA or right AxA was used for arterial cannulation
(Supplementary material, Table S4). Unilateral or bilateral hypo-
thermic ACP (blood temp. 24–28°C) applied by cannulation graft
and/or, if appropriate, by inﬂatable perfusion catheters in the IA
and left CCA with a pressure-controlled ﬂow (50–80 mmHg),
resulting in a ﬂow of about 0.7–1.0 l/min. was used for cerebral
protection. During ACP, the LSA was blocked using a clamp or
Fogarty catheter. NIRS and bilateral RR measurement in radial
arteries were used for neuro-monitoring and moderate hypo-
thermia (24–28°C) for organ protection.
Table 2: Operative data
Variables No (%) or mean ± SD
Arterial cannulation
AXA right 464 (37.7)
Aorta 306 (24.8)
CCA 169 (13.7)
IA 149 (12.1)
Femoral 131 (10.6)
Others 13 (1.1)
Cerebral protection
Bilateral CP 777 (63.1)
Unilateral CP 377 (30.6)
DHCA 74 (6.0)
Retrograde CP 1 (0.1)
Othersa 3 (0.2)
CPB time (min.) 206.4 ± 64.4
CP time (min.) 58.1 ± 28.1
CA time of lower body (min.) 50.1 ± 26.0
CA time of brain (min.) 9.3 ± 11.7
Aortic cross-clamp time (min.) 120.8 ± 44.9
Lowest rectal temp. (°C) 26.1 ± 3.5
AXA: axillary artery; CCA: common carotid artery; IA: innominate artery;
CP: cerebral perfusion; DHCA: deep hypothermic circulatory arrest;
CPB: cardiopulmonary bypass; CA: circulatory arrest; LSA: left
subclavian artery.
abeating heart with cross-clamping between left CCA and LSA.
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• In Freiburg, the preferred cannulation site was the right AxA fol-
lowed by an FA (Supplementary material, Table S4). Unilateral or
bilateral hypothermic ACP (blood temp. 18–23°C) applied by
cannulation graft and/or, if appropriate, by inﬂatable perfusion
catheters in the IA and left CCA with a ﬂow of 0.5–1.2 l/min., tar-
geting a pressure of 40–50 mmHg was used for cerebral protec-
tion. During ACP, the LSA was blocked using a Fogarty catheter.
NIRS was used for neuro-monitoring and deep to moderate
hypothermia (about 20–22°C) for organ protection.
• In Hannover, the aorta was used for cannulation exclusively
(Supplementary material, Table S4). Bilateral moderate hypo-
thermic ACP (blood temp. 27°C) applied via 2 inﬂatable cathe-
ters in the IA and left CCA with a pressure-controlled ﬂow (about
50 mmHg), targeting a ﬂow rate of at least 500 ml/min. During
ACP, the LSA was blocked using either a Fogarty catheter or a
clamp. NIRS was used for neuro-monitoring and moderate
hypothermia (25°C) for organ protection during ACP.
• In Essen, the preferred cannulation site was the right AxA followed
by the aorta (Supplementary material, Table S4). Bilateral hypo-
thermic ACP (blood temp. 18°C) applied by cannulation graft and/
or, if appropriate, by inﬂatable perfusion catheters in the IA and
left CCA with a pressure-controlled ﬂow (targeting 50 mm of Hg)
was used for cerebral protection. During ACP, the LSAwas blocked
using a Fogarty catheter. NIRS was used for neuro-monitoring and
moderate hypothermia (24–26°C) for organ protection.
• In Bad Neustadt, the preferred cannulation site was the right
CCA, followed by the left CCA and IA (Supplementary material,
Table S4). Unilateral mild hypothermic ACP (blood temp. above
28°C) applied via cannulation graft with a pressure-controlled
ﬂow (about 80 mmHg), resulting in a ﬂow of about 1.2 l/min. was
used. All arch branches were cross-clamped with soft clamps ex-
clusively. NIRS and bilateral RR measurement in radial arteries
were used for neuro-monitoring and mild hypothermia (about
30°C) for organ protection.
• In Frankfurt, the preferred cannulation site was the right AxA,
followed in very rare cases by the IA or FA (Supplementary ma-
terial, Table S4). Mainly unilateral or bilateral mild hypothermic
ACP (blood temp. above 28°C) applied by cannulation graft in
the right AxA and/or, if appropriate, by inﬂatable perfusion
catheters in the IA and left CCA, with a pressure-controlled ﬂow
(about 75 mmHg), resulting in a ﬂow of about 1.1–1.4 l/min., was
used. During ACP, the LSA was blocked, mainly using Fogarty
catheter and NIRS was used for neuro-monitoring. Mild hypo-
thermia (about 30°C) was used for organ protection.
Deﬁnitions and statistical analysis
The Ethics Committee of the Cardiovascular Clinic Bad Neustadt
granted approval for the study. Principal investigators of each par-
ticular clinic (Supplementary material, Table S1) conﬁrmed the
validation of their respective dataset, especially that all consecu-
tive patients who underwent arch surgery according to the study
deﬁnition had been included.
The clinical charts of all patients were retrospectively reviewed if
no prospectively collected data were available (depending on the
respective centre). Follow-up consisted of a telephone interview
with patients and/or their physicians and especially included the
following variables: survival, neurological morbidity (permanent),
aortic events and a need for aortic reinterventions. The primary
end-points were set as: early (30 days) and late mortality for any
reason, postoperative permanent neurological deﬁcit (within 7 days
after surgery or after gaining consciousness if longer ventilation was
necessary). The secondary end-points included postoperative early
(30 days) transient neurological deﬁcit, late permanent neurological
morbidity and all aortic events including aortic reinterventions.
Categorical variables were reported using the number and per-
centage of occurrences. Continuous variables were expressed as
mean ± standard deviation. The impact of the available variables on
the early (30-day) mortality was analysed using univariable and mul-
tivariable analyses. For the latter, several logistic regression models
were built to determine the independent predictors for early
(30-day) mortality. Actuarial survival was estimated by the Kaplan–
Meier method. The statistical analysis was performed with the SPSS
statistical software package (version 22.0; IBM, Ehningen, Germany).
RESULTS
Operative data
The extent of surgery depended on the extent of aortic arch
disease and the coexistence of other cardiac pathologies (Table 3).
Arch repair involving all 3 arch arteries (total), 2 arch arteries (sub-
total) or 1 arch artery (partial) was performed in 956 (77.6%), 155
(12.6%) and 121 (9.8%) patients, respectively. The extent of aortic
pathology required additional replacement of the ascending aorta
in 1033 (83.8%) and descending aorta in 44 (3.6%) patients.
Concomitant procedures included aortic valve and/or aortic root
surgery in 574 (46.6%), coronary artery bypass grafting in 205
(16.6%) and mitral valve surgery in 33 (2.7%) patients (Table 3).
There were, however, considerable differences with regard to the
extent of surgery between the sub-cohorts. In some centres, the
ET technique was the preferred method of arch replacement
with more than 70% occurrence (Supplementary material,
Table S5). Beginning in 2012, even a rate of 100% was documen-
ted in 1 centre. In contrast, only 2 centres reported about com-
bined conventional arch and descending aorta replacement
(Supplementary material, Table S5), and the rate of descending
aorta replacements combined with at least partial arch replace-
ment was only 3.6% altogether (Table 3). Also, the incidences of
valve-sparing root repair, complete root replacement with valve
composite graft, concomitant mitral valve surgery and coronary
Table 3: Extent of surgery
Variables No (%) or mean ± SD
Extension of arch repair
Repair 3 arch arteries 956 (77.6)
Repair 2 arch arteries 155 (12.6)
Repair 1 arch artery 121 (9.8)
Ascending aorta replacement 1033 (83.8)
Descending aorta replacement 44 (3.6)
Aortic valve sparing 247 (20.0)
VSRR 190 (15.4)
Aortic valve replacement 327 (26.6)
Valve conduit 218 (17.7)
Mitral valve surgery 33 (2.7)
CABG 205 (16.6)
VSRR: valve-sparing root repair; CABG: coronary artery bypass grafting.
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bypass grafting (CABG) were remarkably different between the
sub-cohorts (Supplementary material, Table S5). Accordingly, op-
erative data such as ischaemic time, perfusion time and tempera-
ture; which are provided in Table 2 for the entire cohort, varied
considerably between particular sub-cohorts (Supplementary ma-
terial, Table S6). Especially, the brain ischaemia time (9.3 ± 11.7)
occurred only in patients undergoing DHCA or those patients
with ACP, in whom a femoral artery or the aorta was cannulated
and in whom the perfusion had to be completely interrupted
during the placement of perfusion cannulas in the arch branches.
Some cerebral perfusion data, especially, the ﬂow, pressure and
blood temperature during ACP, were reported incompletely, and
therefore, had to be excluded from the multivariable statistical
analysis (see below).
Early mortality and morbidity
Four foreign patients, who went to their countries after discharge,
were lost to follow-up before the end of the 30-day postoperative
period. The in-hospital and 30-day mortality rates for the remain-
ing cohort of 1228 patients were 11.4% (140 patients) and 8.8%
(108 patients) (Table 4).
Postoperative complications comprised the incidence of rester-
notomy for haemorrhage, reintubation, tracheostomy, renal failure
(by means of temporary or permanent dialysis), myocardial infarc-
tion and transient or permanent neurological deﬁcits. An occur-
rence of tracheostomy was reported incompletely and therefore
was excluded from statistical analysis.
Resternotomy for haemorrhage was required in 150 (12.2%)
cases. Postoperative respiratory failure occurred in 262 patients
(21.3%), among whom 77 (6.3%) required prolonged ventilation
primarily and 185 (15.0%) after reintubation. Renal failure with
transient or permanent dialysis was required in 108 (8.8%) and 52
(4.2%) cases. The incidence of perioperative myocardial infarction
was low (1.5%) despite the relatively high rate of concomitant cor-
onary heart disease, requiring simultaneous CABG in 205 patients
(16.6%), (Table 3). Focal permanent and transient defects or
transient neuro-psychological deﬁcits were noted in 70 (5.7%), 40
(3.3%) and 97 (7.9%) patients. Postoperative paraplegia occurred
in 13 patients (1.1%).
Statistical analysis revealed signiﬁcant differences between the
surgical outcomes in particular sub-cohorts (Supplementary
material, Table S7). The 30-day mortality ranged between 1.7 and
19.0%, the rate of permanent neurological deﬁcit from 0 to 12.0%
and the paraplegia rate from 0 to 3.6%. In the univariable analysis,
the surgical centre, age, EF, previous CABG, number of previous sur-
geries means sternotomy, concomitant surgeries, cardiopulmonary
bypass (CPB) time and cardiac cross-clamp time were revealed as
predictors of increased 30-day mortality (Table 5). In the multivari-
able analysis, several models were built in which a few variables had
to be excluded. For example, CCA cannulation was performed in
only one centre, and the brain ischaemia occurred only in patients
undergoing DHCA or those patients with ACP in whom a femoral
artery or the aorta was cannulated; consequently, it was also limited
to only a few centres. Lastly, as mentioned above, several preopera-
tive and operative data were not complete and were even missing
entirely in some centres. For example, 2 centres did not provide EF
at all and would have been excluded completely from the analysis.
Nonetheless, it has to be emphasized that in all models, the surgical
centre could be revealed as the most important predictor of early
mortality. Eventually, a model, adjusting the 30-day mortality with a
particular centre, patient age, number of previous surgeries with
sternotomy and concomitant surgeries (Table 6) revealed to be
very suitable in regard to the number of observations (1129 cases
equalling 88% of the study group) and in regard to the conformity
between occurrences and estimated probabilities as shown in the
goodness-of-ﬁt test.
Survival
The follow-up of the study group was 96.5% complete with an
overall follow-up duration of 3.3 ± 2.9 years, resulting in 4,020
patient-years. Forty-three patients were lost to follow-up, including
4 who were lost after discharge but still during the 30-day
Table 4: Outcome and follow-up
Variables No (%) or mean ± SD
30-day mortality 108 (8.8)
In-hospital mortality 143 (11.6)
Re-sternotomy 150 (12.2)
Dialysis 160 (13.0)
Permanent 52 (4.2)
Transient 108 (8.8)
Myocardial infarction 18 (1.5)
Neurological defect
Focal permanent 70 (5.7)
Focal transient 40 (3.3)
Paraplegia 13 (1.1)
Transient neuro–psychological deficit 97 (7.9)
Lost to follow-up 43 (3.5)
Follow-up duration (years) 3.3 ± (2.9)
Overall mortality 317 (25.8)
Table 5: Univariable analysis to identify risk factors for
30-day mortality
Variables Odds Ratio 95% CI P-value
Low High
Centre B 3.09a 0.61 15.72 0.18
Centre C 6.61a 1.96 22.31 0.002
Centre D 7.40a 2.06 26.60 0.002
Centre E 2.58a 0.66 10.16 0.174
Centre F 12.57a 2.32 68.15 0.003
Centre G 8.26a 2.39 28.48 0.001
Centre H 5.33a 1.15 24.70 0.032
Centre I 7.48a 2.17 25.78 0.001
Centre K 13.73a 3.68 51.22 0.000
Centre L 5.10a 0.81 32.16 0.083
Age 1.03 1.01 1.05 0.001
EF 0.97 0.95 0.99 0.001
Pervious CABG 1.58 1.03 2.42 0.035
No of previous surgeriesb 2.64 1.40 4.95 0.003
Concomitant CABG 1.71 1.05 2.79 0.030
Concomitant MVR 1.70 0.58 4.99 0.332
CPB time 1.01 1.01 1.01 0.000
Cardiac cross-clamp time 1.01 1.00 1.01 0.000
CI: confidence interval; EF: ejection fraction; CABG: coronary artery
bypass grafting; MVR: mitral valve repair/replacement; CPB:
cardiopulmonary bypass.
ain relation to centre A.
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postoperative period. After hospital discharge, 176 (14.3%) patients
died, resulting in an overall mortality rate of 25.6% (Table 7). The
actuarial survival after 5 and 8 years was 72.0 ± 1.5% and 64.0 ± 2.0,
respectively (Fig. 1). The respective causes of death were cardiac-
related in 20 (1.6%), aortic-related in 17 (1.4%), neurologic-related
in 4 (0.3%) and non-cardiac-related in 62 (5.0%) patients. However,
in 5.8% (72) of the cases, the causes of death were unknown
(Table 7).
Aortic events
In the entire study period, a total of 130 (10.6%) aortic events oc-
curred, including aortic dissection in 3 (0.2%), formation of a false
aneurysm in a further 3 (0.2%), aortic rupture in 18 (1.5%) and
others (including endoleak development after stented elephant
trunk or distal aortic progression) in 106 cases (8.6%).
DISCUSSION
With the data presented, we are confronted with a fact that overall
surgical risk in elective aortic arch surgery has remained high
during the last decade despite the advancements in surgical tech-
niques. The evaluation of procedural methods additionally
supports the results of the observations from the recently pub-
lished survey from the EACTS vascular domain group on current
trends in cannulation and neuroprotection during surgery of the
aortic arch in Europe [11]. Only a decade ago, DHCA, RCP and
ACP represented three almost equally distributed strategies for
cerebral and visceral organ protection [12]. More recently, a clear
trend towards ACP is noticeable in the literature, and it was con-
ﬁrmed by our results with only 1/1232 patients (0.1%) receiving
RCP and only 74/1232 patients (6.0%) using DHCA for cerebral
protection. While the vast majority of patients (93.7%) were oper-
ated on employing selective ACP, presented data reveal a substan-
tial diversity regarding the technical details, including cannulation
site, ACP ﬂow, ACP pressure and temperature management.
However, even similar surgical and cerebral perfusion techniques
may yield different outcomes due to the variations in cardiopul-
monary bypass perfusion ﬂow and pressure, temperature and
glucose management and haematocrit proﬁle [13]. Additionally,
most of the perfusion variables vary over the duration of the surgi-
cal procedure, so continuous data recording with the advent of
electronic perfusion recording systems may be needed to ﬁnd out
the subtle yet important changes.
Actually, we hoped that the study would enable us to identify
the procedural aspects impacting the surgical outcomes; yet, the
complete intraoperative monitoring data were not continuously
recorded in all centres and therefore not available for retrospect-
ive analysis. Additionally, the techniques were closely connected
with speciﬁc centres (mostly at a 1:1 ratio), making a separate ana-
lysis nonsensical, especially from the statistical point of view. In
other words, it was not possible to differentiate if the results in
particular centres were associated with the characteristics of their
sub-cohorts or speciﬁc procedural methodologies. Consequently,
an assessment of the impact of speciﬁc technical details on surgi-
cal outcomes will be the major task of future studies. The necessity
for prospective randomized multicentre trials has been advocated
several times before, but its realization seems to be very difﬁcult
for many reasons. One of them is a lack of homogenous deﬁni-
tions in the ﬁeld of aortic arch surgery, especially the fundamental
deﬁnition of the area of arch surgery. Most series reporting on
aortic arch surgery include the results of simple ‘hemiarch’ re-
placement, even if it is well recognized that not only the extent of
this repair but also the surgical techniques and outcomes differ
substantially when compared with total aortic arch replacement
[2, 5, 14, 15]. Taking this aspect into account, it is not surprising
that the current guidelines do not give evidentiary
Table 7: Cause of death
Variable In-hospital, No (%) After discharge, No (%)
Total 140 (11.4) 176 (14.3)
Cardiac 46 (3.7) 20 (1.6)
Non-cardiac 66 (5.4) 62 (5.0)
Aortic 11 (0.9) 17 (1.4)
Neurological 18 (1.5) 4 (0.3)
Sudden/unknown 3 (0.2) 72 (5.8)
Table 6: Multivariable analysis to identify risk factor for
30-day mortality
Variables Odds Ratio 95% CI P-value
Low High
Centre B 2.83a 0.54 14.73 0.217
Centre C 6.82a 1.93 24.13 0.003
Centre D 7.28a 1.98 26.82 0.003
Centre E 2.51a 0.63 10.04 0.192
Centre F 14.30a 2.50 81.68 0.003
Centre G 8.30a 2.37 29.04 0.001
Centre H 6.20a 1.30 29.57 0.022
Centre I 6.35a 1.80 22.56 0.004
Centre K 12.57a 3.31 47.70 0.000
Centre L 4.02a 0.62 26.20 0.146
Age 1.05 1.02 1.07 0.000
No of previous surgeriesb 1.21 1.04 1.42 0.016
Concomitant CABG 1.79 1.06 3.04 0.029
Concomitant MVR 2.35 0.75 4.61 0.143
CABG: coronary artery bypass grafting; MVR: mitral valve repair/
replacement; CI: confidence interval.
ain relation to centre A.
bcardiovascular surgeries performed through sternotomy.
Figure 1: Actuarial survival (Kaplan–Meier) after aortic arch replacement.
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recommendations for aortic arch surgery [16, 17]. Such recom-
mendations should not only differentiate between the extents of
surgery but also consider acceptable risk, especially in such path-
ologies like asymptomatic chronic aneurysm (as it has been pro-
vided for decades for asymptomatic carotid stenosis [18]). Another
key deﬁnition concerns the lowest core temperature since sub-
stantial differences may occur depending on whether bladder,
rectal or nasopharyngeal temperatures are reported. Similarly,
perfusion pressure during ACP may be understood as the pressure
recorded on the arterial line or, on the right or left radial artery. In
addition, the ACP ﬂow may be reported misleadingly high in cases
in which an unknown amount of the ﬂow is directed to the right
arm. It seems hardly comprehensible why cerebral perfusion in a
120-kg patient should be double that of a 60-kg patient; and
therefore, the pressure measurement seems to be indispensable.
When compared with a visual evaluation of the backﬂow from an
unclamped supra-aortic artery, the pressure monitoring is object-
ively gaugeable, efﬁcient and reproducible. Furthermore, it needs
to be distinguished between classic clamping of non-perfused
arch vessels when compared with endovascular balloon occlusion,
which is less controllable and may result in accidental injuries,
misplacements and thrombo-embolic events. Nevertheless, there
is still a problem in conducting randomized multicentre trials that
assess particular surgical methods in aortic arch surgery. There
seems to be a creed among particular aortic surgeons who
develop a strong attachment to their distinct perfusion and tem-
perature management protocols with which they achieve good
clinical outcomes and are not willing to switch their routine for
clinical trials. Members of the EACTS vascular domain group re-
cently experienced this renunciation when attempting to initiate a
prospective multicentre trial with a random assignment to either
unilateral or bilateral ACP.
In summary, the presented data reveal that the surgical risk in
elective aortic arch surgery has remained high during the last
decade despite the advancements in surgical techniques. Despite
the widespread acceptance of ACP, a substantial heterogeneity of
technical details in aortic arch surgery is still an issue. Whether the
impact of one or more of these details led to the broad range of
reported mortality and morbidity rates could not ultimately be
delineated; and therefore, the members of the steering committee
of the current investigation strongly recommend the need for
further multicentre studies, preferably registries, in which all
relevant variables have to be thoroughly deﬁned and collected
prospectively.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
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Abstract
OBJECTIVES: The true incidence of aortic events (AEs) and reoperations (REDO) following elective total aortic arch replacement remains
unknown. The aim of this study was to review the incidence of AEs and surgical REDO, and its respective outcomes after 1232 elective arch
repairs at 11 European aortic centres.
METHODS: Retrospective chart review (in the absence of prospective data collection) was performed for statistical analysis. Follow-up
was conducted during routine clinical examination or in a telephone interview with patients and/or their respective physicians.
RESULTS: One hundred fifty-five (12.6%) patients were identified (median follow-up time 48.7months). The recorded AEs comprised aor-
tic dilatation (62.6%), rupture (15.5%), endoleak (11%), false aneurysm (3.9%), dissection (3.2%), infection (2.6%) and others (1.3%). REDO
(open/endovascular) were performed in 85.8% of patients (n = 133). Intraoperative and in-hospital mortality in the REDO patients were
7.5% and 17.3%, respectively. Postoperative neurological complications comprised paraplegia (6.0%) and stroke (1.5%). Survival rates after
REDO at 1, 3 and 5 years were 81.2%, 79.0% and 76.7%, respectively. Univariate analysis identified ‘rupture’ and ‘diameter progression’,
‘older age at REDO’ and the REDO strategies ‘frozen elephant trunk’ and ‘no elephant trunk’ as predictors of increased in-hospital mortality.
Multivariate analysis identified ‘older age at REDO’ (P = 0.008) as the only independent risk factor for in-hospital mortality.
CONCLUSIONS: AEs after elective arch surgery are not irrelevant and mostly involve the distal aspects of the adjoining aorta. In accord-
ance with the underlying pathology, open or endovascular REDO may be performed with an acceptable outcome. Preparation of an ad-
equate proximal landing zone at the time of primary arch surgery is advisable.
Keywords: Aortic arch • Surgery • Follow-up • Aortic events • Aortic reoperation • Thoracic endovascular aortic repair
INTRODUCTION
Despite substantial improvement in survival and outcomes, elect-
ive total aortic arch surgery remains challenging and is associated
with significant morbidity and mortality [1–3]. The use of thoracic
endovascular aortic repair (TEVAR) in the transverse arch is still
limited due to a lack of adequate proximal landing zones (LZs)
and suitable aortic stent grafts, which safely match that of the
arch’s anatomy [4–6]. On the other hand, the use of hybrid tech-
niques, such as the frozen elephant trunk (FET), is increasing, es-
pecially in extensive arch disease [7–9].
Although aortic surgery has been routinely performed for dec-
ades, the true incidence of aortic events (AEs) and reoperations
(REDO) following elective total aortic arch replacement remains
†Presented at the 30th Annual Meeting of the European Association for
Cardio-Thoracic Surgery, Barcelona, Spain, 1–5 October 2016.
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unknown. Therefore, the aim of this analysis was to estimate, on
the basis of mid-term follow-up data after 1232 elective arch re-
placements, the incidence of AEs, surgical strategies and postop-
erative outcomes after REDO.
MATERIALS AND METHODS
As previously reported [1], the perioperative data of 1232 patients
undergoing elective surgery for chronic aortic arch disease with
at least 1 circular aortic anastomosis at 11 European aortic
centres between January 2004 and December 2013 were retro-
spectively analysed (Supplementary Material, Table S1).
Emergency (e.g. acute Type A aortic dissection) or unscheduled
surgery (e.g. iatrogenic aortic injury) and hemiarch repairs were
excluded from the primary analysis. The extent of elective arch
repair was defined as partial, subtotal or total with regard to the
reimplantation of 1, 2 or 3 supra-aortic arteries.
Incidence of aortic events
One hundred fifty-five (12.6%) patients with an AE during a me-
dian follow-up time of 48.7 [interquartile range (IQR) 23.7–81.9]
months were identified and included in this study for further
analysis. The median time interval between primary aortic arch
surgery and occurrence of an AE was 11.3 (IQR 4.2–38.4)
months. The median age at the time of AE and/or REDO was
64.9 (IQR 53.8–70.4) years, and 103 (66.5%) patients were men.
Total arch replacement with reimplantation of all 3 supra-aortic
branches was performed primarily in 149 (96.1%) cases including
41 (26.4%) with conventional elephant trunk (ET) and 79 (51%)
with FET procedures, whereas 5 (3.2%) patients had had a sub-
total and 1 patient (0.6%) had a partial arch replacement.
Additional ascending aortic replacement during primary arch
surgery was performed in supracoronary fashion (n = 87; 56.1%)
or in conjunction with aortic root surgery in 43 (27.7%) patients.
Table 1 lists the details of primary open arch surgery for the
study cohort at the time of AE.
Definitions and statistical analysis
The ethics committee of the Cardiovascular Clinic Bad Neustadt
granted approval for this study. The principal investigators of
each particular clinic (Supplementary Material, Table S1) con-
firmed the validation of their respective data set, especially that
all consecutive patients who underwent arch surgery according
to the study definition had been included.
The methodology of data acquisition for the initial study group
has been reported previously [1]. In brief, the patient data were
retrospectively reviewed in the absence of prospectively collected
data (depending on the respective centre). Follow-up of patients
who were not included in a routine institutional surveillance pro-
gramme was conducted via a telephone interview with patients
and/or their respective physicians. The following variables were
updated or added to the existing data set with regard to AE (with or
without REDO): date and location of AE, reoperation date and
treated aortic segment as well as survival (early and late) and neuro-
logical morbidity (permanent) postoperatively. Follow-up time com-
prised the time interval between the primary aortic arch surgery
and the last patient contact or death of all patients, independently
of occurring AEs. Patient deaths were not excluded.
AEs were defined as any aortic complication and/or aortic
reoperation/reintervention following primary aortic arch repair.
Aortic diameter progression, as a continuous process, was
defined as an AE at the time when a need for surgical or endo-
vascular treatment was evident (as indicated by the treating sur-
geon). The data analysis was performed according to the
statistical and data reporting guidelines of the European Journal
of Cardio-Thoracic Surgery [10].
Categorical variables were reported using the number and per-
centage of occurrences. Continuous variables were expressed as
median and IQR (25th–75th percentile) or mean± standard devi-
ation. The impact of the available variables on the in-hospital mor-
tality was analysed using univariate and multivariate regression
analyses. Binary logistic regression model was built using variables
with a P-value of <0.1 from univariate analysis. A P-value of <0.05
was considered statistically significant. Actuarial survival was esti-
mated by the Kaplan–Meier method. The statistical analysis was
performed with the SPSS statistical software package (version 23.0;
IBM, Ehningen, Germany).
RESULTS
The types of AE, their aortic localization and the treatment are
presented in Table 2. The most frequent type of AE was aortic
diameter progression in 97 (62.6%) patients after a median of
12.5 (IQR 5.5–42.5) months—including patients without ET, with
conventional ET and FET in 14 (14.4%), 29 (29.9%) and 54 (55.7%)
cases, respectively. Comparison of both ET techniques revealed a
Table 1: Preoperative patient data (n = 155)
Patients with aortic event, n (%) 155 (100)
Age at event, median (IQR) 64.9 (53.8–70.4)
Male gender, n (%) 103 (66.5)
Indication for primary arch surgery, n (%)
Aneurysm 92 (59.4)
Chronic dissection 54 (34.8)
False aneurysm 3 (1.9)
Infection/inflammation 4 (2.6)
Other 2 (1.3)
Primary arch surgery, n (%)
Total arch replacement (3 supra-aortic anastomoses) 149 (96.1)
Conventional ET 41 (26.5)
FET 79 (51.0)
Subtotal arch replacement (2 supra-aortic
anastomoses), n (%)
5 (3.2)
Partial arch replacement (1 supra-aortic
anastomosis), n (%)
1 (0.6)
Supracoronary ascending aortic replacement, n (%) 87 (56.1)
Root surgery, n (%) 43 (27.7)
Bentall procedure, n (%) 24 (15.5)
Biological 12 (7.7)
Mechanical 12 (7.7)
David procedure,a n (%) 13 (8.4)
Yacoub procedure,a n (%) 5 (3.2)
Aortic valve replacement, n (%) 23 (14.8)
CABG, n (%) 15 (9.7)
Mitral valve repair, n (%) 2 (1.3)
aIncluding modifications.
CABG: coronary artery bypass graft; ET: elephant trunk; FET: frozen ele-
phant trunk; IQR: interquartile range.
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significantly higher incidence of aortic diameter progression in
patients with primary FET than conventional ET (35.2% vs 17.0%;
P = 0.0001). The occurrence of a false aneurysm was less frequent
(n = 6; 3.8%) with a late onset after arch surgery (median
41months, IQR 37.0–80.0). In comparison, infection (n = 4; 3%)
was found to be the earliest complication of the cohort with a
median time-to-occurrence of 5.3 (IQR 1.1–12.4) months.
Endoleak (n = 17; 11%) occurred at a median time frame of 6.8
(IQR 2.9–34.6) months. Acute life-threatening AE by means of
‘rupture’ and ‘dissection’, including 2 Type A and 3 Type B aortic
dissections, occurred after a median time interval of 18.4 (IQR
6.5–31.5) and 48.6 (IQR 0–78.9) months, respectively. The median
time interval between primary aortic arch surgery and occur-
rence of any AE was 11.3 (IQR 4.2–38.4) months.
The recorded AEs were distributed in the following locations:
ascending aorta/arch, descending and abdominal aorta in 9.0%
(n = 14), 79.4% (n = 123) and 10.3% (n = 16), respectively. Two
(1.3%) patients had died in different peripheral hospitals due to
acute aortic rupture. However, no further information, other
than the plain cause of death (aortic rupture), regarding the exact
aortic location could be obtained retrospectively.
In 133 patients suffering an AE, either an open or an endovas-
cular REDO was performed, whereas 22 (14.1%) patients were ei-
ther deemed inoperable or died prior to any intervention
(Table 2).
Of note, 9 of the 133 patients required repeated treatment
during follow-up time by means of 2 (n = 8, 6%) or 3 (n = 1, 0.8%)
REDO procedures.
Surgical strategies
Open REDO was performed in 58 (43.6%) patients. The median
interval between elective arch repair and open REDO was 13.9
(IQR 5.9–35.9) months. Proximal open repair of the ascending
aorta or aortic arch was required in only 9 (6.8%) patients,
whereas 49 (36.8%) patients underwent open surgical repair of
the distal aorta, including the descending and abdominal aorta in
42 (31.6%) and 7 (5.3%) cases, respectively. Endovascular REDO
of the thoracic or abdominal aorta was performed after a median
time period of 9.2 (IQR 3.8–41.4) months. TEVAR was the pri-
marily performed technique in 70 (52.6%) patients, whereas
an abdominal endografting was performed in only 5 (3.2%)
Figure 1: Actuarial survival estimation (Kaplan–Meier method) with 95% confi-
dence interval after aortic REDO. Survival was calculated starting with the pro-
cedure. AE: aortic event; REDO: reoperation.
Table 3: Outcome after REDO (n = 133)
Ascending/
arch REDO,
n (%)
Descending
REDO,
n (%)
Abdominal
REDO,
n (%)
Overall,
n (%)
REDO procedures 9 (6.8) 112 (84.2) 12 (9.0) 133 (100)
Mortality
In-hospital 2 (1.5) 18 (13.5) 3 (2.3) 23 (17.3)
During follow-up 0 11 (8.3) 0 11 (8.3)
Overall 2 (1.5) 29 (21.8) 3 (2.3) 34 (25.6)
Neurological complications
Paraplegia 0 7 (5.3) 1 (0.8) 8 (6.0)
Stroke 1 (0.8) 1 (0.8) 0 2 (1.5)
REDO: reoperation.
Table 2: Aortic events: pathologies, localizations and treatments
Ascending aorta/arch, n (%) Descending aorta, n (%) Abdominal aorta, n (%) Unknown location, n (%) Overall, n (%)
Aortic events 155 (100)
Aortic diameter progressiona 2 (1.3) 83 (53.5) 12 (7.7) 0 97 (62.6)
Aortic rupture 2 (1.3) 17 (11.0) 3 (1.9) 2b (1.3) 24 (15.4)
Aortic dissection 2 (1.3) 3 (1.9) 0 0 5 (3.2)
False aneurysm 5 (3.2) 1 (0.6) 0 0 6 (3.8)
Endoleakage 0 17 (11.0) 0 0 17 (11.0)
Infection 2 (1.3) 2 (1.3) 0 0 4 (2.3)
Other events 1 (0.6) 0 1 (0.6) 0 2 (1.3)
REDO procedures 133 (100)
Open surgery 9 (6.8) 42 (31.6) 7 (5.3) 0 58 (43.6)
Endovascular surgery 0 70 (52.6) 5 (3.8) 0 75 (56.4)
Aortic events without REDO 1 (4.5) 13 (59.1) 3 (13.6) 2 (9.1) 22 (100)
aProgression to an aneurysmatic aortic diameter requiring endovascular or surgical treatment.
bDeath occurred in different peripheral hospitals; no information other than ‘aortic rupture’ could be obtained retrospectively.
REDO: reoperation.
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patients for diameter progression of abdominal aortic aneurysms
(Table 2).
Outcomes after reoperation
Median follow-up times for the entire AE cohort (n = 155) and for
the REDO subcohort (n = 133) were 48.7 (IQR 23.7–81.9) months
and 51.8 (IQR 29.8–83.9) months, respectively.
The intraoperative mortality in the REDO subcohort was 7.5%
(n = 10) with 6 (4.5%) intraoperative deaths during open surgery
and 4 (3.0%) fatal endovascular reinterventions (P = 0.3309).
Overall in-hospital mortality (including 10 intraoperative deaths)
was 17.3% (n = 23). New (permanent) postoperative neurological
complications comprised paraplegia (n = 8; 6.0%) and stroke
(n = 2; 1.5%). Paraplegia was more frequent after open (n = 5) than
after endovascular (n = 3) procedures (8.6% vs 4.0%; P = 0.2951)
with an incidence after descending (n = 7) and abdominal (n = 1)
aortic REDO of 6.2% and 12.5% (P = 0.4341), respectively. The re-
spective 1-, 3- and 5-year survival rates after REDO were 81.2%,
79.0% and 76.7% (Fig. 1, Table 3).
Comparison of the survivals after open surgery of the proximal
aorta (ascending aorta/arch) and descending aorta showed no
significant differences (log rank, P = 0.613) (Fig. 2). However, com-
parison of REDO for descending aortic pathology showed a trend
toward better survival at 5 years after TEVAR versus open surgery:
77.2% vs 69.1% (log rank, P = 0.059) (Fig. 3).
Univariate analysis identified the AE rupture (P < 0.001) and AE
diameter progression (P = 0.006), older age at REDO (mean
61.3 ± 12.3 vs 70.1 ± 6.6 years; P = 0.002) and the primary surgical
strategies ‘FET’ (P = 0.021) and ‘no elephant trunk’ (P = 0.029) as
predictors of increased in-hospital mortality. However, multivari-
ate analysis identified older age at REDO (P = 0.008) as the only
independent risk factor for in-hospital mortality (Table 4;
Supplementary Material, Table S2).
Causes of death for the entire study cohort (n = 155) were
noted as aortic (18.6%), cardiac (3.8%), non-cardiac (5.1%),
neurological (0.6%), sudden/unknown (2.6%) and other (0.6%)
(Supplementary Material, Table S3). However, aortic-related
deaths occurred in 14 (63.6%) of the 22 non-REDO patients.
DISCUSSION
Open surgery is still considered the gold standard for definite
treatment of aortic arch pathologies with well-documented post-
operative results worldwide [1, 3, 11, 12]. However, little is known
about AEs after elective arch replacements and subsequent thera-
peutic strategies. As shown in the current analysis, most indica-
tions for REDO typically arise from the descending thoracic aorta
rather than from the aortic arch or the ascending aorta. Despite
being less frequently present and not directly related to proximal
aortic arch repair in the study group, abdominal AEs can also de-
velop over time and, if not diagnosed in time, may result in fatal
outcomes (e.g. aortic rupture). This stresses the need for routine
surveillance programmes after proximal aortic surgery—using
advanced imaging techniques and interdisciplinary teams—to de-
tect indications for REDO of the non-treated aortic segments at
an early stage [13].
Of the 1232 electively operated aortic arch repairs between
2003 and 2013 [1], 155 (12.6%) patients experienced an AE during
the median follow-up period of 48.7months. Reoperation of the
Table 4: Significant parameters associated with in-hospital
mortality as identified by univariate and multivariate analyses
Univariate analysis P-value
Primary arch surgery
No ET 0.029
FET 0.021
Aortic event
Diameter progression 0.006
Rupture 0.001
Age at REDO 0.002
Multivariate analysis OR 95% CI P-value
Low High
Age at REDO 1.087 1.005 1.176 0.008
CI: confidence interval; ET: elephant trunk; FET: frozen elephant trunk;
OR: odds ratio; REDO: reoperation.
Figure 3: Actuarial survival estimation (Kaplan–Meier method) with 95% confi-
dence interval after REDO of the descending aorta: open versus endovascular
surgery. Survival was calculated starting with the procedure. TEVAR: thoracic
endovascular aortic repair; REDO: reoperation.
Figure 2: Actuarial survival estimation (Kaplan–Meier method) with 95% confi-
dence interval after open REDO: proximal versus distal. Survival was calculated
starting with the procedure. Asc.: ascending; REDO: reoperation.
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proximal aorta by means of ascending aortic REDO was very low
and occurred in only 0.7% of the initial study cohort. This result
confirms that elective open surgery of the arch, accompanied by
surgical treatment of aortic valve and/or root, provides a very
durable result for the proximal part of the aorta. In contrast,
postoperative AEs frequently involve the distal aortic arch and
the adjacent descending aorta, and often need to be resolved by
several reinterventions.
At the descending aortic level, 112 (84.2%) of 133 REDO pa-
tients underwent either open (n = 42, 31.6%) or endovascular
(n = 70, 52.6%) surgery due to an AE. The most frequent AE in the
study group (n = 155) was aneurysmal diameter progression in
the descending aortic segment (n = 83, 54.2%), representing 6.7%
of the original study cohort (n = 1232). Distal aneurysmal diam-
eter progression occurred more frequently after conventional ET
or FET procedures (n = 74) than in patients without ET (n = 9)
(6.0% vs 0.7%), suggesting that extensive aortic disease or some
mild descending aortic dilatation most likely had been present at
the primary operation of patients treated by ET or FET. However,
the significantly higher incidence of diameter progression in FET
compared with conventional ET patients was rather unexpected
due to the recent theory of positive aortic remodelling [14, 15].
In the literature, the true incidence of aneurysmal dilatation of
the distal aorta after proximal aortic arch surgery is not well
defined but has been reported to vary from 5% to 35% of pa-
tients with Marfan syndrome, depending upon the extent of pre-
vious surgery and the quality of follow-up [16]. The increased
wall tension and the pressure rise in the residual aorta after pros-
thetic replacement of the ascending aorta, as observed by
Scharfschwerdt et al. [17] in an in vitro model, may additionally
increase the risk of distal aortic dilatation and subsequent sur-
gery. This also seems to apply for the risk of aortic rupture and
dissection, both of which occurred most frequently in the des-
cending aortic segment (Table 2).
In the absence of a proximal LZ, an open extensive aortic
REDO may be the only treatment option. However, primary sur-
gery including ET and FET procedures may prevent open REDO
in the downstream aorta by facilitating subsequent endovascular
repair [8, 13, 18, 19] (Fig. 4). As an alternative to ET/FET proced-
ures, a proximal move of supra-aortic arteries to the ascending
aorta can, during conventional arch surgery, sufficiently create an
appropriate LZ [12, 20]. This strategy of creating a sufficient LZ
during primary arch surgery is also supported by the finding that
TEVAR showed a trend towards better survival rates when com-
pared with open REDO of the descending aorta. However, if the
respective aortic pathology (e.g. descending aortic aneurysm) ex-
tends to the distal level of the descending aorta, the stent graft of
the FET prosthesis usually cannot be properly anchored. In such
cases, the use of longer hybrid prostheses or TEVAR extension in
the same session may be required; however, there is an increased
risk of paraplegia [13, 21].
In the univariate analysis, primary arch replacement with FET
was identified as a predictor of increased operative mortality. It
remains unclear, however, whether FET is most frequently used
in high-risk patients with extensive arch and descending path-
ology, especially because in some centres, this technique seems
to be used preferably or even exclusively in all patients [1]. On
the other hand, it is a fact that the use of the FET technique is
associated with a longer circulatory arrest time that, undoubt-
edly, can impact surgical outcome. Nevertheless, a lack of prox-
imal LZ after arch replacement can hinder a later use of TEVAR
and can make a more risky and extended open surgery neces-
sary. Therefore, the approach to the primary arch replacement
should definitely consider the preparation of a sufficient LZ for
potential reinterventions.
Older age at REDO was found to be the only independent risk
factor for operative mortality by multivariate analysis. As a matter
of fact, surgery in the elderly is often compromised by associated
comorbidities, resulting in higher mortality rates [22]. Shortly
after primary surgery, the disease process as such may have al-
ready strained the body’s resources and, as found in the study
group, early REDO may be required emergently due to lethal
events, such as aortic infection or rupture.
The most evident neurological complication after open and
endovascular REDO was paraplegia with an overall occurrence of
6%. These observations stress the need for further measures to
Figure 4: Endovascular extension of the frozen elephant trunk prosthesis (white arrow) (A) at the descending aortic level by thoracic endovascular repair (B) and at
the abdominal level by 4-branched endovascular repair (C).
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completely eliminate paraplegia as the most devastating compli-
cation of thoracic and thoraco-abdominal aortic surgery. As
there is still no consensus as to whether to reimplant or sacrifice
the aortic segmental arteries during open thoracic surgery and
thoraco-abdominal surgery. In TEVAR segmental artery preserva-
tion is not possible at all, new concepts such as spinal cord collat-
eral network preconditioning by segmental artery occlusion prior
to either open or endovascular aortic repair should be con-
sidered in the future [23]. However, this new strategy of spinal
cord precondition requires further experimental and clinical
evaluation [24, 25].
Limitations
Due to the retrospective nature of the study and the heterogen-
eity of the study cohort, as regards the different participating
centres and the primary surgical indications and techniques of
total arch repair performed, the underlying results and their
implications may be limited. However, to our knowledge, this
retrospective clinical multicentre analysis currently comprises the
largest cohort of patients suffering from AEs after primary elective
total aortic arch replacement and may therefore offer valuable
information to the cardiovascular community.
CONCLUSIONS
In summary, the presented data reveal that the rate of AEs and
REDO after elective surgery is not irrelevant and mainly involves
the descending aorta. Open and endovascular reoperations have
acceptable outcome. However, TEVAR seems beneficial for sur-
vival at the descending level, and, consequently, preparation of
an adequate proximal LZ at the time of primary arch surgery is
advisable. Moreover, routine follow-up and institutional surveil-
lance programmes are necessary after aortic arch surgery for
early recognition of pathological sequelae and consequently, the
need for reoperation.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
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Abstract
OBJECTIVES: Management of patients with acute aortic dissection type A (AADA) and cerebral malperfusion secondary to occlusion or
stenosis of the left common carotid artery (LCCA) or right common carotid artery (RCCA) is a signiﬁcant challenge. The aim of this study is
to present our institutional strategy and postoperative results for this high-risk patient cohort.
METHODS: Between November 2005 and July 2013, 23 of 354 consecutively operated AADA patients [median age: 66.3; interquartile
range (IQR): 55.2–69.9] suffered from cerebral malperfusion due to bilateral (n = 1) or unilateral occlusion of the LCCA/RCCA (n = 22).
AADA repair comprised hemi- (n = 14) or total (n = 9) arch replacement in combination with aortic valve repair (n = 7) or replacement (n =
11), root replacement (n = 15) and coronary bypass (n = 3). Extra-anatomic aorto-carotid bypass was performed in all patients. Aorto-
carotid bypass was performed at the beginning of the procedure to allow for unilateral selective cerebral perfusion (n = 17; 73.9%) or
during the procedure if persisting malperfusion was suspected by near-infrared spectroscopy (n = 6; 26.1%).
RESULTS: The median follow-up was 15.2 months (IQR: 4.8–34.1) and 100% complete. Median hospital stay and ICU stay were 16.0 (IQR:
12.5–26.0) and 13.7 (IQR: 2.0–16.5) days, respectively. Rethoracotomy for haemorrhage or cardiac tamponade was performed in 6 (26.1%)
patients. Other postoperative complications comprised low cardiac output with extracorporeal membrane oxygenation (n = 2; 8.7%),
sepsis (n = 4; 17.4%), respiratory insufﬁciency (n = 10; 43.5%), renal failure with temporary dialysis (n = 7; 30.4%) and visceral malperfusion
(n = 2; 8.7%) requiring stent grafting (n = 1) or laparotomy with intestinal resection (n = 1). New stroke with or without permanent sensory
or motor deﬁcit was diagnosed in 8 (34.8%) patients. Temporary neurological deﬁcits were seen in 9 (39.1%) individuals. Hospital and 1-year
mortality rates were 13.0 and 30.4%, respectively. Overall survival after 36 months of the 23 patients (Group I = Extra-anatomic bypass) versus
the remaining 331 AADA patients without distal RCCA/LCCA occlusion (Group II = no extra-anatomic bypass) was 69.6% (n = 16) in Group I vs
72.5% (n = 240) in Group II (P = 0.90).
CONCLUSION: Extra-anatomic bypass for LCCA or RCCA occlusion allows for early selective cerebral perfusion during AADA repair, and may
reduce the risk of neurological complications in patients with preoperative cerebral malperfusion.
Keywords: Type A aortic dissection • Cerebral malperfusion • Distal carotid artery occlusion • Carotid cannulation • Selective cerebral
perfusion • Stroke • Neurological complications
INTRODUCTION
Involvement of aortic arch branches in patients suffering from acute
aortic dissection type A (AADA) occurs with varying frequency,
ranging from 5 to 43% [1]. Secondary cerebral malperfusion may
occur in such patients, signiﬁcantly inﬂuencing long-term outcome
due to increased mortality and perioperative stroke rate [2].
Immediate restoration of cerebral perfusion is a goal of aortic repair
in such patients, but is very unlikely if occlusion of the distal left
(LCCA) or right (RCCA) common carotid arteries is present. Such
occlusion may occur secondary to complete collapse of the true
lumen with or without thrombus formation. Extra-anatomic aorto-
carotid bypass has been suggested to restore cerebral perfusion in
†Presented at the 28th Annual Meeting of the European Association for Cardio-
Thoracic Surgery, Milan, Italy, 11–15 October 2014.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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these high-risk patients [3– 5]. However, no clinical series with
regard to postoperative outcome have been published thus far for
this surgical strategy.
The purpose of this study was to therefore present our institu-
tional surgical strategy and outcomes after extra-anatomic bypass
for AADA patients with preoperative cerebral malperfusion due to
common carotid artery occlusion.
PATIENTS ANDMETHODS
A total of 354 patients suffering from AADA were operated on at
our centre between November 2005 and July 2013. We identiﬁed
a subgroup of 23 patients with cerebral malperfusion due to oc-
clusion or severe stenosis of the RCCA (n = 12), the LCCA (n = 10)
or both arteries (n = 1). The median patient age was 66.3 years
[interquartile range (IQR): 55.2–69.9] and 18 (78.3%) were males.
The operative reports and clinical charts of the operated patients
were retrospectively reviewed. The local ethics committee did not
require individual patient consent.
The patients’ characteristics and preoperative data are summar-
ized in Table 1.
Deﬁnition of malperfusion
Cerebral malperfusion was diagnosed if AADA patients had neuro-
logical symptoms and signs with radiographic evidence of dissec-
tion of the corresponding aortic branch vessel(s). In those patients
who were already sedated and intubated upon presentation to
our hospital, neurological symptoms were noted as recorded by
the emergency physician or referring hospital. Patients with cere-
bral malperfusion and complete occlusion of the RCCA and/or
LCCA formed the focus of the current study. Patients with a dissec-
tion membrane in aortic branch vessels without carotid artery
occlusion or severe stenosis were not included.
The proportions of patients with coronary, mesenteric, spinal
and limb malperfusion, as previously described [2], are displayed
in Table 1.
Clinical presentation
All patients were admitted to our institution emergently within 7.0 h
(median; IQR: 4.9–12.1) after AADA occurrence. Preoperative
patient data are given in Table 1.
Diagnosis of AADA was made via computed tomography (CT) of
the thorax in all cases (Fig. 1). Additional cranial CT examinations
were performed because of signiﬁcant neurological deﬁcits in 8
patients, revealing a large cerebral infarct in 3. Aortic dissection with
unilateral or bilateral carotid occlusion or severe stenosis was diag-
nosed in all 23 patients (Fig. 2). Other supra-aortic vessels that were
dissected (but not occluded or severely stenosed) included the bra-
chiocephalic trunk, the left subclavian artery and the left vertebral
artery in 91, 65 and 9% of patients, respectively. Four patients pre-
sented with monoplegia of the left (n = 3) or plegia of both upper
extremities (n = 1). Dissection of the aortic root was detected in
15 cases (65%)—including 3 patients with coronary malperfusion.
Dissection of the descending/throaco-abdominal aorta was observed
in 16 patients (70%) with dissection of the coeliac trunk in 7 patients,
the superior mesenteric artery in 1 patient, the left renal artery in 5
patients, the right renal artery in 1 patient, the inferior mesenteric
artery in 3 patients and the common iliac arteries in 14 patients.
Surgical procedures
We have previously published details of our institutional surgical
strategy to address AADA in the presence of malperfusion syn-
dromes [2]. In brief, surgical access was achieved via a full sternot-
omy in all patients. In 17 patients (74%), the occluded RCCA
(n = 10) or LCCA (n = 7) was exposed at the beginning of the pro-
cedure, usually at the level of the carotid bifurcation. The vessel
was then cannulated either directly (n = 5) or via anastomosis of a
6 or 8 mm prosthetic graft (n = 12) above the level of occlusion to
allow for early selective cerebral perfusion via an extra line (Fig. 3).
Subsequently, venous drainage as well as additional arterial can-
nulation was performed to allow for cardiopulmonary bypass
(CPB). After reaching the target cooling temperature, the aortic
arch was opened and an additional perfusion cannula was
inserted into either the proximal LCCA (n = 10) or the brachioce-
phalic trunk (n = 2) to allow for bilateral selective cerebral perfu-
sion (SCP) (10 ml × kg−1 ×min−1). In 5 patients with unilateral
perfusion via the LCCA, bilateral SCP was achieved via additional
axillary artery cannulation (Fig. 4). In the single patient who pre-
sented with occlusion of both the LCCA and RCCA, bilateral SCP
was performed via prosthetic grafts anastomosed to both of these
vessels at the level of the carotid bifurcation. Additional cannula-
tion sites and operative details are given in Table 2.
Systemic cooling was carried out down to an oesophageal tem-
perature of 26.0 ± 3.3°C with a maximal CPB temperature gradient
of 6°C. Distal aortic perfusion (25–32°C; 3 l/min) was performed
Table 1: Preoperative data
Patient characteristics (n = 23)
Age (years), median (IQR) 66.3 (55.2–69.9)
Male gender, n (%) 18 (78.3)
Left ventricular ejection fraction (mean ± SD) 54.5 ± 7.1
Hypertension, n (%) 15 (65.2)
Hyperlipidaemia, n (%) 6 (26.1)
Diabetes mellitus [n (%)] 5 (21.7)
Chronic obstructive pulmonary disease [n (%)] 1 (4.3)
Renal insufficiency [n (%)] 2 (8.7)
With permanent dialysis 1 (4.3)
Obesity [n (%)] 2 (8.7)
Clinical presentation and neurological symptoms
ASA score [median (IQR)] 4.0 (IQR 4.0–4.5)
Intubated [n (%)] 5 (21.7)
Cardiogenic shock [n (%)] 3 (13.0)
Pericardial tamponade [n (%)] 3 (13.0)
Anicosoria [n (%)] 4 (17.4)
Previous syncope [n (%)] 7 (30.4)
Previous seizure [n (%)] 1 (4.3)
Vertigo [n (%)] 5 (21.7)
Photopsia [n (%)] 1 (4.3)
Confusion [n (%)] 7 (30.4)
Malperfusion syndromes
Cerebral [n (%)] 23 (100)
Coronary [n (%)] 3 (13.0)
Mesenteric [n (%)] 0 (0)
Spinal [n (%)] 0 (0)
Lower limb [n (%)] 2 (8.7)
IQR: interquartile range; SD: standard deviation; ASA: American Society
of Anesthesiologists.
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retrogradely via the femoral artery or antegradely via a side-graft
after the distal aortic anastomosis for adequate visceral and spinal
cord protection if a prolonged duration of lower body circulatory
arrest was expected (n = 2).
Aortic root repair with or without aortic valve repair (n = 7) or
replacement (n = 11) was performed in routine fashion during the
cooling phase. Concomitant coronary bypass was performed in
the 3 patients with coronary malperfusion. During SCP and lower
body circulatory arrest, proximal hemiarch (n = 14) or total arch
replacement with an elephant trunk (n = 9) was performed as pre-
viously described [6]. Additional extra-anatomic reconstruction of
supra-aortic branches was performed in 34.8% of patients.
During rewarming, a prosthetic graft was anastomosed to the
affected RCCA/LCCA (if not performed at the beginning of the
procedure) and tunnelled below the sternocleidomastoid muscle
and anastomosed as an extra-anatomic bypass to the ascending
aortic graft.
Near-infrared spectroscopy (NIRS) was routinely used for cere-
bral oxygenation monitoring of the frontal cortex to detect poten-
tial cerebral malperfusion in all patients. In 6 patients without
initiation of SCP via the RCCA/LCCA at the beginning of the pro-
cedure, extra-anatomic aorto-carotid bypass was performed
during or at the end of the procedure if persisting malperfusion
was suspected by NIRS/Doppler sonography (n = 6; 26.1%).
Follow-up
The follow-up was 100% complete (median: 15.2; IQR: 4.8–34.1),
and included a telephone interview with the patient or patient’s
family members, as well as a written questionnaire was sent to the
patient’s general practitioners.
Study variables and deﬁnitions
Intraoperative death or death within the ﬁrst 24 h postoperatively
was deﬁned as intraoperative death. New stroke was deﬁned either
by new (postoperative) permanent neurological impairment or
signs of new CT infarct/haemorrhage. Stroke was sub-classiﬁed into
three subgroups: (i) no/minimal symptoms, (ii) persistent stroke
with symptoms and (iii) deteriorating stroke with fatal outcome.
Postoperative temporary or permanent (TND/PND) neurological
deﬁcits were deﬁned as neurological deﬁcits/complications noted
for the ﬁrst time after the operation. Neurological deﬁcits that
resolved during the clinical course were deﬁned as TND, while
PND was deﬁned as persisting signiﬁcant cognitive, sensory or
motor deﬁcits.
Renal failure was deﬁned as an increase in serum creatinine
>1.5 mg/dl, temporary (resolved by the time of discharge) or
Figure 1: Computed tomography (CT) scan showing involvement of all supra-aortic branches in a patient with acute aortic dissection type A (A). Acute dissection of
the aortic arch with malperfusion of the brachiocephalic trunk and a dissection membrane within the left common carotid artery (B). Preoperative cranial CT revealing
subacute cerebral ischaemia indicating preoperative stroke (C). Postoperative cranial CT of the same patient showing left-sited cerebral haemorrhage originating from
the area of preoperative cerebral infarction (D).
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Figure 2: Computed tomography scan of a patient with right common carotid artery occlusion at the level of the carotid bifurcation with retrograde ﬁlling
(A). Examples of complete true lumen collapse due to unilateral (B and C) and bilateral common carotid artery occlusion/stenosis (D).
Figure 3: Intraoperative view showing extra-anatomic aorto-carotid bypass (A). Schematic ﬁgure of the procedure and 3D reconstruction by computed
tomography (B).
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permanent need for haemodialysis. Respiratory insufﬁciency was
deﬁned as weaning failure from mechanical ventilation by means
of mechanical ventilation (>7 days), required reintubation or
tracheostomy. Hospital mortality was deﬁned according to
current guidelines as death in hospital prior to discharge or within
30 days after surgery (regardless of location).
The American Society of Anesthesiologists (ASAs) physical status
classiﬁcation system was used in all 23 patients on admission to
evaluate the patient and estimate the urgency of surgery.
Statistical methods
Standard deﬁnitions were used for patient variables and outcomes.
Categorical data are reported as frequencies (percentages) and con-
tinuous variables as median (IQR) or mean (±standard deviation), re-
spectively. Statistical analyses were performed with the GraphPad
Prism 6 software (GraphPad, Inc., La Jolla, CA, USA). Survival analysis
was performed according to the methods of Kaplan and Meier, and
statistical differences were analysed by the log-rank test. Values of
P < 0.05 were considered to be signiﬁcant. Patients that died intrao-
peratively or within the ﬁrst 24 h were excluded from the survival
analysis by the methods of Kaplan and Meier. At 36 months post-
operatively, the number of patients at risk in Group I was considered
to be too low to allow for further comparison (>36 months).
RESULTS
Hospital and follow-up mortality
The respective in-hospital and 1-year mortality rates were 13.0%
(n = 3) and 30.4% (n = 7). After a median time period of 15.2
months (IQR: 4.8–34.1), 16 (69.6%) patients were still alive (Table 3).
Of the 3 perioperative deaths, 2 patients were intubated because
of a large stroke conﬁrmed by preoperative CT (including the
single patient with bilateral common carotid artery occlusion).
Postoperatively, both patients suffered from cerebral haemorrhage in
the area of infarction, and never regained consciousness (Fig. 1C and
D). The third patient developed postcardiotomy low cardiac output
syndrome, requiring extracorporeal membrane oxygenation (ECMO)
therapy. He subsequently died of sepsis with resulting multiorgan
failure.
We also compared survival of the 23 patients with cerebral mal-
perfusion secondary to RCCA/LCCA occlusion (Group I) with that
of the remaining 331 AADA patients without RCCA/LCCA occlu-
sion (Group II). The follow-up information was available for all dis-
charged patients, and was of comparable duration between both
groups. After a median follow-up of 33.7 months (IQR: 11.9–55.9),
223 (67.4%) patients of Group II were still alive. The overall survival
after 36 months was 69.6% (n = 16) in Group I versus 72.5% (n =
240) in Group II (P = 0.90) (Fig. 5).
Postoperative complications
Complications leading to resternotomy occurred in 6 (26.1%)
patients due to postoperative haemorrhage (n = 2; 8.7%) and
Figure 4: Cannulation sites for bilateral selective cerebral perfusion: perfusion of the RCCA (via prosthetic graft) in combination with direct LCCA cannulation (A);
LCCA perfusion (via prosthetic graft) in combination with additional axillary artery (B) or direct RCCA cannulation (C).
Table 2: Operative data
Operative procedures
Extra-anatomic bypass [n (%)] 23 (100)
RCCA 12 (52.2)
LCCA 10 (43.5)
RCCA & LCCA 1 (4.3)
Additional repair 8 (34.8)
Brachiocephalic trunk 2 (8.7)
Proximal left carotid artery 5 (21.7)
Left subclavian artery 3 (17.4)
Right subclavian artery 4 (13.4)
Aortic valve repair [n (%)] 7 (30.4)
Aortic valve replacement [n (%)] 11 (47.8)
Aortic root replacement [n (%)] 15 (65.2)
Supracoronary ascending aortic replacement [n (%)] 8 (34.8)
Hemiarch repair [n (%)] 14 (60.9)
Total arch repair [n (%)] 9 (39.1)
With conventional elephant trunk 4 (17.4)
CABG [n (%)] 3 (13.0)
Additional cannulation sites
Axillary artery [n (%)] 15 (65.2)
Femoral artery [n (%)] 7 (30.4)
Brachiocephalic trunk [n (%)] 1 (4.3)
Ascending aorta [n (%)] 1 (4.3)
Cardiac apex [n (%)] 1 (4.3)
Venous drainage sites
Right atrium [n (%)] 17 (73.9)
Femoral vein [n (%)] 6 (26.1)
Perfusion data
SCP time (min), mean ± SD 33.4 ± 14.2
LBCA time (min), mean ± SD 33.5 ± 14.4
Lowest oesophageal temperature (°C), mean ± SD 26.1 ± 3.3
CPB time (min), mean ± SD 198.2 ± 53.6
Cross-clamp time (min), mean ± SD 111.4 ± 36.2
Reperfusion time (min), mean ± SD 49.2 ± 21.8
SD: standard deviation; RCCA/ LCCA: right/left common carotid artery;
CABG: coronary artery bypass graft; SCP: selective cerebral perfusion;
LBCA: lower body circulatory arrest; CPB: cardiopulmonary bypass.
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pericardial tamponade (n = 4; 17.4%). Three other patients (13%)
developed pericardial effusion during their clinical course requir-
ing elective pericardial drainage. Postoperatively, 2 of 16 patients
with aortic dissection extending into the thoraco-abdominal aorta
showed signs of mesenteric malperfusion, and were treated by
either thoracic endovascular aortic repair (n = 1) or laparotomy
with duodenojejunal resection (n = 1). Two patients required
ECMO therapy due to low cardiac output syndrome (Table 3).
Ten patients (43.5%) developed respiratory insufﬁciency and
percutaneous tracheostomy was required in 6 cases. Acute renal
failure requiring temporary dialysis occurred in 7 (30.4%) patients.
New postoperative neurological deﬁcits corresponding to peri-
operative cerebral malperfusion were noted in 14 (60.9%) of the
23 patients (Table 3). Stroke rate was 34.8% (n = 8)—excluding the
3 patients with preoperative CT conﬁrmation of stroke—with 4
patients showing no/minimal symptoms, 3 patients affected by
persisting stroke with symptoms and 1 patient suffering from de-
teriorating stroke. In addition, postoperative cranial CT revealed
cerebral haemorrhage (n = 3) and/or oedema (n = 3) in 6 cases.
Permanent neurological deﬁcits (PNDs) due to persisting stroke
comprised permanent hemiparesis (n = 2) and hemiplegia (n = 1).
Temporary neurological deﬁcits (TNDs) occurred in 9 patients,
and included temporary tetraparesis (n = 1), temporary hemipar-
esis (n = 5)/hemiplegia (n = 1) and postoperative seizure (n = 2). Of
note, 6 (26.1%) patients recovered from surgery without any
neurological complications, whereas 4 other patients (17.4%)
experienced an episode of delirium as the only postoperative
complication. All postoperative complications are listed in Table 3.
Overall median time to hospital discharge was 16.0 days (IQR:
12.5–26.0) with a median intensive care unit stay of 7.0 days (IQR:
2.0–16.5).
DISCUSSION
End-organ malperfusion syndromes have been reported to occur
in approximately one-third of AADA patients [7], and are asso-
ciated with an increased in-hospital mortality ranging between
14.6 and 30.5% [2, 8, 9].
One of the main principles of AADA management is the imme-
diate restoration of blood ﬂow into the true aortic lumen by emer-
gency open surgery [10]. We previously analysed 279 AADA
patients—including 92 (33.4%) patients with end-organ ischaemia
—and identiﬁed preoperative malperfusion syndrome as a signiﬁ-
cant risk factor for long-term mortality after AADA repair (HR, 1.7;
95% conﬁdence intervals, 1.2–3.1) [2]. The Kobe group identiﬁed
prolonged time-to-surgery of more than 9.1 h to signiﬁcantly
predict poor survival and lack of neurological recovery in patients
with central nervous malperfusion [9]. However, restoration of
cerebral blood ﬂow by conventional AADA repair may be very dif-
ﬁcult if severe stenosis or occlusion of the common carotid arter-
ies is present. Such lesions are usually the result of true lumen
collapse and thrombus formation within the false lumen, and may
prohibit sufﬁcient perfusion by SCP via the axillary artery, brachio-
cephalic trunk or proximal left carotid artery.
Direct carotid cannulation [11] and extra-anatomic distal aorto-
carotid bypass have been suggested to successfully restore cerebral
perfusion in AADA patients with preoperative cerebral malperfu-
sion, either prior to [3], during [4] or following central aortic repair
[5]. We feel that immediate aortic repair in combination with
extra-anatomic revascularization offers the best treatment option
in this high-risk subgroup of AADA patients. Treatment of the 23
patients by extra-anatomic distal aorto-carotid bypass was per-
formed in 6.5% of all operated AADA patients at our institution
between November 2005 and July 2013. Despite the high-risk
nature of such patients, our observed in-hospital mortality of
13.0% and 3-year survival of 69.6% did not signiﬁcantly differ from
Figure 5: Postoperative survival of patients with common carotid artery occlu-
sion with cerebral malperfusion (Group 1) versus all other patients with acute
aortic dissection type A (Group 2); intra-operative deaths excluded from
analysis.
Table 3: Postoperative data
Mortality, n (%)
In-hospital 3 (13.0)
1-year 4 (30.4)
Hospital stay (days), median (range; IQR) 16 (12.5–26.0)
Intensive care unit stay (days), median (range; IQR) 7 (2.0–16.5)
Postoperative interventions and complications
Resternotomy, n (%) 6 (26.1)
Haemorrhage 2 (8.7)
Pericardial tamponade 4 (17.4)
Drainage for pericardial effusion [n (%)] 3 (13.0%)
Mesenteric malperfusion, treated by 2 (8.7)
TEVAR 1 (4.3)
Laparotomy (with duodenojejunal resection) 1 (4.3)
Postoperative ECMO therapy 2 (8.7)
Sepsis [n (%)] 4 (17.4)
Respiratory insufficiency [n (%)] 10 (43.5)
Percutaneous tracheostomy 6 (26.0)
Reintubation 6 (26.0)
Postoperative pneumonia 2 (8.7)
Renal failure with temporary dialysis 7 (30.4)
Postoperative neurological complications
New neurological deficits [n (%)] 14 (60.9)
Stroke [n (%)] 8 (34.8)
No/minimal symptoms 4 (17.0)
Persisting stroke 3 (13.0)
Deteriorating stroke 1 (4.3)
Permanent neurological deficits [n (%)] 3 (13.0)
Hemiparesis 2 (8.7)
Hemiplegia 1 (4.3)
Temporary neurological deficits [n (%)] 9 (39.1)
Tetraparesis 1 (4.3)
Hemiparesis 5 (21.7)
Hemiplegia 1 (4.3)
Seizure 2 (8.7)
Cerebral oedema without stroke 2 (8.7)
IQR: interquartile range; SD: standard deviation; TEVAR: thoracic
endovascular aortic repair; ECMO: extracorporeal membrane
oxygenation.
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the 331 operated AADA patients without carotid artery occlusion
(Fig. 5). We would hypothesize from this observation that our
treatment strategy may have prevented fatal perioperative stroke
in these high-risk patients.
Severe preoperative neurological complications such as stroke
and/or coma have been considered as major contraindications for
emergency aortic repair by some investigators [12]. Estrera et al.
[13] reported on the surgical outcome of 14 of 151 consecutive
AADA patients with preoperative stroke, and found that the
neurological status improved or completely recovered in 8 cases,
while neurological deﬁcits remained the same in the remaining 6.
The authors concluded that, since no worsening of neurological
symptoms occurred postoperatively, immediate surgical repair is
warranted even if AADA is complicated by stroke. In 2006, Pocar
et al. published their results on 5 comatose AADA patients due to
cerebral malperfusion of which 4 completely recovered and only
a single patient suffered from left hemiparesis and cognitive im-
pairment. These authors concluded that coma (with stroke) may
not represent an absolute contraindication for emergency surgery
[14]. In our reported series, 2 of the 3 patients diagnosed with
stroke on preoperative CT developed cerebral haemorrhage, and
never regained consciousness, while the third patient recovered
completely without clinically relevant neurological symptoms.
Since cranial CT imaging was performed in only 8 patients, the
actual preoperative stroke rate was probably much higher in our
patient population. Despite the fact that all 23 patients on admission
either showed clinical signs or had a recent history of signiﬁcant
cerebral malperfusion, 9 (39.1%) patients recovered completely
without relevant neurological deﬁcits during their postoperative
course. New neurological complications were noted in the remain-
ing 14 (60.9%) patients, however, with 8 completely resolving during
their hospital course. In summary, only 6 (26.1%) out of 23 patients
with signiﬁcant preoperative central nervous malperfusion devel-
oped PND with signiﬁcant neurological compromise. Therefore, we
also recommend emergency surgery in AADA patients, even if com-
plicated by preoperative stroke.
Extra-anatomic revascularization may be a valuable option in
high-risk AADA patients presenting with cerebral malperfusion
due to distal common carotid artery occlusion. We now routinely
initiate unilateral SCP via the respective carotid artery at the be-
ginning of the procedure, and perform additional perfusion of the
contralateral side (i.e. bilateral SCP) after opening the aortic arch
(Fig. 4), followed by distal aorto-carotid bypass after central aortic
repair in such patients.
CONCLUSIONS
Patients with preoperative cerebral malperfusion due to distal
common carotid artery occlusion or stenosis represent a very
high-risk subgroup of AADA patients. Extra-anatomic distal aorto-
carotid bypass allows for early initiation of SCP, and is associated
with acceptable postoperative morbidity and mortality. Such a
strategy may result in decreased mortality in these high-risk
patients.
ACKNOWLEDGEMENTS
The authors thank Sven Peterss and Paris Charilaou for their
support during the preparation of the manuscript.
Conﬂict of interest: none declared.
REFERENCES
[1] Borst HG, Heinemann MK, Stone CD. Surgical Treatment of Aortic
Dissection. 1st edn. New York: Churchill Livingstone International, 1996.
[2] Girdauskas E, Kuntze T, Borger MA, Falk V, Mohr F-W. Surgical risk of pre-
operative malperfusion in acute type A aortic dissection. J Thorac
Cardiovasc Surg 2009;138:1363–9.
[3] Walterbusch G, Oelert H, Borst H. Restoration of cerebral blood ﬂow by
extraanatomic bypass in acute aortic dissection. Thorac Cardiovasc Surg
1984;32:381–2.
[4] Abe T, Terada T, Noda R, Sakurai H. Aortocarotid bypass at the time of
central aortic repair for type A acute aortic dissections. J Thorac
Cardiovasc Surg 2012;143:976–8.
[5] Sartipy U, Malmstedt J, Holm P, Öwall A, Dellgren G. Aorto-carotid bypass
for cerebral malperfusion after aortic dissection surgery: a case report.
Heart Surg Forum. 2006;9:E818–9.
[6] Misfeld M, Leontyev S, Borger MA, Gindensperger O, Lehmann S, Legare
J-F et al. What is the best strategy for brain protection in patients undergo-
ing aortic arch surgery? A single center experience of 636 patients. Ann
Thorac Surg 2012;93:1502–8.
[7] Patel HJ, Williams DM, Dasika NL, Suzuki Y, Deeb GM. Operative delay for
peripheral malperfusion syndrome in acute type A aortic dissection: a
long-term analysis. J Thorac Cardiovasc Surg 2008;135:1288–96.
[8] Geirsson A, Szeto WY, Pochettino A, McGarvey ML, Keane MG, Woo YJ
et al. Signiﬁcance of malperfusion syndromes prior to contemporary sur-
gical repair for acute type A dissection: outcomes and need for additional
revascularizations. Eur J Cardiothorac Surg 2007;32:255–62.
[9] Morimoto N, Okada K, Okita Y. Lack of neurologic improvement after
aortic repair for acute type A aortic dissection complicated by cerebral
malperfusion: predictors and association with survival. J Thorac
Cardiovasc Surg 2011;142:1540–4.
[10] Bachet J. Acute type A aortic dissection: can we dramatically reduce the
surgical mortality? Ann Thorac Surg 2002;73:701–3.
[11] Urbanski PP. Carotid artery cannulation in acute aortic dissection with
malperfusion. J Thorac Cardiovasc Surg 2006;131:1398–9.
[12] Fukuda I, Imazuru T. Intentional delay of surgery for acute type A dissec-
tion with stroke. J Thorac Cardiovasc Surg 2003;126:290–1.
[13] Estrera AL, Garami Z, Miller CC, Porat EE, Achouh PE, Dhareshwar J et al.
Acute type A aortic dissection complicated by stroke: can immediate
repair be performed safely? J Thorac Cardiovasc Surg 2006;132:1404–8.
[14] Pocar M, Passolunghi D, Moneta A, Mattioli R, Donatelli F. Coma might
not preclude emergency operation in acute aortic dissection. Ann Thorac
Surg 2006;81:1348–51.
APPENDIX. CONFERENCE DISCUSSION
Scan to your mobile or go to
http://www.oxfordjournals.org/page/6153/1
to search for the presentation on the EACTS library
Dr G. Weiss (Vienna, Austria): During the study period more than 350 patients
were operated for aortic dissections, and out of those, 23 patients were identi-
ﬁed who had undergone an extra-anatomic carotid bypass. Did all patients
in your centre receive a bypass to the carotid artery if the CT scan revealed a
malperfusion?
The more standardized surgical strategy is to exclude the primary entry tear
and limit the operation to a conventional repair of the aortic arch in expect-
ation that the restored blood ﬂow in the true lumen leads to adequate reperfu-
sion of the dissected carotid artery. Since stroke rate was rather elevated at
35%, it would have been interesting to know how high the stroke rate was in
the patient group not undergoing extra-anatomic bypass surgery.
My second question is about timing and imaging. You mentioned that every
patient received a cranial CT scan before surgery. It is well known that the diag-
nosis of stroke cannot be deﬁnitely conﬁrmed by CT scan within the ﬁrst six
hours after the initial event. However, in three patients, a stroke was diagnosed
before surgery, and these patients received an extra-anatomic bypass to a
carotid artery. There is also evidence that revascularization of cerebral areas
with a recent stroke might be harmful in terms of intracranial bleeding. What
was the purpose of performing a bypass to the carotid artery in a patient with a
veriﬁed stroke?
A
O
R
TI
C
SU
R
G
ER
Y
M. Luehr et al. / European Journal of Cardio-Thoracic Surgery 7
85
My third question, what would be your surgical strategy if you observe a dis-
sected carotid artery by CT without any clinical symptoms? Would you still
perform an extra-anatomic bypass?
My last question, in rare occasions the dissection does not end in the
common carotid artery but extends into the internal carotid artery or even at
an intracranial level. Would you still perform a bypass in these cases?
Dr Luehr: I would like to answer your ﬁrst question regarding the patients
with cerebral malperfusion and if all of those patients receive an extra-anatomic
bypass. So what we did in our series was to retrospectively identify all patients
with distal carotid occlusion treated by extra-anatomic bypass, which turned
out to be a little difﬁcult. However, I cannot exclude that there might have been
one or two with distal carotid occlusion but without carotid-to-aortic bypass
that I didn’t identify.
In our previous series on the outcome of patients with type A dissection related
malperfusion syndromes, we had 14% of patients with preoperative cerebral mal-
perfusion, and 41% of those 39 patients had a stroke. Unexpectedly, in this series
the incidence of stroke is even lower, which actually underlines our surgical strategy.
With regard to the second question, there is no clear consensus regarding
the treatment of patients with preoperative stroke. We did not have a CT scan
of the cranium in every patient of the series. Most of those patients were emer-
gently admitted to our centre, often with an externally performed chest CT
clearly showing type A aortic dissection and were taken to the OR right away.
Only patients that were already intubated or showed neurological impair-
ment had an additional cranial CT scan. It was eight patients in the series, and
three of those had a preoperative stroke.
Postoperatively, all patients that showed neurological impairment, had CT of the
cranium just to make sure and we found eight strokes in those patients. As I
showed you before, four had no or only minor symptoms which were not clinically
relevant while four patients had a severe stroke, including two patients with cere-
bral haemorrhage, and they obviously did not do very well. But in total it was only
six patients that suffered from signiﬁcant neurological deﬁcits postoperatively.
I guess it was your third question regarding a situation in which a patient has
a unilateral right distal carotid dissection but has no clinical symptoms? We
would, as it is our institutional routine approach or strategy for type A aortic
dissection, cannulate the axillary artery, and aim for bilateral selective cerebral
perfusion after aortotomy via the left carotid artery. But we would always look
at the NIRS monitoring, which we do routinely as well. And once there is some
evidence of malperfusion to the brain, we would always try to get to the caro-
tids and make sure that the brain is perfused, of course.
The last question, if I remember correctly, was what to do if the dissection
extends above the carotid bifurcation. Well, it’s difﬁcult in those patients.
Fortunately, we didn’t see such cases in our series. However, once you have a
dissection extending into the internal carotid artery or even higher, there is not
a lot you can do.
So I guess our strategy would be to dissect the carotid artery at the bifurca-
tion, identify the true lumen, glue the layers, perfuse the brain and do the extra-
anatomic bypass after central aortic repair.
Dr B. Rylski (Freiburg, Germany):My question is on the follow-up CT.
Could you please tell us if you observed any kind of remodelling of the
carotid artery? Did the dissection disappear after anastomosing it to the
bypass?
Dr Luehr: We had ﬁve patients with a thrombus in the false lumen, so there
was some evidence for a false lumen which was expanding. But I did not ﬁnd
any patient who had postoperatively a false lumen that was somehow in the re-
modelling process.
So once the carotids were revascularized, we could see nicely that the caro-
tids were perfused, but we did not identify or see any remodeling of the false
lumen.
Dr S. Soliman (Cairo, Egypt): My question is about the patients who need
total arch replacement and those with dissected carotids. Do you also do extra-
anatomical bypass for them or just you do the total arch bypass?
Dr Luehr: We had nine patients with a total arch replacement due to dissec-
tion involving the whole arch and the supra-aortic branches. Therefore, we per-
formed complete revascularization of the dissected supra-aortic vessels in
those cases.
However, in those patients that had a distal carotid occlusion with resulting
true lumen collapse, we performed an extra-anatomic bypass to the respective
vessel additionally because we could not ensure that, even though we might
have connected the respective true lumen to the prosthetic arch graft, sufﬁcient
bilateral cerebral perfusion was achieved afterwards.
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Abstract
Objective: Aortic endovascular stent-graft implantation is associated with low morbidity and mortality rates. Overstenting of the left
subclavian artery may be necessary to create a satisfactory proximal ‘landing zone’ for the stent-graft. Few cases have been published reporting
adverse neurological events after overstenting of the left subclavian artery. We thus evaluated whether this procedure is associated with a higher
rate of neurological complications by focusing on the management of the supra-aortic vessels. Methods: Twenty patients suffering from aortic
arch aneurysms (n = 3), descending aortic aneurysms (n = 7), acute (n = 6) and chronic (n = 4) type-B aortic dissections underwent stent-graft
repair with complete (n = 14) or partial (n = 6) overstenting of the left subclavian artery. Three patients underwent overstenting of the entire
aortic arch with ascending aortic-bi-carotid bypass grafting. One patient with right carotid and vertebral artery occlusion underwent initial
carotid-to-subclavian bypass. All patients subsequently underwent neurological examination and Doppler ultrasound for detection of neuro-
logical and peripheral vascular complications. Results: Aortic stent-graft repair was successful in all patients without acute neurologic
complications. Two patients developed late central adverse neurological events: right-sided vertebral artery occlusion with brainstem infarction
(n = 1) and impaired binocular vision combined with dizziness (n = 1), necessitating secondary subclavian transposition in one patient. Peripheral
symptoms related to occlusion of the left subclavian artery were observed in five patients as sensory andmotoric deficits of the left hand and arm.
Conclusions: Overstenting of the left subclavian artery as treatment of aortic pathologies in high-risk patients is feasible but associated with the
risk of neurological complications and peripheral symptoms. Side effects were mild or transient in most of our patients. Detailed preoperative
exploration of vascular anatomy and pathology via Doppler ultrasound, CT- or MRI scan is mandatory to avoid adverse neurological events. Prior
surgical revascularization of the left subclavian artery is essential in patients with high-grade stenoses, occlusions, or anatomic variants of the
supra-aortic branches. Delayed surgical revascularization is necessary only in patients with relevant subclavian steal syndrome or severe
peripheral vascular symptoms.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Endovascular stent-graft implantation (ESI) is a less
invasive treatment of aortic pathologies, associated with
lower morbidity and mortality rates than conventional open
aortic repair [1—4]. Open surgical treatment of aortic
diseases necessitates aortic cross-clamping and occasion-
ally hypothermic circulatory arrest. In contrast to open
repair, ESI requires suitable proximal and distal ‘landing
zones’ for stent-graft fixation. Thus, 2 cm of normal aortic
wall is needed for adequate sealing [5,6]. Thoracic aortic
pathologies such as aneurysms or dissections often involve
the origin of the supra-aortic branches. If the distal aortic
arch is affected, overstenting of the left subclavian artery
(LSA) can be performed to elongate the proximal ‘landing
zone’ [7,8]. However, this strategy has been associated
with delayed onset of vertebrobasilary insufficiency and
arm ischemia [9]. Surgical transposition of the LSA to the
left common carotid artery (LCCA) or LCCA-to-LSA bypass
prior to ESI is sometimes necessary to preserve the blood
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flow and avoid adverse events resulting from LSA over-
stenting [10].
After preoperative evaluation of the supra-aortic vessels
we applied a tailored approach with overstenting of the LSA
without revascularization in the absence of supra-aortic
vascular disease and performed selective subclavian revas-
cularization only in patients with supra-aortic vascular
pathology. There are a few cases reporting adverse events
after overstenting of the LSA, and no consensus exists on how
best to manage and treat patients requiring overstenting of
the LSA [6]. We thus evaluated whether overstenting of the
LSA is associated with a higher rate of neurological
complications and peripheral symptoms by focusing on
management of supra-aortic vessels.
2. Materials and methods
Since 1996, we have considered ESI of aortic diseases as an
alternative to open surgical aortic repair in 265 high-risk
patients. Between December 2000 and March 2006, 20 of
these patients (10 female and 10 male) with a mean age of
64.3  12.23 years (range 39—79 years) were suffering from
thoracic or thoracoabdominal aortic diseases close to or
involving the supra-aortic arteries requiring complete over-
stenting or partial covering of one or more supra-aortic
vessels with endovascular stent-grafts.
The patients’ preoperative risk factors and comorbidities
are found in Table 1. Due to the high perioperative risk these
particular patients presented, conventional surgical repair
was not deemed appropriate. Preoperative Doppler ultra-
sound of the supra-aortic branches was performed in 15
patients and was not feasible due to time constraints in five
emergent or urgent cases. In 3 of the 20 patients (15%),
preoperative Doppler ultrasound detected mild supra-aortic
vessel pathologies (wall thickening of the right and LCCA
(n = 3) and atherosclerotic plaques in the internal and
external carotid arteries (n = 2)). Two patients had severe
supra-aortic vessel pathologies with complete occlusion of
the right internal carotid and vertebral artery (n = 1) and
occlusion of the LSA based on a type-B aortic dissection with
incomplete subclavian steal syndrome (n = 1) (Table 2).
Additionally, evaluation for elective and urgent patients
was done by angiography, computed tomography (CT), or
magnetic resonance imaging (MRI) to exclude stenoses,
occlusion, or anatomical variants of the supra-aortic branches
and aortoiliac axis (Fig. 1). The supra-aortic branches were
examined to determine whether an adequate ‘landing zone’
would be available.
Pathologies included aneurysms of the aortic arch (n = 3)
and descending aorta (n = 7), and acute (n = 6) and chronic
(n = 4) type-B aortic dissections. Twoof the chronic dissections
involved a secondary aneurysm. Two patients (10%) had a
preoperative history of stroke and five patients had undergone
aortic surgery due to aortic type-A dissection (n = 3) and aortic
coarctation (n = 2). Seven of the 20 patients (35%) required
emergency stent-grafting for treatment of contained rupture
(n = 2) resulting from acute (n = 1) or chronic (n = 1) aortic
dissections, malperfusion of the renal and visceral arteries
(n = 3) or of the iliac and femoral arteries (n = 2). Indication for
stent-grafting in 10 patients with aneurysms (50%) was rapid
progression of aneurysm, aneurysm greater than 5 cm, or
excentric aneurysms. Ten patients with acute or chronic type-
B dissections (50%) were treated for associated complications
such as contained rupture, visceral or renalmalperfusion, limb
ischemia, persistent pain despite medication, or secondary
aneurysm associated with the dissection (Table 2).
Eleven patients with atherosclerotic aneurysms (n = 6)
and aortic type-B dissections (n = 5) in whom the LSA origin
revealed aneurysm involvement or proximity to the primary
entry site of the dissection required partial or complete
overstenting of LSA by ESI. Nine patients in whom the
distance from the LSA to the beginning of the aneurysm
(n = 4) or to the primary dissection entry site (n = 5) was
under 1.5 cm also required partial or complete overstenting
of the LSA (Table 3).
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Table 1
Preoperative risk factors and co-morbidities
Pat Stroke/TIA Hypertension Hyperlipidemia COPD Obesity CAD Atrial fibrillation Renal insufficiency
1 — — — — — — — —
2 — Yes — — — Yes Yes Yes
3 — Yes — — — — — —
4 — Yes Yes — — — — —
5 — Yes Yes — — — — —
6 — Yes — — — — — —
7 — Yes — — — — — —
8 — Yes — — — — — —
9 — Yes — Yes — — Yes —
10 Yes Yes Yes — Yes Yes — —
11 — Yes Yes — — — — —
12 — Yes — — — Yes — —
13 — Yes Yes — Yes Yes — —
14 — Yes — Yes — — — —
15 — Yes Yes — — Yes — —
16 — Yes — — — — — —
17 — — — — — — — —
18 Yes Yes Yes — — — — Yes
19 — Yes — — Yes Yes — —
20 — Yes — — Yes — Yes
COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; TIA = transient ischemic attack.
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In 14 patients, the LSA was completely overstented,
preventing antegrade perfusion of the LSA. In 3 of these 14
patients, aortic-bi-carotid bypass without revascularization
of the LSA was initially performed prior to overstenting of
the entire aortic arch for aortic arch aneurysm. Simulta-
neous revascularization of the LSA by LCCA-to-LSA bypass
was carried out in 1 of the 14 patients treated by complete
overstenting of the LSA. That last patient presented with an
occlusion of the right internal carotid artery and the right
vertebral artery (VA) preoperatively, and a history of three
strokes, ruling out any occlusion of the supra-aortic
branches without additional revascularization. All initial
bypass procedures were performed during the same
operation prior to ESI. Details of the surgical revasculariza-
tions of the supra-aortic branches are shown in Table 3.
Coverage of the LCCA with the bare metal tip of the
endovascular stent-graft was necessary in four further
patients in that group, which still allowed sufficient
antegrade perfusion of the LCCA.
In six patients, the LSAwas not completely covered by the
endovascular stent-graft, thus permitting antegrade LSA
perfusion. In four of those patients, the LSAwas only covered
by the baremetal tip, and in two of them the proximal coated
portion of the stent-graft did not completely occlude the LSA
orifice (Table 3).
2.1. Intraoperative neurophysiological monitoring
Cerebral perfusion was controlled in each patient by an
arterial line placed in the right radial artery. Intraoperative
neurophysiological monitoring with transcranial motor-
evoked potentials (tcMEP) and somatosensory-evoked poten-
tials (SSEP), as well as cerebrospinal fluid (CSF) pressure
monitoring was applied in 17 (elective = 5, urgent = 7,
emergent = 5) patients as a control mechanism to identify
spinal cord ischemia during ESI (Table 3). This technique has
been described in detail previously [11,12]. Whenever CSF
pressure exceeded 15 mmHg, CSF drainage was carried out.
In three patients who underwent emergency surgery,
intraoperative neurophysiological monitoring was not
applied.
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Table 2
Preoperative data
Pat Age Sex Prior cardio-vascular
surgery
Aortic pathology Supra-aortic pathology Urgency Rupture Malperfusion
1 40 M Aortic coarctation TAA (5.5 cm) — Elective — —
2 79 M — Chronic type-B dissection — Urgent — —
3 53 M — Chronic type-B dissection Dissection involving the LSA causing
proximal LSA occlusion and incomplete
subclavian steal syndrome
Emergent — Iliac/femoral
4 60 F — Acute type-B dissection — Urgent — —
5 63 M — Acute type-B dissection — Emergent — Renal/visceral
6 39 F Aortic coarctation TAA (7.1 cm) — Elective — —
7 58 M — Acute type-B dissection — Emergent — Renal/visceral
8 44 F — Acute type-B dissection — Emergent — Iliac/femoral
9 79 F — TAA (7.6 cm) Plaques of the ICAs and ECAs, thickened
walls of the CCAs
Urgent — —
10 67 M — TAA (5.3 cm) + infrarenal
aortic stenosis
Occlusion of the right ICA and the right VA Urgent — —
11 67 F — Acute type-B dissection Plaques of both ICAs, thickened walls of
the CCAs
Emergent Yes —
12 73 M — TAA (6.0 cm) — Elective — —
13 73 F Type-A dissection,
CABG
AAA + TAA (5.5 cm) — Urgent — —
14 69 M — AAA + TAA (6.0 cm) — Urgent — —
15 67 F Type-A dissection,
CABG
AAA + TAA (6.5 cm) Thickened walls of the CCAs Urgent — —
16 78 M — TAA (5.5 cm) — Elective — —
17 72 F — Chronic type-B dissection — Elective — —
18 72 F Type-A dissection TAA (rapidly growing) — Emergent Yes —
19 72 F — TAA (5.5 cm) — Urgent — —
20 60 M CABG Chronic type-B dissection — Emergent — Renal/visceral
M, male; F, female; CABG, coronary artery bypass grafting; TAA, thoracic aortic aneurysm; AAA, aortic arch aneurysm; ICA, internal carotid artery; ECA, external
carotid artery; LSA, left subclavian artery; CCA, common carotid artery; VA, vertebral artery.
Fig. 1. Preoperative 3D-MRI with aortic arch and thoracoabdominal aneurysm
(Crawford type I) involving the supra-aortic great arteries (left); postoperative
3D-MRI after endovascular stent-graft implantation with three stent-grafts
covering the entire aortic arch to the celiac axis (middle), and aortic-bi-
carotid bypass using woven prosthesis (right).
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2.2. Ascending aortic-bi-carotid bypass
Following upper L-shaped hemisternotomy, the ascending
aorta was exposed in usual fashion. The brachiocepahlic
trunk and LCCA were circumferentially dissected. After
systemical heparinization with 100 IU/kg bodyweight, the
ascending aorta was tangentially clamped and a longitudinal
arteriotomy performed. An end-to-side anastomosis between
the proximal portion of a bifurcated Dacron prosthesis
(GelweaveW, Vascutek, Scotland, UK) and the ascending
aorta took place with reinforcement of Teflon felt strips with
a 4-0 Prolene running suture (Ethicon Inc., Somerville, NJ,
USA). The cross-clampwas gently released, and the air within
the graft removed. The supra-aortic vessels were then
exposed. First, the brachiocephalic trunk, and then the LCCA
were cross-clamped. Following longitudinal arteriotomy,
each branch of the bifurcated prosthesis was side-to-end
anastomosed to the right and LCCA. Blood flow was restored
after complete deaeration in usual fashion (Fig. 1).
2.3. Endovascular stent-graft implantation
We used four types of commercial endovascular stent-
graft devices in our study. The selection of the stent-graft
devices was based on availability, length, required diameter,
and anatomical findings. Stent-graft diameter was calculated
from the largest proximal or distal neck diameter and an
over-sizing factor of 10%. The EXCLUDER/TAG (W. L. GORE &
Associates, Flagstaff, AZ, USA), the Talent/Valiant (Med-
tronic, Santa Rosa, CA, USA), the Zenith TX 1 (Cook,
Bloomington, IN, USA), and the Palmaz (Cordis Endovascular,
New York, NY, USA) stent-graft devices were implanted in the
operating room under general anesthesia (Table 3). For
optimal visualization, the patient was positioned with the
left shoulder elevated in order to maximize the distance
between the supra-aortic branches’ origins. The common
femoral artery access was chosen in 16 patients. Due to
severe calcification, significant stenoses or occlusion of the
femoral arteries, or significant thoracoabdominal kinking, an
alternative stent-graft access was chosen in four patients:
one common iliac artery, one infrarenal aorta, and in two
cases the ascending aorta (Table 3). Intraoperative angio-
graphy was performed using ‘breath-hold’ technique using a
mobile C-arm intensifier (Siemens, Munich, Germany). The
stent-grafts were advanced under fluoroscopic guidance and
deployed during mild systemic hypotension. We used latex
balloons (Reliant balloon, Medtronic, Sunrise, Fl) to improve
expansion for modeling the stent-grafts to the aortic wall.
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Table 3
Intraoperative data
Pat Endovascular stent-grafts Access Surgical revascularization Degree of supra-aortic
overstenting
Neuromonitoring
(tcMEP, SSEP, CSFP)
1 1 Valiant/Medtronic (28  150 mm) FA — LSA completely Yes
2 1 Zenith TX 1/Cook (42  166 mm) FA — LSA partially w/coated part Yes
3 1 EXCLUDER/GORE (40  200 mm) FA — LSA completely Yes
4 2 Talent/Medtronic (44  113 mm/
44  111 mm)
FA — LSA partially w/coated part Yes
5 1 Talent/Medtronic (38  114 mm) FA — LSA partially w/uncoated part Yes
6 1 Zenith TX 1/Cook (22  100 mm) FA — LSA completely Yes
7 1 Zenith TX 1/Cook (34  140 mm) FA — LSA completely Yes
8 1 Talent/Medtronic (38  100 mm) FA — LSA completely Yes
1 Zenith TX 1/Cook (40  100 mm)
9 2 Talent/Medtronic (34  100 mm/
38  100 mm)
IA — LSA partially w/uncoated part No
10 1 Talent/Medtronic (42  111 mm) FA Initial carotid-to-subclavian
bypass
LSA completely Yes
1 Palmaz/Cordis (23 150 mm)
11 1 Talent/Medtronic (36  114 mm) FA — LSA completely No
12 4 Valiant/Medtronic (1 44  200 mm,
1 46  200 mm, 1 46  100 mm,
1 42  100 mm)
FA Secondary LSA transposition LSA completely Yes
13 1 TAG/GORE (40  200 mm), AAo Initial ascending aortic-bi-carotid
bypass
Aortic arch completely Yes
1 Talent/Medtronic (42  111 mm)
1 Valiant/Medtronic (40  200 mm)
14 1 TAG/GORE (24  200 mm) AAo Initial ascending aortic-bi-carotid
bypass
Aortic arch completely Yes
15 1 TAG/GORE (40  200 mm) FA Initial ascending aortic-bi-carotid
bypass, secondary carotid
subclavian bypass
Aortic arch completely Yes
2 Talent/Medtronic (46  112 mm)
16 2 Talent/Medtronic (36  114 mm/
38  114 mm)
FA — LSA completely Yes
17 2 Talent/Medtronic (42  113 mm) FA — LSA partially w/uncoated part Yes
18 1 Talent/Medtronic (42  115 mm) IA — LSA completely No
19 1 Talent/Medtronic (40  160 mm) FA — LSA completely Yes
20 1 EXCLUDER/GORE (40  150 mm) FA — LSA partially w/uncoated part Yes
FA, femoral artery; AAo, ascending aorta; IA, iliac artery; LSA, left subclavian artery; tcMEP, transcranial motor evoked potentials; SSEP, somatosensory-evoked
potentials; CSFP, cerebrospinal fluid pressure.
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Aortography documented adequate aneurysm exclusion,
sealing of the proximal entries in cases of aortic dissection,
and occurrence of endoleaks. We defined successful ESI as
deployment in the correct aortic passage with satisfactory
blood flow proximal and distal of the stent-graft.
2.4. Follow-up
Follow-up CT- or MRI scans were performed before
hospital discharge and after 3, 6, and 12 months, and
annually thereafter (Fig. 1). Mean follow-up was 19.7  17.3
months (range 2—60 months). All pre- and postoperative
clinical examinations, as well as those during follow-up
included bilateral blood pressure measurements, multislice
CT- or MRI scans, and Doppler ultrasound of the supra-aortic
vessels.
2.5. Neurological evaluation and examination
All surviving 18 patients underwent neurological follow-up
performed by an experienced neurologist. A careful medical
history was taken to detect transient or persistent neuro-
logical deficits prior to or after ESI. Furthermore, we took
thorough patient histories, enquiring in particular about
transient or persistent central neurological deficits (i.e.,
brainstem ischemia becoming manifest in vertigo, dizziness,
acute deficits in motoric function or sensibility, dysarthria,
dysphagia, or ocular movement disorders) or peripheral
symptoms (i.e., arm claudication, numbness, or weakness) at
rest or following exercise of the ipsilateral upper limb.
Neurological examination was performed to detect cranial
nerve lesions with special attention paid to the existence of
left-sided Horner syndrome. Furthermore, themotor-sensory
system was examined with special regard to central or
peripheral origin of paresis or sensory disorders of the left
upper extremity, and to cerebellar or gait disorders.
Subclavian steal syndrome was defined as presence of
subclavian steal effect as diagnosed by ultrasound and the
presence of clinical symptoms [13].
2.6. Ultrasound examination
Ultrasound measurements were taken by two experienced
sonographers assessing the carotid arteries using Doppler
ultrasound scanning. A 2 MHz probe was used for transnuchal
scanning of the vertebrobasilar vascular territory; 4 MHz
linear and 8 MHz curved array scanners were employed for
examination of extracranial arteries (HDI 5000; ATL Bothell,
USA). With the patient in a supine position, a careful search
was made for transverse and sagittal planes of all supra-
aortic vessels (i.e., the proximal and distal subclavian artery,
the VAs from the origin to intracranial course including the
basilary artery, and the common, external, and internal
carotid arteries on both sides). Associated graft interponents
(e.g., aortic-bi-carotid bypass) were carefully analyzed for
superimposed thrombi or stenoses defined as circumscribed
luminal narrowing in B-mode and significant flow accelera-
tion in Doppler ultrasound.
We classified the degree of subclavian steal effect (i.e.,
the extend of hemodynamic changes in the vertebral arteries
in ultrasound measurement regardless of clinical symptoms),
varying from (I): systolic flow deceleration, to (II): alternat-
ing flow profile, to (III): completely reversed flow. LSA
occlusion or high-grade stenoses were assumed in cases of
completely reversed flow in the ipsilateral VA and upon
detection of vertebro-vertebral, carotido-vertebral, or
externo-vertebral collateral flow. Diagnosis of subclavian
steal effect was confirmed using functional tests based on
reactive hyperemia following compression of the upper left
extremity, which resulted in an increase in the reverse
component of the VA blood flow. Furthermore, a difference in
blood pressure in the radial arteries or a difference in blood
pressure between both arms 30 mmHg confirmed the
diagnosis.
2.7. Data collection
In accordance with current legislative recommendations,
all interventions were performed with approval of our
institutional review board. All patients were informed in
detail about ESI and additional revascularization procedures.
All patients provided written consent. Data were maintained
in a database of this Department of Cardiovascular Surgery.
The collected data were reviewed according to the guide-
lines indicated by our institutional review board.
3. Results
Aortic stent-graft repair was successful in each patient in
this series. All aneurysms were excluded without intrao-
perative complications. Closure of the entry tear and
expansion of the true lumen with reperfusion of visceral,
renal, or iliac arteries was achieved in all patients suffering
from chronic or acute aortic dissections. Themean number of
stent-grafts in all 20 patients was 1.65 (range 1—4) with a
mean overstented aortic portion of 22 cm in length. Mean
duration of all procedures was 189 min (30—550 min). The
median hospital stay was 12 days.
3.1. Intraoperative neurophysiological monitoring
No patient suffered from complications related to spinal
cord ischemia, even though we observed alterations in tcMEP
(i. e., extended latency or shortened amplitude) in three
cases after stent-graft deployment. When alterations of
evoked potentials occurred, we initiated spinal-cord protec-
tion efforts. These protection methods have been described
in detail [11,12]. In all other 14 patients measured, tcMEP
potentials were consistent at the end of the operation. SSEP
potentials were consistent in all measured patients.
3.2. Follow-up
Our follow-up was 100%. Two patients in our series died of
unrelated causes, yielding no mortality related to ESI. One
developed necrotic pancreatitis with peritonitis resulting in
multiorgan failure 72 days after the ESI procedure. In that
case, the LSA had only been covered with the bare metal tip
of the stent-graft device, allowing antegrade perfusion of the
LSA. The other patient had a complete overstented LSA and
died 3 years after the initial operation.
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3.3. Hemodynamics and peripheral symptoms related to
LSA occlusion
Occlusion of the LSA was followed by a differential in
blood pressure between the right and the left arm. A lower
(n = 5) or complete loss (n = 5) of blood pressure of the left
arm occurred postoperatively in 50% of the patients. During
follow-up, four patients with completely overstented LSA
still had left arm pulses that could be measured noninva-
sively.
Pathological blood flows in the supra-aortic branches were
detected in 10 of the 14 patients (71%) who had undergone
complete LSA occlusion. Doppler ultrasound showed devel-
opment of subclavian (n = 2), vertebro-vertebral (n = 2),
vertebro-basilar (n = 2), combined vertebro-vertebral, and
carotid-vertebral (n = 2) steal effects, as well as crossflow in
the deep neck arteries (n = 1). The following degrees of
subclavian steal effects (SSE) were observed: (I) systolic
deceleration (n = 1); (II) alternating flow profile (n = 2); and
(III) completely reversed flow (n = 7). The relationship
between flow patterns and vascular peripheral symptoms
is shown in detail in Table 4. Of the 14 patients with complete
overstenting of the LSA, 5 patients (36%), developed
associated peripheral symptoms. All had pathological blood
flow degree III. These five patients suffered from ischemic-
related peripheral arm deficits such as exercise-induced,
sensory (n = 3), and motoric (n = 3) deficits of the left hand,
temporary (n = 1) and persisting (n = 2) weakness of the left
arm, and sensory deficits (numbness) of the left arm (n = 3).
The symptoms were mild and improved over time in four of
them, not necessitating subclavian revascularization. One of
them presented 4 months after the initial operation with a
combination of several neurological symptoms such as
numbness of the left arm and hand, weakness of the left
arm, and disturbed fine motor skills of the left hand. The
patient was successfully treated surgically with delayed
LCCA-to-LSA bypass and proximal LSA ligation leading to
improvement of symptoms. In the remaining five patients
with pathological blood flow (I = 1, II = 2, III = 2), no
peripheral symptoms were observed (Table 4).
In the group of patients (n = 6) in whom complete
overstenting of the LSA was avoidable, we identified no
pathological changes in supra-aortic blood flow.
3.4. Neurological outcome
All patients recovered from surgery without any initial
signs of significant neurological complications during their
hospital stay. In the follow-up period, none of the 14 patients
with complete overstenting of the LSA developed reversible
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Table 4
Postoperative data
Pat Situation of flow direction in
the vertebrobasilar system
(degree of subclavian
steal effect I—III)
Central neurological
symptoms related to
LSA occlusion
Peripheral symptoms related
to LSA occlusion
Neurological complications not
related to ESI and LSA occlusion
Mortality
1 SSE III — — — —
2 — — — Intracerebral bleeding unrelated
to prior surgery
—
3 SSE II — — — —
4 — — — — —
5 — — — Dysesthesia due to a lesion of a
cutaneous branch of the right
femoral nerve
—
6 SSE III Impaired binocular
vision, dizziness
Disturbed fine motor skills of the
left hand, temporary weakness
of the left arm
— —
7 — — — — —
8 SSE III — Weakness of the left arm, numbness
of the left hand
— —
9 — — — — Unrelated to
prior surgery
10 SSE I — — — —
11 SSE III — Disturbed fine motor skills of the
left hand, numbness of the left arm
— —
12 SSE II Brainstem (pontine)
infarction
— — —
13 SSE III — — — —
14 SSE III — Numbness of the left arm and hand Recurrent laryngeal nerve irritation —
15 SSE III — Numbness and weakness of the left arm,
numbness and disturbed fine motor
skills of the left hand
— —
16 — — — — —
17 — — — — —
18 — — — — Unrelated to
prior surgery
19 — — — — —
20 — — — — —
LSA, left subclavian artery; ESI, endovascular stent-graft implantation; SSE, subclavian steal effect (degree I = systolic deceleration, degree II = alternating flow
profile, degree III = completely reversed).
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exercise-induced signs of central vertebrobasilar insuffi-
ciency, including the 10 patients who had a subclavian steal
effect detected on Doppler examination. Five of 20 patients
(25%) presented with adverse neurological events during
follow-up (Table 4). In two (10%) of them, neurological events
were associated with complete LSA occlusion. These two
patients suffered from late central neurological events such
as right-sided brainstem infarction (n = 1) and transient
ischemic attack manifested by impaired binocular vision
combined with dizziness (n = 1). The acute right-sided
pontine brainstem infarction, confirmed by cerebral MRI,
occurred 2 months after ESI due to an acute occlusion of the
right hypoplastic VA causing left-sided facial paresis,
dysarthria, severe hemiparesis, and hemihypesthesia (initial
NIH stroke scale = 14). The patient underwent LSA transposi-
tion to the LCCA to prevent further brainstem infarction due
to the impaired perfusion of the vertebro-basilary arteries.
Other neurological complications not related to the
occlusion of supra-aortic vessels occurred in three patients.
One suffered from dysesthesia due to a lesion of a cutaneous
branch of the right femoral nerve (stent-graft access),
another patient was hoarse as a result of recurrent laryngeal
nerve irritation following aortic-bi-carotid bypass, and the
third patient suffered from intracerebral bleeding unrelated
to previous surgery due to a hypertensive crisis while under
anticoagulation therapy (Table 4).
3.5. Endoleaks and other stent-graft related problems
We identified postoperative problems with the implanted
stent-grafts via CTscans during follow-up. No type II endoleak
due to overstenting of the LSA was observed in our cohort. In
one patient (5%), an incomplete seal in the proximal
attachment zone (type Ia endoleak) occurred, and two
patients (10%) showed an incomplete seal between the stent-
graft segments (type III endoleak). All three patients were
successfully treated with additional stent-grafts, in a mean
time of 133 days (range 10—400 days). The initial implanted
stent-graft in another patient collapsed 1 year after
implantation due to material failure. This patient was also
successfully treated with an additional stent-graft.
4. Discussion
Open surgical repair of the aortic arch, the descending and
the thoracoabdominal aorta are invasive procedures with
highmorbidity andmortality rates [4,14]. ESI is a less invasive
and effective treatment for high-risk patients showing a low
complication rate [11,12]. One of the most difficult aspects
of stent-graft application is the absence of an adequate
proximal ‘landing zone’, because the LSA is often involved in
or too close to aortic pathologies.
For optimal stent-graft fixation, the ‘landing zones’should
be over 2 cm long. Patients with a proximal ‘landing zone’ of
at least 1.5 cm can undergo ESI with the intention to preserve
antegrade flow in the LSA. Complete coverage of the LSA
ostium must take place occasionally to expand the applica-
tion of stent-graft devices for aortic pathologies beside the
LSA [15]. The carotid arteries limit the use of stent-grafts in
pathologies located in the aortic arch.
Patients with atherosclerotic subclavian artery stenoses
or occlusions are often asymptomatic, as the slow disease
progression promotes collateral vessel development [16].
The LSA is not usually transposed, because LSA overstenting
without revascularization is a well-tolerated procedure in
patients with normal supra-aortic branches [17,18]. In
contrast, acute LSA occlusion by overstenting of the LSA in
the absence of collateral vessels might lead to problems
induced by ischemia.
In the study of Go¨rich et al. [17] of incomplete LSA
overstenting in 4 and complete occlusion of the LSA in 19
patients, three patients (13.6%) reported ischemic arm
symptoms but none of them showed persistent signs of
vertebrobasilary insufficiency. In the series of Tiesenhausen
et al. [9], three of eight patients (37.5%) with partial or
complete occlusion of LSA had vertebrobasilar symptoms. In
the study of Schoder et al. [2], six of eight patients (75%) with
complete occlusion of the LSA presented symptoms.
Secondary transposition of LSA was necessary in two of those
patients, in one patient to treat critical arm ischemia and in
the other to treat an endoleak. Paraparesis and paraplegia
occurred in 5.1% of their patients. One of them underwent
overstenting of the LSA.
Surgical revascularization of the supra-aortic vessels may
present a potential strategy for expanding the applicability
of thoracic aortic ESI. Some patients require revasculariza-
tion of the LSA, such as CABG patients with patent left
internal mammary arteries, because LSA occlusion in such
cases may cause myocardial ischemia [19]. Anatomic
variants, such as origin of the left VA at the arch, or the
absence of fusion of the VAs to the basilary artery, or an
otherwise functionally-compromised circle of Willis, do not
permit LSA occlusion without previous revascularization [2].
As reported in the literature, occlusion of one VA caused
vertebrobasilary ischemia resulting in cerebellar infarction in
2.7% [20]. Bilateral VA occlusion (by overstenting of the LSA
and an additional pathological right VA) caused persistent
neurological deficits in 23% of the patients [2]. Carotid or
vertebral artery stenosis as well as aberrant subclavian
arteries (lusoria) require revascularization of the LSA, as
overstenting of the lusorian artery carries the increased risk
of consecutive cerebellar infarction [15,19].
Another indication for transposing the LSA, or for LCCA-to-
LSA bypass surgery with proximal ligation, is to avoid
retrograde perfusion of the aneurysm sac or the false lumen
in dissections [9]. With coverage of the LSA, retrograde
perfusion from the LSA may prevent thrombosis in the
aneurysmal sac and can cause type-II endoleaks. Interest-
ingly, we observed no type-II endoleaks after complete
overstenting of the LSA in our series. If type-II endoleaks
occur, coil embolization or surgical ligation of the LSA may
become necessary [14]. The rate of primary endoleaks after
thoracic aortic ESI was reported to be 11—25% [2,7,10].
In case of aortic arch involvement, other surgical
revascularization techniques to maintain cerebral perfusion
have been developed to make ESI in the aortic arch possible
[21—23]. Czerny et al. [24] carried out reconstructions of the
supra-aortic branches in patients with aortic arch aneurysms
or type-B aortic dissections. Treatment was by sequential
transposition of the LCCA into the brachiocephalic trunk and
of the LSA into the already-transposed LCCA.
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However, surgical revascularization of the LSA has a 1—5%
mortality rate [15]. Surgical complications after LSA
transposition in Schoder et al.’s [2] series were Horner
syndrome and hoarseness in 7.1% of the patients. An 11% rate
of recurrent nerve paralysis was described in another series
[6]. Therefore, we question the need for prophylactic LSA
transposition or LCCA-to-LSA bypass due to the fact that most
patients with subclavian steal syndrome are asymptomatic.
Flow inversion from a normal right VA to the left VA seems
adequate to compensate after LSA occlusion in patients with
normal supra-aortic vessels. These revascularization techni-
ques should thus be reserved only for those patients
developing ischemic symptoms or presenting a potentionally
compromised collateral blood supply.
To summarize, our results clearly demonstrate the
difficulty and complexity of endovascular stent-graft repair
of the aortic arch and descending aortic pathologies with
overstenting of the supra-aortic branches. In the absence of
supra-aortic vascular pathologies, intentional LSA occlusion
may be justified when a proximal ‘landing zone’ for ESI is
required without subclavian revascularization. Hemodyna-
mically relevant stenoses, occlusions, or anatomic variants of
the supra-aortic branches are preoperative risk factors that
can lead to a higher rate of neurological complications after
LSA overstenting. Preoperative exploration of the supra-
aortic branches by Doppler ultrasound, CT- or MRI scan is
therefore mandatory. Surgical supra-aortic revascularization
techniques managing aortic arch vessels can expand the
applicability of ESI even in patients presenting with stenoses,
occlusions, or anatomical variants of the supra-aortic
branches. Should overstenting of the LSA become necessary
in patients with insufficient collateral pathways and a thus
significantly increased risk of brain ischemia or peripheral
ischemic events, we recommend revascularization of the
supra-aortic branches in advance rather than as a secondary
procedure. In the absence of supra-aortic vessel pathologies,
prophylactic transposition of the LSA or LCCA-to-LSA bypass is
not required prior to intentional stent-graft occlusion of the
LSA, but surgical revascularizations may be designated as an
electivemeasure after ESI when ischemic symptoms do occur.
In conclusion, overstenting of the LSA resulted in ischemic
disorders and neurological events in a number of our
patients. However, coverage of the LSA and other supra-
aortic vessels — to make ESI possible in the aortic arch and in
the presence of descending aortic pathologies with addi-
tional supra-aortic revascularization — is an effective
treatment for high-risk patients with an overall lower rate
of morbidity and mortality compared to open surgery.
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Appendix A. Conference discussion
Dr M. Turina (Zurich, Switzerland): Thank you very much for this report,
which raises many questions really. Would you consider monitoring the blood
pressure in the left radial artery as sufficient during overstenting or do you rely
simultaneously on the ultrasound measurements in the operating room?
Dr Weigang: We monitored the blood pressure on both arms pre-, intra-
and postoperatively. Surprisingly, we found a blood pressure signal on the left
arm as well in some of our patients undergoing overstenting of the left
subclavian artery. We do not take ultrasound measurements during these
procedures.
Dr G. Ziemer (Tuebingen, Germany): When you checked your supra-aortic
flow after implantation of the graft you said you had two subclavian steal
syndromes but you didn’t treat them. So I think you did not mean subclavian
steal syndromes as this would imply neurologic symptoms. You meant just flow
reversal in the vertebral artery without symptoms, which is not subclavian
steal syndrome. So was there reverse of the flow in the left vertebral artery
without symptoms?
Dr Weigang: Yes, that’s right. Most of these patients had no severe
neurological symptoms.
An independent neurologist performed the follow-up examinations of our
patients after the overstenting of the left subclavian artery. He observed two
subclavian steal syndromes and other collateral pathways such as vertebro-
vertebral, vertebro-basilar, combined vertebro-vertebral, and carotid-ver-
tebral steal effects as well as crossflow in the deep neck arteries.
Dr Turina: The comment is totally right, because speaking of a syndrome
denotes symptomatic or subclavian reduction or reversal of the flow. The title
of your slide is correct but the terminology is not.
Dr Weigang: Some of the patients had subclavian steal syndrome.
Dr Ziemer: Flow reversal in the left vertebral artery, which does not lead
to symptoms and therefore it is not a syndrome. This should be easily
distinguished.
Dr Weigang: But they had symptoms, as I showed here.
In the group with complete overstenting of the left subclavian artery we
observed two central neurological complications. One patient had brainstem
infarction with hemiparesis and the other patient suffered from impaired
vision and dizziness due to transient ischemic attack.
Additionally we observed peripheral symptoms in five patients in the same
group, including numbness of the left arm or hand, disturbed fine motor skills
of the left hand, weakness of the left arm due to arm claudication.
Dr Ziemer: Then the syndromes, namely symptomatic patients have to be
in the clinical findings list or slide.
Dr Weigang: They had symptoms.
Five of our patients had peripheral and two had central neurological
symptoms. Another three patients presented with neurological symptoms
which were not related to overstenting of the left subclavian artery.
Dr Ziemer: Semantics possibly. Vertebral artery flow reversal without
symptoms is no syndrome.
Dr Weigang: That is a question of definition.
Dr Turina: So you mean eight of the 14 had symptoms and that had a
subclavian steal syndrome?
Dr Weigang: Yes.
Dr Turina: Six did not.
Dr P. Ghosn (Montreal, Canada): I have two questions. The first one is how
do you explain the right-sided infarction in your series? And the second one, in
view of the high percentage of symptoms after the subclavian exclusion, did
you consider doing a bypass to the subclavian artery prior to putting your stent
graft into the aorta?
Dr Weigang: To answer your first question, this was a patient who suffered
from a right-sided brainstem infarction two months after the initial operation.
At that time that patient had developed a new occlusion of the right vertebral
artery. To prevent another brainstem infarction we performed a left subclavian
transposition in him.
Can you repeat your second comment, please?
Dr Ghosn: About bypassing the left subclavian artery before inserting your
stent graft, like a carotid subclavian bypass or carotid subclavian transposition
to keep the flow going into the subclavian artery before inserting your stent
graft in the aorta.
Dr Turina: The question is why don’t you consider putting the graft first
and then overstenting.
Dr Weigang: The literature describes many complications with such
revascularization techniques. The mortality rate is 1—5% for subclavian
transposition and bypass grafting of the supra-aortic branches. Therefore, we
carry out those examinations in advance of the stent-graft implantation. If a
proximal landing zone with overstenting of the left subclavian artery is
necessary, we perform subclavian transposition or carotid-to-subclavian
bypass only when anatomic variants, stenoses or occlusion of the supra-aortic
branches have been detected in the preoperative examinations.
Dr Turina: And blood pressure reduction in the radial artery would not be
considered an indication?
Dr Weigang: No. We had patients with no blood pressure signal in the left
arm without symptoms. On the other hand, we had patients with complete
overstenting of the left subclavian artery with neurological symptoms and a
blood pressure signal around 70 mmHg in the left arm.
Dr M. Krason´ (Zabrze, Poland): I would like to ask you one question
regarding your antihypertensive regimen postoperatively, because if you have
to rely on collateral flow that is reversible in vertebral artery flow, you would
expect to have some higher pressure, because it is not regular flow, and having
that, probably some deficits could not happen. This is one remark.
And second, we have had several patients with complete overstenting of
the left subclavian artery, and in these patients there was no pulsatile flow at
the left radial artery. And probably, in my opinion, if you have pulsatile flow
and pressure as high as 70 mmHg, it is not complete covering.
DrWeigang: To address your second question first: after the procedure, we
routinely perform CT scans in all of our patients. Fourteen of our patients
underwent complete covering of the left subclavian artery without type-II
endoleaks.
And regarding your first remark: if you have good intracranial cross flow
and collateral flow, the patients don’t have such symptoms. However,
neurological complications after endovascular stent-graft repair in the aortic
arch and the descending aortic position are underreported in the literature,
because most of these problems do not occur until after a couple of months.
And I am quite sure that if you are sending your own patients to an independent
neurologist, they will find also some of the problems you never expected.
Dr Krason: What was the mean age of the group with left subclavian artery
overstented, because it is also an issue? If you have pretty young patients you
have a safer approach, if you have older patients, the risk is much higher. The
mean age in the group?
Dr Weigang: The mean age of our patients with overstenting of the left
subclavian artery was 64 years.
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Background. Our study aim was to evaluate the impact
of left subclavian artery (LSA) ﬂow preservation during
thoracic endovascular aortic repair (TEVAR) on outcome.
Methods. Between August 2001 and October 2016, 176
patients (mean age, 61.3 ± 15.8 years) underwent TEVAR
with complete LSA coverage. Fifty-ﬁve of those patients
(31.3%) also underwent LSA revascularization, whereas
121 patients (68.7%) did not. Perioperative data were ac-
quired retrospectively for statistical analysis at the three
study institutions.
Results. Overall in-hospital and follow-up mortality
was 8.5% (n [ 15) and 9.1% (n [ 16), respectively,
including 88 urgent and emergent cases (50%). Stroke
(independent of location) and permanent paraplegia rates
were 6.8% and 6.3%, respectively, for the entire cohort.
Isolated upper-left extremity malperfusion exclusively
occurred in 12 (9.9%) of the 121 patients without LSA
revascularization. Left-hemispheric stroke was observed
four times more often in patients without LSA revascu-
larization and left arm malperfusion (16.7% versus 3.7%,
p [ 0.095). Multivariate analysis identiﬁed no LSA
revascularization (odds ratio [OR] 3.779, 95% conﬁdence
interval [CI]: 1.096 to 13.029, p [ 0.035), two or more
endografts (OR 3.814, 95% CI: 1.557 to 9.343, p [ 0.003),
and coronary artery disease (OR 3.276, 95% CI: 1.262 to
8.507, p [ 0.015) as independent risk factors for
procedure-related adverse events (left-hemispheric
stroke, left arm malperfusion, and permanent paraplegia)
after TEVAR with complete LSA overstenting.
Conclusions. Every 10th patient with LSA over-
stenting and no revascularization experienced left arm
malperfusion. No LSA revascularization, extensive
aortic coverage with two or more endografts, and cor-
onary artery disease increased the risk of permanent
paraplegia, left-hemispheric stroke, and left arm mal-
perfusion. Patients should undergo LSA revasculari-
zation to prevent left vertebral artery-associated central
neurologic complications and to maintain upper-left
extremity perfusion.
(Ann Thorac Surg 2019;-:-–-)
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Extending thoracic endovascular aortic repair (TEVAR)to the level of the aortic arch requires strategies to
preserve supraaortic perfusion by rerouting procedures
in cases of overstenting of supraaortic vessels to prevent
posterior cerebellar malperfusion, symptomatic spinal
cord injury (SCI), and, ﬁnally, the blood supply to the
upper-left extremity [1–4]. In emergency situations when
the acute thoracic aortic pathologic process determines
the pace and the time for primary revascularization
strategies, sophisticated imaging to reconﬁrm sufﬁcient
collateralization is a viable alternative. The only data
currently available addressing this issue have mainly
been from single centers [5].
Aim of this multicenter study was to compare the
outcome of patients undergoing TEVAR and overstenting
of the left subclavian artery (LSA) with and without a
primary revascularization strategy.
Patients and Methods
Perioperative data on 176 consecutive patients (128 men,
72.7%) undergoing TEVAR with complete overstenting of
the LSA for acute and chronic thoracic aortic disease at
the Leipzig Heart Center, the Heart Center Freiburg
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University, and the Ludwig Maximilian University
Munich were retrospectively analyzed between August
2001 and October 2016. Two study groups were deﬁned
for statistical analysis with regard to LSA revasculariza-
tion before TEVAR: LSA revascularization versus no LSA
revascularization.
Table 1 illustrates our preoperative patient data and
details on previous surgical procedures.
TEVAR
The TEVAR technique was performed at the three
participating centers as previously reported [6–8]. In
general, TEVAR procedures were performed in a (hybrid)
operating room equipped with a C-arm and carbon ﬁber
operating table. All procedures were performed in pa-
tients under general anesthesia. Rapid pacing took place
to support exact endograft positioning. Vascular access
was obtained by an inguinal incision downward or by
percutaneous preclosure technique—according to the
individual clinical scenario—of the common femoral ar-
tery for retrograde delivery of the stent graft. The
following commercially available devices were implanted:
Talent/Valiant or Valiant Captivia (Medtronic Vascular,
Santa Rosa, CA), TAG/C—TAG (W. L. Gore and Associ-
ates, Flagstaff, AZ), Endoﬁt (Endomed Inc, Phoenix, AZ),
and Relay NBS plus (Bolton Medical, Inc, Sunrise, FL).
Endograft sizing was routinely based on preoperative
computed tomography (CT) angiography.
Table 1. Preoperative Patient Data
Variable
All Patients
(N ¼ 176)
LSA Revascularization
(n ¼ 55)
No LSA Revascularization
(n ¼ 121) p Value
Age at TEVAR, years 61.3 � 15.8 63.4 � 11.5 60.4 � 17.8 0.170
Male sex 128 (72.7) 39 (70.9) 89 (73.6) 0.718
Connective tissue disease 3 (1.7) . 3 (2.5) 0.553
COPD 30 (17.0) 7 (12.7) 23 (19.0) 0.389
History of smoking 50 (28.4) 21 (38.2) 29 (24.0) 0.071
Coronary artery disease 41 (23.3) 16 (29.1) 25 (20.7) 0.250
Hypertension 137 (77.8) 47 (45.5) 90 (74.4) 0.119
Diabetes 24 (13.6) 8 (14.5) 19 (15.7) 0.816
Obesity 55 (31.3) 15 (27.3) 40 (33.1) 0.487
Renal insufﬁciency 47 (26.7) 6 (10.9) 41 (33.9) 0.002a
Preop ventilation 22 (12.5) 1 (1.8) 21 (17.4) 0.003a
Preop neurologic deﬁcit
Temporary 5 (2.8) . 5 (4.1) 0.327
Permanent 2 (1.1) . 2 (1.7) 1.000
Aortic pathologic process
Aneurysm 60 (34.1) 26 (47.3) 34 (28.1) 0.016a
Acute TBAD 58 (33.0) 15 (27.3) 43 (35.5) 0.304
Chronic TBAD 31 (17.6) 8 (14.5) 23 (19.0) 0.529
Traumatic injury 5 (8.5) 3 (5.5) 12 (9.9) 0.397
Other 12 (6.8) 3 (5.5) 9 (7.4) 0.756
Aortic diameter, mm 47.9 � 16.3 53.6 � 14.2 45.3 � 16.5 0.001a
Aneurysm 61.0 � 13.8 61.0 � 13.1 61.0 � 14.6 1.000
Other pathologic process 41.0 � 13.0 47.0 � 11.4 39.0 � 13.1 0.001a
Previous surgery
Open cardiac 12 (6.8) 5 (9.1) 7 (5.8) 0.520
Open aortic 24 (13.6) 11 (20.0) 13 (10.7) 0.104
Ascending 14 (8.0) 6 (10.9) 8 (6.6) 0.372
Proximal arch 7 (4.0) 3 (5.5) 4 (3.3) 0.679
Descending 9 (5.1) 4 (7.3) 5 (4.1) 0.463
Abdominal 1 (0.6) . 1 (0.8) 1.000
TEVAR/EVAR 10 (5.7) 5 (9.1) 5 (4.1) 0.463
Descending 4 (2.3) 1 (1.8) 3 (2.5) 1.000
Abdominal 4 (2.3) 2 (3.6) 2 (1.7) 0.590
Iliac axis 2 (1.1) 2 (3.6) . 0.096
a Statistically signiﬁcant.
Values are expressed as mean � SD or n (%).
COPD ¼ chronic obstructive pulmonary disease; EVAR ¼ endovascular aortic repair; LSA ¼ left subclavian artery; Preop ¼ preoperative;
TBAD ¼ type B aortic dissection; TEVAR ¼ thoracic endovascular aortic repair.
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Details on the TEVAR procedures are given in Table 2.
LSA Revascularization
Of 176 TEVAR patients with LSA overstenting, LSA
revascularization was performed in 55 patients (31.3%)—
to create an adequate landing zone (LZ) or to minimize
the risk of stroke, SCI, and left arm malperfusion—
whereas the LSA was not revascularized in the remaining
121 patients (68.7%). In 41 patients (74.5%), the LSA was
revascularized concurrently with TEVAR (before endog-
raft deployment), whereas 14 patients (25.5%) underwent
LSA revascularization in another operation before
TEVAR. These revascularization procedures comprised
left common carotid-to-LSA bypass grafting (n ¼ 47,
85.5%) or transposition (n ¼ 8, 14.5%). Just 1 patient un-
derwent an additional right-to-left common carotid
bypass (1.8%) (Table 2).
The decision—whether to prophylactically revascular-
ize the LSA—was made by an interdisciplinary team at
each respective study center (including cardiac and
vascular surgeons, endovascular specialists, radiologists,
and anesthesiologists).
Neuroprotection of the Spinal Cord
Neuroprotective strategies during TEVAR to avoid SCI
varied among study centers. In general, cerebrospinal
ﬂuid drainage was applied as recommended in all cen-
ters—routinely for all patients in only one center—if an
increased risk of SCI was expected preoperatively (eg,
extensive aortic coverage) or if clinical symptoms
occurred perioperatively [9]. In addition, the mean
arterial pressure (MAP) was maintained supranormal
(>80 mm Hg) intraoperatively and postoperatively on the
intensive care unit for at least 48 hours at all participating
centers. Furthermore, two centers routinely applied so-
matosensory/motor evoked potentials [10] or near
infrared spectroscopy (NIRS) of the lumbar paraspinal
musculature [11] to detect potential SCI perioperatively.
However, lumbar NIRS as a neuromonitoring strategy
was not routinely used until 2012 [12].
Deﬁnitions and Statistical Analysis
The ethics committees at the participating centers granted
approval for this study. The principal investigators at
each clinic conﬁrmed the validation of their data sets
according to the study deﬁnition.
Data were acquired retrospectively at the three study
institutions. Only patients with endograft deployment in
LZ 2 with complete LSA overstenting were included.
Exclusion criteria were LZ 0, 1, and 3, as well as partial
coverage of the LSA oriﬁce in LZ 2. Follow-up of patients
not included in a routine institutional surveillance pro-
gram was conducted by a telephone interview with pa-
tients or their respective physicians. Follow-up time
comprised the time interval between TEVAR and last
patient contact or death of all patients. No expired patient
was excluded.
In-hospital mortality was deﬁned as death before hos-
pital discharge after TEVAR. Reoperations were deﬁned
as any open or endovascular operation related to TEVAR
or post-TEVAR complications. Pulmonary insufﬁciency
was deﬁned as single or combined need for reintubation,
Table 2. TEVAR Procedural Details
Variable
All Patients
(N ¼ 176)
LSA Revascularization
(n ¼ 55)
No LSA Revascularization
(n ¼ 121)
p
Value
TEVAR duration, minutes 128.7 � 84.6 201.2 � 106.9 95.5 � 41.1 <0.001a
Priority
Elective 88 (50.0) 32 (58.2) 56 (46.3) 0.193
Urgent 59 (33.5) 13 (22.0) 46 (38.0) 0.084
Emergent 29 (16.5) 10 (18.2) 19 (15.7) 0.667
Urgent/emergent 88 (50) 23 (41.8) 65 (53.7) 0.193
Endografts (total) 248 78 170 .
Endografts per patient 1.4 � 0.6 1.4 � 0.7 1.4 � 0.6 0.900
1 115 (65.3) 36 (65.5) 79 (65.3) 1.000
2 53 (30.1) 16 (29.1) 37 (30.6) 1.000
3 or more 11 (6.3) 4 (7.3) 7 (5.8) 0.706
Endograft length,b mm 224.9 � 126.5 224.9 � 117.0 224.9 � 130.7 0.999
LSA revascularization
Before TEVAR 14 (8.0) 14 (25.5) . .
In conjunction with TEVAR 41 (23.3) 41 (74.5) . .
LSA revascularization procedures
Bypass 47 (26.7) 47 (85.5) . .
Transposition 8 (4.5) 8 (14.5) . .
a Statistically signiﬁcant. b Cumulative length of endograft devices.
Values are expressed as mean � SD or n (%).
LSA ¼ left subclavian artery; TEVAR ¼ thoracic endovascular aortic repair.
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prolonged ventilation (>5 days), or tracheostomy. Para-
plegia was deﬁned either as temporary or permanent
with regard to complete recovery during that individual’s
hospital stay. Postoperative stroke was deﬁned as any
new cerebral infarction after the TEVAR procedure
diagnosed and veriﬁed by a clinical neurologist or
computed brain tomography. Only symptomatic patients
with clinically relevant subclavian steal syndrome (ver-
tebrobasilar territory neurologic symptoms) or left arm
claudication with a difference in blood pressure between
both arms of greater than 15% mm Hg were deﬁned as
left arm malperfusion. A speciﬁc procedure-related
adverse event after LSA overstenting, as the study’s pri-
mary end point, was deﬁned as single or combined
occurrence of left-hemispheric stroke, permanent para-
plegia, left arm malperfusion, or a combination.
Categorical variables were reported by using the
number and percentage of occurrences. Continuous var-
iables were expressed as mean � SD or (if the SD
exceeded the mean value) as median with interquartile
range (IQR; 25th to 75th percentile). The impact of patient
baseline characteristics, comorbidities, previous treat-
ments (open/endovascular surgery), prophylactic LSA
revascularization, and intraoperative data of the TEVAR
procedure (Tables 1 and 2) on the incidence of procedure-
related adverse events was investigated by univariate and
multivariate regression analysis. A binary logistic
regression model was built by using the variables with p
value less than 0.1 from univariate analysis: no LSA
revascularization (p ¼ 0.069), aortic coverage with two or
more endografts (p ¼ 0.011), coronary artery disease (p ¼
0.011), and preoperative renal insufﬁciency (p ¼ 0.095).
For the univariate and multivariate regression analyses a
p value of less than 0.05 was considered statistically sig-
niﬁcant. Actuarial survival was estimated by the Kaplan-
Meier method with the log-rank (Mantle-Cox) test for
group comparison. Statistics were analyzed with SPSS
statistical software package (version 25.0; IBM, Ehningen,
Germany).
Results
TEVAR indications in our study cohort were aortic
aneurysm (n ¼ 60, 34.1%), acute (n ¼ 58, 33.0%) and
chronic (n ¼ 31, 17.6%) type B aortic dissection, traumatic
aortic injury (n ¼ 15, 8.5%), and other aortic pathologic
processes (n ¼ 12, 6.8%). The maximum mean aortic
diameter at the time of TEVAR was 61.0 � 13.8 mm for an-
eurysms and 41.0 � 13.0 mm for other aortic pathologic
processes. Previous cardiac, open or endovascular aortic
surgery had been performed in 12 patients (6.8%), 24 pa-
tients (13.6%), and 10 patients (5.7%), respectively (Table 1).
In total, 248 aortic endografts (mean: 1.4 � 0.6 aortic
endografts per patient) were administered in the 176
consecutive patients in an elective (n ¼ 88, 50.0%), urgent
(n¼ 58, 33.0%), or emergent (n¼ 30, 17.0%) setting (Table 2).
The entire study cohort’s median follow-up time was
16.8 months (interquartile range [IQR]: 1.3 to 48.7
months). Median intensive care unit and hospital stay
were 2 days (IQR: 1.0 to 5.0 days) and 12 days (IQR: 7.0 to
19.5 days), respectively. Overall in-hospital and follow-up
mortality rates did not differ signiﬁcantly between pa-
tients with or without LSA revascularization and
amounted to 8.5% (n ¼ 15) and 9.1% (n ¼ 16) (p ¼ 0.291)
(Table 3). Of note, 11 of the 15 patients who died in
hospital were treated on an urgent or emergent basis,
resulting in an in-hospital mortality for elective versus
urgent/emergent cases of 4.5% versus 12.5% (p ¼ 0.102).
Actuarial survival estimation of patients with or without
LSA revascularization revealed no signiﬁcant differences
(log rank p ¼ 0.570); the respective 1-, 3-, and 5-year
survival rates for both groups (LSA revascularization
versus no LSA revascularization) were 91.8% � 5.0%
versus 84.7% � 5.7%, 88.0% � 7.1% versus 81.7% � 6.4%,
and 80.0% � 12.1% versus 76.0% � 8.1% (Fig 1).
Reoperations
The overall endovascular reintervention rate for TEVAR-
related complications was 10.8%, whereas open LSA
revascularization was required in 5.8%. Open surgery for
secondary LSA revascularization was performed in 10 of
the 121 patients (8.3%) without prior LSA revasculariza-
tion—compared with 0% of LSA revascularization pa-
tients (p ¼ 0.032). The indication for secondary LSA
revascularization was clinically relevant left arm mal-
perfusion in all 10 patients after a median time interval of
4.5 days (IQR: 2.0 to 18.0 days). Furthermore, open sur-
gery during follow-up because of aortic dissection and
aortoesophageal ﬁstula was required in 6 patients (5.0%)
without LSA revascularization after a median of 54.5 �
44.8 days, whereas open reoperations by sternotomy were
not required in the 55 patients with previous LSA revas-
cularization (p ¼ 0.100). Endovascular reoperations were
substantially more often required in patients with LSA
revascularization than without (21.8% versus 5.8%).
TEVAR extension (re-TEVAR) was the most frequent
procedure in the study group (n ¼ 12, 6.8%), whereas
other required endovascular procedures comprised
reballooning (n ¼ 2, 1.1%) and LSA coil embolization (n ¼
5, 2.1%) (Table 3). Freedom from aortic reintervention for
LSA revascularization versus no LSA revascularization is
shown in Figure 2 (log rank p ¼ 0.072).
Postoperative Complications
Postoperative complications are listed in Table 3. Left arm
malperfusion occurred in 12 patients (9.9%) after TEVAR
without LSA revascularization versus 0% in the previ-
ously revascularized group (p ¼ 0.018). New post-
operative neurologic complications were stroke (6.8%,
n ¼ 12) and spinal cord ischemia (7.4%; n ¼ 13). The
stroke occurrence did not signiﬁcantly differ between
groups (5.5% versus 7.4%, p ¼ 0.756). Similarly, we
observed no difference in the incidence of left-
hemispheric stroke between patients with and without
LSA revascularization (3.6% versus 5.0%, p ¼ 1). How-
ever, left-hemispheric stroke was observed four times
more frequently in patients without LSA revasculariza-
tion and resulting left arm malperfusion compared with
patients without left arm malperfusion (16.7% versus
3.7%, p ¼ 0.095).
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As a result of spinal cord ischemia, temporary and
permanent paraplegia occurred in 2 patients (1.1%) and
11 patients (6.3%); however, their incidence did not differ
signiﬁcantly between study groups (LSA revasculariza-
tion versus no LSA revascularization): 1.8% versus 0.8%
(p ¼ 0.529) and 5.5% versus 6.6% (p ¼ 1), respectively
(Table 3). The incidence of permanent paraplegia after
elective or urgent/emergent TEVAR was 6.8% (n ¼ 6) and
5.6% (n ¼ 5), respectively (p ¼ 1).
Risk Factor Analysis for LSA Overstenting-Related
Adverse Events
A single or combined occurrence of left-hemispheric
stroke, permanent paraplegia, or left arm malperfu-
sion after complete LSA overstenting was noted in
14.8% (n ¼ 26) of the 176 patients. Univariate analysis of
our entire study cohort (n ¼ 176) revealed that no LSA
revascularization (p ¼ 0.069), two or more endografts
(p ¼ 0.011), and coronary artery disease (p ¼ 0.011) were
Table 3. Postoperative Outcome
Outcome
All Patients
(N ¼ 176)
LSA Revascularization
(n ¼ 55)
No LSA Revascularization
(n ¼ 121)
p
Value
ICU stay, days 5.8 � 9.5 3.7 � 5.2 6.8 � 10.7 0.011a
Hospital stay, days 14.9 � 12.0 15.1 � 10.4 14.7 � 12.7 0.400
Open LSA revascularization 10 (5.7) . 10 (8.3) 0.032a
Bypass 6 (3.4) . 6 (5.0) 0.179
Transposition 4 (2.3) . 4 (3.3) 0.311
Endovascular reinterventions 19 (10.8) 12 (21.8) 7 (5.8) 0.003a
Re-TEVAR 12 (6.8) 6 (11.0) 6 (5.0) 0.196
Re-ballooning 2 (1.1) 1 (1.8) 1 (0.8) 0.529
LSA coil embolization 5 (2.8) 5 (9.1) . 0.003a
Open surgery (during follow-up) 6 (3.4) . 6 (5.0) 0.100
Postoperative complications
Hemorrhage 1 (0.6) . 1 (0.8) 1.000
Endoleak 32 (18.2) 10 (18.2) 22 (18.2) 1.000
Ia 14 (8.0) 4 (7.3) 10 (8.3) 1.000
Ib 10 (5.7) 3 (5.5) 7 (5.8) 1.000
II 6 (3.4) 2 (3.6) 4 (3.3) 1.000
III 2 (1.1) 1 (1.8) 1 (0.8) 0.529
Pulmonary insufﬁciency 35 (19.9) 5 (9.1) 30 (24.8) 0.015a
Re-intubation 6 (3.4) 3 (5.5) 3 (2.8) 0.378
Prolonged ventilation 13 (7.4) . 13 (10.7) 0.010a
Tracheostomy 16 (9.1) 2 (3.6) 14 (11.6) 0.154
Renal insufﬁciency (dialysis) 9 (5.1) 2 (3.6) 7 (5.8) 0.722
Left arm malperfusion 12 (6.8) . 12 (9.9) 0.018a
Aortic dissection type A 4 (2.3) 1 (1.8) 3 (2.8) 1.000
Classic 3 (1.7) . 3 (2.8) 0.553
Retrograde 1 (0.6) 1 (1.8) - 0.314
Aorto-esophageal ﬁstula 2 (1.1) . 2 (1.7) 1.000
Paraplegia
Temporary 2 (1.1) 1 (1.8) 1 (0.8) 0.529
Permanent 11 (6.3) 3 (5.5) 8 (6.6) 1.000
Stroke 12 (6.8) 3 (5.5) 9 (7.4) 0.756
Left hemisphere 8 (4.5) 2 (3.6) 6 (5.0) 1.000
Right hemisphere 9 (5.1) 2 (3.6) 7 (5.8) 0.722
Sepsis 2 (1.1) . 2 (1.7) 1.000
Multi-organ failure 7 (4.0) 2 (3.6) 5 (4.1) 1.000
Mortality 31 (17.6) 7 (12.7) 24 (19.8) 0.291
In-hospital 15 (8.5) 4 (7.3) 11 (9.1) 0.779
During follow-up 16 (9.1) 3 (5.5) 13 (10.7) 0.396
a Statistically signiﬁcant.
Values are expressed as mean � SD or n (%).
ICU ¼ intensive care unit; LSA ¼ left subclavian artery; TEVAR ¼ thoracic endovascular aortic repair.
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associated with a higher risk of procedure-related
adverse events. Multivariate analysis showed that no
LSA revascularization (odds ratio [OR] 3.779, p ¼ 0.035),
two or more endografts (OR 3.814, p ¼ 0.003), and
coronary artery disease (OR 3.276, p ¼ 0.015) were in-
dependent risk factors for procedure-related
adverse events after TEVAR with complete LSA over-
stenting (Table 4).
Comment
The treatment of aortic pathologic processes that involve
the descending aorta has changed in recent years thanks
to TEVAR’s clinical implementation and technical im-
provements [2, 13]. TEVAR has now become the treat-
ment of choice for patients with a traumatic aortic injury
or complicated acute type B aortic dissection [2, 14]. Acute
and chronic pathologic processes of the proximal
descending aorta often involve the aortic arch or at least
require a suitable proximal LZ of at least 2 cm in the distal
arch to enable successful endovascular repair with posi-
tive aortic remodeling, but the LSA’s intentional coverage
by TEVAR is not without risk and may raise the risk of
perioperative cerebrovascular accidents and SCI [3, 9, 15,
16]. However, prophylactic open LSA revascularization
may exacerbate the risk of minor (eg, seroma, nerve
damage, lymph leak) and major (neurologic) periopera-
tive complications, and it is known to be associated with
operative mortality, ranging from 1.2% to 5% [17–19].
Some investigators, therefore, suggest performing pro-
phylactic revascularization of the LSA only when an
increased risk of neurologic complications, especially
stroke or SCI, is likely [20, 21].
The present results are in line with other reports on
endovascular aortic treatment [3, 22], thereby conﬁrming
TEVAR as a valuable treatment strategy in our arma-
mentarium for descending aortic disease that extends into
the aortic arch. Because 50% of our study patients un-
derwent operation on an urgent or emergent basis, their
overall in-hospital mortality was only 8.5%—with a low
in-hospital mortality rate of 4.5% for the elective cases.
Note that postoperative pulmonary complications
occurred in almost 20% of patients, potentially coinciding
with their high incidence of chronic obstructive pulmo-
nary disease and need for preoperative ventilation, which
were both higher in the previously non-revascularized
patient group. Open reoperations by sternotomy for
rare TEVAR complications, namely (retrograde) aortic
dissection (2.3%) and aortoesophageal ﬁstula (1.1%), were
limited to patients without previous LSA revasculariza-
tion and occurred with a similar incidence as that re-
ported in the literature [23, 24].
Fig 1. Actuarial survival estimation (Kaplan-Meier) after thoracic
endovascular aortic repair (TEVAR) with complete Left Subclavian
Artery (LSA) overstenting (LSA revascularization versus no LSA
revascularization). (Pts ¼ patients.)
Fig 2. Freedom from aortic reintervention (Kaplan-Meier estimation)
after thoracic endovascular aortic repair (TEVAR) with complete left
subclavian artery (LSA) overstenting (LSA revascularization versus
no LSA revascularization). (Pts ¼ patients.)
Table 4. Independent Risk Factors for Procedure-Related
Adverse Events After Complete LSA Overstenting
Risk Factors Odds Ratio
95% Conﬁdence
Interval
p ValueLow High
No LSA revascularization 3.779 1.096 13.029 0.035
Two or more endografts 3.814 1.557 9.343 0.003
Coronary artery disease 3.276 1.262 8.507 0.015
LSA ¼ left subclavian artery.
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Endovascular procedures within the aortic arch carry
the risk of devastating neurologic complications such as
perioperative cerebrovascular accidents and SCI, espe-
cially when complete LSA occlusion becomes necessary
to achieve an adequate LZ for TEVAR [3]. These com-
plications may be caused or aggravated by the occurrence
of left subclavian steal syndrome, especially in the pres-
ence of anatomic variations such as an incomplete circle
of Willis or a hypoplastic right vertebral artery [3, 25, 26].
Therefore, the primary end point of our underlying
study—to evaluate the impact of LSA ﬂow preservation
during TEVAR—was deﬁned as the occurrence of a single
or combined procedure-related adverse event, namely
left arm malperfusion, left-hemispheric stroke, or per-
manent paraplegia.
In general, minor, otherwise nonsymptomatic upper-
left extremity symptoms because of arm malperfusion,
such as blood pressure differences or activity-
dependent subclavian steal syndrome, may be easily
overlooked clinically but have been reported to occur in
up to 21% of patients after complete LSA overstenting
[3]. In our study cohort, symptomatic left arm malper-
fusion (eg, because of left arm claudication or subcla-
vian steal with resulting vertebrobasilar territory
neurologic symptoms) occurred exclusively in 12 pre-
viously non-revascularized patients (9.9%), ultimately
requiring early secondary open LSA revascularization
in 10 patients after a median of 4.5 days. Patients with
left arm malperfusion experienced a left-hemispheric
stroke four times more often.
Neurologic complications after TEVAR with LSA
overstenting are known to vary between 2% and 14.3% for
stroke [2, 14, 19, 21] and 0% and 5% for SCI [19, 27–29], but
there is little data on the latter. The overall incidence of
postoperative stroke (independent of location) in the
present study was 6.8% (n ¼ 12), including 8 patients
(4.5%) with left-hemispheric stroke. Despite a substan-
tially higher incidence of atherosclerotic aneurysms in the
LSA revascularization group (47.3% versus 28.1%, p ¼
0.016), no statistically signiﬁcant differences were found.
Temporary and permanent paraplegia rates in the study
cohort were 1.1% and 6.3%, respectively (Table 2).
Patients with coronary artery disease as an indepen-
dent risk factor (23.3% of the study cohort) were found to
be at a 3.3-fold increased risk to develop adverse events
related to complete LSA overstenting. It may well be that
patients with coronary artery disease also had cerebro-
vascular disease and aortic calciﬁcation, especially
because the incidence of (atherosclerotic) aortic aneu-
rysms was as high as 46.3%. Unfortunately, the degree of
aortic calciﬁcation—as a potential risk factor for stroke—
could not be determined retrospectively for this study
cohort. Cardiac catheterization before TEVAR seems to
be a valuable diagnostic tool not only to assess the coro-
nary arteries’ status but also to pre-estimate the degree of
aortic calciﬁcation.
The arterial spinal cord collateral network is fed by
three major inﬂow sources comprising the subclavian
(vertebral), aortic segmental (thoracic and lumbar), and
internal iliac (hypogastric) arteries [30]. The risk of
permanent paraplegia rises especially if two arterial
inﬂow sources of spinal cord blood ﬂow are compromised
simultaneously [31]—without enough time to enable the
collateral network to adapt [30]. The deployment of two
(or more) endografts usually results in a longer aortic
coverage and requires more endovascular manipulation
within the aortic arch, a factor likely to increase the risk of
cerebrovascular accidents and SCI in these patients. The
deployment of at least two endografts was identiﬁed as an
independent risk factor (with a relative risk of 3.8) for
adverse events after LSA overstenting through multivar-
iate analysis. In our series, the cumulative device length
of 1 versus 2 or more endografts—as the above-
mentioned independent risk factor—was 149.8 � 34.7
mm versus 360.3 � 118.1 mm (p < 0.001). This result is in
line with previous clinical reports of hybrid (eg, frozen
elephant trunk) and TEVAR techniques that showed an
increased incidence of paraplegia in conjunction with
extended descending aortic endograft coverage [9, 20, 31].
Especially in elderly patients presenting with athero-
sclerotic aneurysms or chronic aortic disease, the spinal
cord’s arterial blood supply may already be compromised
because of acquired vascular stenosis or thrombosis (with
subtotal or total occlusion), which in combination with
extended endograft coverage will most likely affect spinal
blood supply.
Because aortic segmental artery preservation—as a
measure to prevent SCI in open aortic surgery—is
impossible during extended TEVAR with LSA
coverage, new concepts such as spinal cord collateral
network preconditioning—by minimally invasive
segmental artery coil embolization—may be considered
before TEVAR to reduce the risk of paraplegia in
certain patients [32].
Study Limitations
The preoperative CT scan protocols for TEVAR patients
(with LSA overstenting) varied at the three participating
centers over time or were limited to an aortic angiography
with imaging of the proximal supraaortic branches
(especially in urgent/emergent situations). Therefore,
important anatomic variations, such as dominance of the
left or right vertebral artery or completeness of the circle
of Willis, could not be fully obtained for statistical anal-
ysis retrospectively. Perioperative stroke may occur
silently and often remains undetected if no clinical
symptoms are present and postoperative brain imaging is
clinically not indicated. Postoperative neurologic evalua-
tion and CT of the brain were not routinely performed in
asymptomatic patients in this series. Paraplegia—as the
most dreaded complication after TEVAR—may occur
delayed and for various reasons. The respective data of
applied perioperative neuroprotective strategies—such as
the amounts of drained cerebrospinal ﬂuid, drops below
the lumbar NIRS baseline and relevant changes of so-
matosensory/motor evoked potentials—to avoid potential
spinal cord ischemia could not be fully obtained retro-
spectively. Therefore, the interpretation of our results
with regard to SCI may be limited.
7Ann Thorac Surg LUEHR ET AL
2019;-:-–- TEVAR WITH OVERSTENTING OF THE LSA
104
Conclusion
Every 10th patient who underwent LSA overstenting but no
revascularization experienced left arm malperfusion. Pa-
tients without LSA revascularization and resultant left arm
malperfusion experienced left-hemispheric stroke more
frequently. We found that no LSA revascularization,
extensive aortic coverage with two or more endografts, and
coronary heart disease increased the risk of permanent
paraplegia, left-hemispheric stroke, and left arm malperfu-
sion. LSA revascularization should be performed to prevent
left vertebral artery-associated central neurologic compli-
cations and to maintain upper-left extremity perfusion.
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Abstract
OBJECTIVES: The purpose of this study is to retrospectively evaluate, with an ‘all-comers’ approach, the survival and outcome of patients
following secondary surgical or interventional procedures after thoracic endovascular aortic repair (TEVAR).
METHODS: Between October 2002 and December 2013, 371 patients with different aortic pathologies underwent primary TEVAR at our
institution. Fifty-six out of the 371 patients (15.1%, 18 females, mean age 62.3 ± 13.7 years) required secondary procedures, either interven-
tionally (N = 31; 55.4%) or surgically (N = 25; 44.6%), due to stent graft-related complications. After TEVAR complications comprised
endoleaks (N = 28; 7.5%), organ malperfusion (N = 9; 2.4%), aorto-oesophageal/-bronchial ﬁstulae (N = 9; 2.4%), stent graft infections
(N = 4; 1.1%), aneurysm progression (N = 3; 0.8%), retrograde type A aortic dissection (N = 2; 0.5%) and aortic regurgitation (N = 1; 0.3%).
RESULTS: The overall in-hospital mortality rate was 10.7% (N = 5): open surgery (N = 1; 4%) versus reintervention (N = 5; 16%; P = 0.14). The
cumulative survival rates after secondary procedures at 6 months, 1 year and 3 years were 80.4, 73.5 and 69.3%, respectively. Postoperative
complications either for open surgery or reintervention comprised stroke (8 vs 9.6%; P = 0.82), paraplegia (4 vs 6.4%; P = 0.68), renal failure
(16 vs 3.2%; P = 0.09), respiratory failure (12 vs 0%; P = 0.04), sepsis (16 vs 3.2%; P = 0.87), organ malperfusion (4 vs 3.2%; P = 0.87) and need
for a tertiary procedure (8 vs 6.4%; P = 0.82).
CONCLUSIONS: Stent graft complications after primary TEVAR were not infrequent and often required secondary procedures for deﬁnite
treatment. Endoleaks (type Ia), organ malperfusion, stent graft infections, ﬁstula formation and expanding aneurysm occurred predomin-
antly during early and mid-term follow-up. Despite the high-risk nature of the complications, secondary open surgical or interventional
procedures may be successfully performed with an acceptable outcome.
Keywords: Thoracic endovascular repair • Aortic aneurysm • Chronic aortic dissection • Stent graft complications • Reoperation •
Reintervention
INTRODUCTION
Thoracic endovascular aortic repair (TEVAR) has become an estab-
lished alternative to open surgery for a variety of thoracic aortic
diseases (i.e. aneurysm and type B dissection), particularly in
patients with a high operative risk and unclear overall life expect-
ancy, or in the acutely unstable patient to achieve rapid aortic
stabilization. Growing experience with endovascular interventions
and continued technological advancements have resulted in a
wide spectrum of indications for TEVAR and a progressively in-
creasing utilization of new advanced technologies for more
complex aortic anatomy and pathologies, e.g. thoraco-abdominal
aortic aneurysms [1, 2]. However, the more liberal use of TEVAR
carries the risk of serious complications that may require second-
ary procedures, such as endovascular reinterventions and/or open
surgical repair. Experience with secondary procedures for failed or
complicated primary TEVAR is limited and the outcome after rein-
terventions/operations is only infrequently reported.
The purpose of the current report was to retrospectively evalu-
ate, with an ‘all-comers’ approach, the survival and the outcome
of patients following secondary procedures after TEVAR.
PATIENTS ANDMETHODS
From October 2002 to December 2013, 371 patients underwent
primary TEVAR, including 126 (33.9%) patients with intentional
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overstenting of the left subclavian artery (LSA), for different thor-
acic aortic pathologies at our institution. The respective indica-
tions for primary TEVAR as well as detailed patient baseline
characteristics are summarized in Table 1.
Secondary procedures after thoracic endovascular
aortic repair
Fifty-six (15.1%; 18 females, mean age 62.3 ± 13.7 years) of the 371
patients underwent secondary procedures due to stent graft-
related complications. Following elective TEVAR, reinterventions
or operations were performed in 30 patients (54%) with chronic
type B aortic dissection (TBAD; N = 13), thoracic aortic aneurysm
(N = 16) or penetrating atherosclerotic ulcer (N = 1). In compari-
son, secondary procedures after rescue/emergency TEVAR were
required in 26 patients (46%) suffering from acute (N = 3) or
impending aortic rupture (N = 12), complicated TBAD (N = 10)
and pseudoaneurysm (N = 1). The respective indications for sec-
ondary procedures following elective and emergency TEVAR are
summarized in Table 2.
Reinterventions were performed in 55.4% (31/56), while 44.6%
(25/56) of patients required open surgical repair as a secondary
treatment. The decision on ‘how to treat’ was made on an individ-
ual basis and was based on the clinical status and the underlying
stent graft complication. In any case of stent graft infection [includ-
ing aorto-oesophageal/-bronchial ﬁstulae (AOF/ABF), N = 13] and
occurrence of retrograde type A aortic dissection (N = 2), urgent/
emergency open surgery was chosen as the only treatment option.
Otherwise, complications such as endoleaks (N = 23), aneurysm pro-
gression (N = 3), malperfusion syndrome (N = 9) or other causes
(N = 1) were only treated by open surgery if (endovascular) interven-
tional procedures were unfeasible or contraindicated, e.g. in the
absence of an adequate aortic landing zone (minimal length 20 mm)
or rapid aneurysm progression.
The respective complications after primary TEVAR with regard
to the performed secondary procedures are listed in Table 3.
Open surgical repair
Secondary open surgery was performed in 25 (44.6%) of the 56
patients. The details of our institutional surgical technique to
address stent graft complications after TEVAR have been described
previously [3, 4]. In brief, surgical access was achieved via a left-
sided posterolateral thoracotomy (n = 14), full sternotomy (n = 10)
or both (N = 1). Arterial cannulation for cardiopulmonary bypass
(CPB; N = 22) was performed via the femoral artery (N = 12), the ax-
illary artery (N = 4) or both (N = 3). In 3 cases, the brachiocephalic
trunk was used as the arterial cannulation site. Three patients were
operated without CBP via left-sided thoracotomy. Antegrade bilat-
eral selective cerebral perfusion (ASCP) was used as an adjunct to
hypothermic circulatory arrest (HCA) in 10 patients via the right
axillary artery (N = 4) or directly after aortotomy by using balloon
perfusion catheters in the brachiocephalic trunk (N = 6) and left
carotid artery (N = 10) with a ﬂow sufﬁcient to maintain a pressure
of 50–60 mmHg at moderate hypothermia of 21–28°C. Additional
perfusion of the LSA was performed in 2 cases for additional spinal
cord protection. Intraoperative duration times (median) for HCA,
CPB, ASCP and aortic cross-clamping were 46 min (range 20–59),
175 min (range 55–264), 54 min (range 20–62) and 80 min (range
22–152), respectively. Perioperative cerebrospinal ﬂuid (CSF) drain-
age as an additional measure to minimize the risk of paraplegia was
used up to 72 h postoperatively in 9 cases.
Aortic repair comprised total or distal aortic arch replace-
ment (N = 10), isolated descending aortic (N = 9) and/or
Table 1: Preoperative baseline characteristics of all 371 patients treated by primary TEVAR
Baseline characteristics All patients No. of second procedures Secondary procedure P-value
Age, years (median; IQR) 69 (57–75) 69 (59–76) 64 (53–72) 0.10
Female sex, n (%) 108 (29.1) 90 (28.6) 18 (32.1) 0.58
Hypertension, n (%) 299 (80.6) 249 (79.0) 50 (89.3) 0.07
CHD, n (%) 74 (19.9) 59 (18.7) 15 (26.8) 0.16
Marfan’s syndrome, n (%) 3 (0.8) 3 (1.0) – 0.46
Smoking, n (%) 95 (25.6) 79 (25.1) 16 (28.6) 0.58
COPD, n (%) 61 (16.4) 49 (15.6) 12 (21.4) 0.27
IDDM, n (%) 58 (15.6) 48 (15.2) 10 (17.9) 0.61
Obesity (BMI ≥30), n (%) 99 (26.7) 81 (25.7) 18 (32.1) 0.31
Renal insufficiency, n (%) 103 (27.8) 89 (28.3) 14 (25.0) 0.61
Previous neurological dysfunction, n (%) 45 (12.1) 39 (12.4) 6 (10.7) 0.46
Preoperative paraplegia, n (%) 4 (1.1) 4 (1.3) – –
Stroke, n (%) 31 (8.4) 27 (8.5) 4 (7.1) –
Other, n (%) 9 (2.4) 7 (2.2) 2 (3.6) –
Previous cardiac surgery, n (%) 88 (23.7) 72 (22.8) 16 (28.6) 0.35
Aortic pathology
Dissection, n (%) 129 (35) 106 (34) 23 (41) 0.28
Aneurysm, n (%) 113 (30) 96 (30) 17 (30) 0.90
Covered rupture, n (%) 82 (22) 70 (22) 12 (21) 0.80
Acute rupture, n (%) 20 (5.5) 17 (5.5) 3 (6) 0.70
Fistula, n (%) 4 (1) 4 (1.5) – 0.48
Other, n (%) 23 (6.5) 22 (7) 1 (2) 0.10
Total, n (%) 371 (100) 315 (100) 56 (100) –
IQR: interquartile range; CHD: coronary heart disease; COPD: chronic obstructive pulmonary disease; IDDM: insulin-dependent diabetes mellitus; BMI: body
mass index; TEVAR: thoracic endovascular aortic repair.
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thoraco-abdominal aortic repair (N = 4). Additional aortic valve
reconstruction due to aortic valve regurgitation—most likely
caused by wire perforation during the primary TEVAR procedure—
was performed in 1 patient. Complete stent graft removal was per-
formed in 11 cases due to stent graft infection (N = 4), AOF (N = 5)
or ABF (N = 2). A single AOF patient—presenting with severe medias-
tinitis and several oesophageal abscesses—underwent oesophagect-
omy with cervical oesophagostomy via a right-sided posterolateral
thoracotomy prior to scheduled aortic surgery with stent graft
removal.
Interventional procedures
Secondary interventions were performed in 31 (55.4%) patients.
Endovascular repair included various catheter techniques such as
re-TEVAR, re-ballooning of the implanted stent graft, endovascular
coiling of aortic branches, stenting of stenosed aortic branches and
endostapling. Other reinterventions included carotid-to-subclavian
bypass/transposition (Table 3).
Repeated TEVAR, which was the preferred reintervention follow-
ing primary TEVAR, was performed due to endoleaks (N = 15) and
aneurysm progression (N = 2) in 17 (54.8%) of the 31 patients of the
reintervention group under general anaesthesia. Re-ballooning was
used to reattach the implanted stent graft to the aortic wall in 2
patients presenting with type Ib endoleak. A single patient—initially
treated for a large thoraco-abdominal aneurysm with intentional
LSA coverage—suffered from persistent type Ib endoleak despite a
repeated re-ballooning procedure. To avoid open surgery, the
Aptus EndoStapling System (Aptus Endosystems, Sunnyvale, CA,
USA) was used to provide ﬁxation and sealing of the previously
implanted stent graft to the aortic wall, ﬁnally resulting in complete
resolution of the type Ib endoleak (Fig. 1).
Two patients with type II endoleak originating from the LSA with
relevant progression of aortic diameter during early follow-up
underwent endovascular coil embolization of the LSA, 66 and 88
days after TEVAR, via percutaneous brachial artery access.
Delayed end-organ malperfusion as the indication for reinter-
vention was observed in 9 cases. In 3 patients with visceral malper-
fusion syndrome, stenting of the respective aortic side branches
(coeliac trunk:N = 1 and superior mesenteric artery: N = 2) was per-
formed under local anaesthesia via a percutaneous access. In the
remaining 6 patients, intentional LSA coverage had resulted in left
vertebrobasilar insufﬁciency (N = 1) or left upper limb ischaemia
(N = 5) and subsequently were treated by carotid-to-subclavian
transposition (N = 2) or carotid-to-subclavian bypass using a pros-
thetic graft (N = 4).
Statistical analysis
All continuous variables are expressed as the mean ± standard devi-
ation, or as median with interquartile range (IQR). The categorical
variables are reported as counts and percentages. Categorical
variables were compared using the χ2test or Fisher’s exact test and
independent continuous variables were compared by unpaired
Student’s t-test or the Kruskal–Wallis test as appropriate. Survival
Table 2: Indications for primary and secondary procedures
Primary indication for TEVAR Indication for secondary procedure
Type of endoleak Aneurysm
progression
Malperfusion
syndrome
Retrograde type A
dissection
AOF/
ABF
Stent graft
infection
Aortic
regurgitationIa Ib II III
Elective
Aneurysm (n = 16) 2 2 2 1 – 2 1 4 2 –
TBAD (n = 13) 6 1 1 – 1 3 1 – – –
PAU (n = 1) – – – – – – – 1 – –
Rescue/emergency
Rupture/fistulae (n = 3) – – 1 – 1 – – 1 –
TBAD (n = 10) 7 – – 2 1 – – – –
Covered rupture (n = 12) – 3 2 – 2 – 4 1 –
Pseudoaneurysm (n = 1) – – – – – – – – 1
Total (n = 56) 15 6 3 4 3 9 2 9 4 1
TEVAR: thoracic endovascular aortic repair; AOF/ABF: aorto-oesophageal/aorto-bronchial fistula; TBAD: type B aortic dissection; PAU: penetrating
atherosclerotic ulcer.
Table 3: Stent graft complications and treatment strategies
Stent graft
complication
Secondary procedures
Open surgery
(N = 25)
Reintervention (N = 31):
Re-TEVAR
(N = 17)
Others (N = 14)
Type of endoleak
Ia 8 7 –
Ib – 3 3 (1× ES; 2× BA)
II – 1 2 (2× EC)
III – 4 –
Aneurysm
progression
1 2 –
Malperfusion
syndrome
– – 9 (6 × CSB/T;
3 × ST)
Retrograde type A 2 – –
AOF/ABF 9 – –
Stent graft infection 4 – –
Aortic regurgitation 1 – –
TEVAR: thoracic endovascular aortic repair; ES: endostapler; BA:
ballooning; CSB/T: carotid–subclavian bypass/transposition; ST:
stenting; EC: endovascular coiling; AOF/ABF: aorto-oesophageal/
aorto-bronchial fistula.
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and freedom from secondary procedure survival estimates were
generated using the Kaplan–Meier analysis. The threshold of signiﬁ-
cance was set at P < 0.05. All statistical analyses were performed
with SPSS® V. 20 software package (IBM®, Armonk, New York,
NY, USA).
Postoperative follow-up comprised clinical surveillance [com-
puted tomography (CT), endoscopy, clinical examinations, etc.] at
3, 6 and 12 months (and annually thereafter) amended by routine
annual telephone questionnaire of the patient, and their respect-
ive general physicians. The clinical charts of all patients were retro-
spectively reviewed.
Secondary procedure was deﬁned as any endovascular, open
surgical or hybrid procedure related to aortic disease during follow-
up, including early and late conversion, except for planned staged
procedures. Secondary open surgery was deﬁned as any operation
requiring reopening of the chest with or without aortic replace-
ment. All endovascular procedures were deﬁned as interventions.
Carotid–subclavian artery bypass or transposition—without the
need for reopening the chest, CPB and circulatory arrest—was
deﬁned as an interventional procedure. Endoleaks were categor-
ized as described by Grabenwöger et al. [5].
In-hospital mortality was deﬁned according to the STS guidelines
as death in hospital prior to discharge or within 30 days after
surgery (regardless of location). Stroke was deﬁned as new-onset
neurological deﬁcit and/or evident brain injury visualized by CT
scan. Paraplegia was deﬁned as either permanent or temporary bi-
lateral motor deﬁcit of the lower extremities: early (immediately
after the procedure) and delayed (after a period of intact motor
function during the postoperative course). Renal failure was deﬁned
as an increase in serum creatinine >1.5 mg/dl, temporary—resolved
by the time of discharge—or permanent need for haemodialysis.
Respiratory insufﬁciency was deﬁned as weaning failure from mech-
anical ventilation requiring mechanical ventilation (>7 days), reintu-
bation or a tracheostomy.
The following stent grafts have been used in the study for
primary intervention: the TAG and the newer-generation C-TAG
devices (W.L. Gore and Associates, Flagstaff, AZ, USA); Talent/
Valiant/Captivia (Medtronic, Minneapolis, MN, USA); Zenith (Cook,
Inc., Bloomington, IN, USA); and Endoﬁt (LeMaitre Vascular,
Burlington, MA, USA). Stent graft selection was at the discretion of
the endovascular surgeon.
RESULTS
Fifty-six (15.1%) out of 371 patients treated by TEVAR for various
thoracic aortic pathologies required a secondary procedure due to
stent graft-related complications. Secondary procedures were per-
formed either interventionally or surgically in 55.4% (31/56) and
44.6% (25/56) of patients, respectively (Table 3). In total, 60 after
TEVAR procedures were performed in the 56 patients, including 4
patients undergoing two procedures. The overall median follow-up
after primary stent graft implantation was 21.4 months (IQR 6.5–
51.4; N = 371). The median follow-up for the 56 patients who
underwent a secondary procedure following primary TEVAR was
10.5 months (IQR 1.7–39.1).
Preoperative baseline characteristics of all 371 patients were
not statistically different between patients with or without a sec-
ondary procedure (Table 1).
The overall median interval after primary TEVAR to secondary
procedure was 2.98 months (IQR: 0.32–16.60 months) in the study
group. However, the respective intervals (time to the secondary pro-
cedure) varied between the respective after TEVAR complications:
endoleaks (median: 3.7 months; IQR: 1.4–17.9), malperfusion syn-
drome (median: 0.16 months; IQR: 0.05–0.85), AOF/ABF (median:
3.0 months; IQR: 1.0–27.0), stent graft infection (median: 2.7 months;
IQR: 0.9–6.2), retrograde type A aortic dissection (median: 0.38
months), aneurysm progression (median: 20.1 months; IQR: 17.0–
30.0) and aortic regurgitation (median: 0.1 months). Table 4 sum-
marizes the different time intervals until treatment for early and
mid-term complications after primary TEVAR.
The overall in-hospital mortality rate after secondary surgical or
interventional treatment after primary TEVAR was 10.7% (N = 6):
open surgery (4%; N = 1) versus reintervention (16.1%; N = 5;
P = 0.41). The cumulative survival rates at 6 months, 1 year and 3
years were 80.4, 73.5 and 69.3%, respectively. Survival was not sig-
niﬁcantly different between both groups (log-rank test: P = 0.60).
Figure 2 shows the survival curves estimated by the Kaplan–Meier
method, stratiﬁed by secondary management strategy after
TEVAR.
Neurological complications, by means of stroke and paraplegia,
occurred in both groups. The overall incidence rate of stroke was
8.9% (N = 5). The group-speciﬁc incidence rate of stroke was 8.0%
(N = 2) in the open surgical group and 9.6% (N = 3) in the
Figure 1: Three-dimensional reconstructed computed tomographic (CT) scan (A) after thoracic endovascular aortic repair (TEVAR) with two Valiant stent grafts
(Medtronic). The CT scan revealed (B) an endoleak type Ib, despite a repeated ballooning procedure to enable the stent grafts to adapt to the aortic wall. Aortogram
(C) showing the deployment of an endostapling device (HeliFx EndoAnchors, Aptus Endosystems), which was placed circumferentially around the stent graft.
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reinterventional group (P = 0.82). Paraplegia occurred less fre-
quently (N = 3; 5.6%) with only 1 (4.0%) case following open surgi-
cal treatment and 2 (6.4%) cases after re-TEVAR (P = 0.82).
Renal failure (N = 5; 8.9%) occurred more often in the open
surgery group than in the reinterventional group (16 vs 3.2%);
however, no statistical difference was found between groups
(P = 0.09). Postoperative sepsis (N = 5; 8.9%) showed a similar distri-
bution between groups (16 vs 3.2%; P = 0.09). Malperfusion syn-
drome following secondary procedures occurred in 1 patient of
both groups (N = 2; 3.6%). Respiratory failure was found to only
occur in the open surgery group (N = 3; 12%) and reached statistical
signiﬁcance (P = 0.04). Tertiary procedures, by means of reopera-
tions or reinterventions, occurred in 4 (7.1%) patients: open surgery
(N = 2; 8.0%) versus reintervention (N = 2; 6.4%).
Post-TEVAR complications are listed in Table 5.
DISCUSSION
In the past decade, TEVAR was primarily reserved for emergency
treatment of high-risk patients with unclear overall life expectancy
or as a ‘bridge-to-surgery’ in case of acute aortic rupture. However,
increasing experience with high procedural success rates has
resulted in a progressive use in aortic surgery, which is now being
proposed as an alternative for most aortic pathologies affecting the
descending aorta, and in individual cases even for extensive thoraco-
abdominal pathologies [6]. As the number of TEVAR survivors
grows, reports of complications are on the increase [7, 8], with an
incidence rate of open repair after TEVAR approaching 2.2–7.2% in
experienced centres. It seems likely that the incidence of severe
stent graft-related complications or even TEVAR failure is currently
under-reported in the medical literature, and therefore the asso-
ciated morbidity and mortality may be signiﬁcantly higher than in
primary open repair [3, 9, 10].
In the current study, 371 patients treated by TEVAR at our insti-
tution were retrospectively screened for secondary procedures
due to stent graft complications within a time period of more than
10 years. Overall, 56 patients (15.1%) underwent a secondary pro-
cedure after TEVAR with a median time interval to secondary
treatment of 2.98 months. Twenty-ﬁve (6.7%) out of 371 patients
required open surgical repair, which is in line with recently pub-
lished clinical reports [11]. Recent publications on elective TEVAR
report endovascular reinterventions to occur with an incidence
rate between 0 and 32.3% [12], while the incidence rate of verteb-
robasilar ischaemia and subclavian steal syndrome after complete
LSA overstenting may be as high as 24 and 20%, respectively [13].
In comparison, 25 (6.7%) patients of the current study required an
endovascular reintervention after primary TEVAR, whereas 6 out
of 126 (4.8%) patients after intentional LSA coverage required a
revascularization procedure due to vertebrobasilar insufﬁciency or
left upper limb ischaemia.
The time to secondary procedure after TEVAR differed between
the respective complications—with aortic regurgitation and retro-
grade aortic dissection being the fastest and aneurysm progression
being the slowest complications to occur (Table 4). Interestingly,
patients with stent graft infections and AOF/ABF formation pre-
sented rather early during follow-up at 2.7 months (median) and
3.0 months (median), respectively. However, time to secondary
procedure for the reintervention group (median: 1.57 months; IQR
0.14–17.00) was shorter in comparison with the open surgery
group (median: 3.83 months; IQR 1.00–14.40).
In-hospital mortality was not signiﬁcantly different between
the treatment groups (P = 0.14). The higher trend for in-hospital
Figure 2: Kaplan–Meier survival curve stratiﬁed by the two groups that under-
went secondary procedures (open surgery versus reintervention) due to com-
plications after primary thoracic endovascular aortic repair (TEVAR). No
signiﬁcant difference with regard to survival was found (log-rank test, P = 0.6)
after 36 months.
Table 4: Time to secondary procedure
Treatment Time-to-secondary
treatment (months)
Secondary procedure (overall), median (IQR) 2.98 (0.32–16.60)
Open surgery, median (IQR) 3.83 (1.00–14.40)
Reintervention, median (IQR) 1.57 (0.14–17.00)
Stent graft complications
Endoleak (N = 28), median (IQR) 3.7 (1.4–17.9)
Aneurysm progression (N = 3), median (IQR) 20.1 (17.0–30.0)
Malperfusion syndrome (N = 9), median (IQR) 0.16 (0.05–0.85)
Retrograde type A (N = 2), median 0.38
AOF/ABF (N = 9), median (IQR) 3.0 (1.0–27.0)
Stent graft infection (N = 4), median (IQR) 2.7 (0.9–6.2)
Aortic regurgitation (N = 1), months 0.1
IQR: interquartile range; AOF/ABF: aorto-oesophageal/aorto-bronchial
fistula.
Table 5: Early outcome and post-procedural complications
stratified by the secondary management strategy
Complication Open surgery
(N = 25)
Reintervention
(N = 31)
P-value
In-hospital mortality, n (%) 1 (4) 5 (16) 0.14
Paraplegia, n (%) 1 (4.0) 2 (6.4) 0.68
Stroke, n (%) 2 (8.0) 3 (9.6) 0.82
Renal failure, n (%) 4 (16.0) 1 (3.2) 0.09
Sepsis, n (%) 4 (16.0) 1 (3.2) 0.09
Malperfusion, n (%) 1 (4.0) 1 (3.2) 0.87
Respiratory failure, n (%) 3 (12.0) 0 0.04a
Tertiary procedure
(interventional or
surgical), n (%)
2 (8.0) 2 (6.4) 0.82
aSignificantly different.
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mortality of the reintervention group (16%)—even though not stat-
istically different—could be explained by a high rate of emergency
cases (acute or impending aortic rupture) of the descending aorta
with re-TEVAR performed as a rescue therapy (Fig. 3).
Ten late deaths occurred during follow-up of the secondary
procedure cohort (N = 56), including 1 aorta-related death due to
a new aortic rupture distally to the stent graft. In the other 9 cases,
causes of death included respiratory failure (N = 3), heart failure
(N = 4), pancreatitis (N = 2) and cancer (N = 1). The cumulative sur-
vival rates of both groups at 6 months, 1 year and 3 years were
80.4, 73.5 and 69.3%, which are in line with other clinical series
of endovascular aortic centres. Roselli et al. [14] reported similar
survival rates of 83, 75, and 67% at 6 months, 1 year and 3 years,
respectively. In comparison, the observed in-hospital and mid-
term mortality rates were similar in both groups (log-rank test
P = 0.06; Fig. 2).
The currently reported incidence rate of endoleaks following
TEVAR ranges from 1 to 29% [15, 16]. In our series, the overall inci-
dence rate of endoleaks was 7.5% (N = 28; out of 371 patients)
with type Ia endoleak being the most frequent indication for a
secondary procedure (26.8%; N = 15; out of 56 patients). Of note,
12 of these patients were initially treated for chronic TBAD, which
tended to have shorter-than-recommended landing zones and
larger aortic diameters.
Currently, no expert consensus regarding the indications for
secondary endovascular or open surgical repair in patients with
type I endoleaks after TEVAR exists. An adequate landing zone in
Zone 3 or 4 according to Ishimaru’s classiﬁcation usually allows for
re-TEVAR, which is commonly accepted as the primary choice of
reintervention. However, in case of steep angulation, short length
of the proximal landing zone or progressive aortic lesions adjacent
to or even involving the distal aortic arch conversion to open sur-
gical repair is often required [17]. Open surgical repair of proximal
type Ia endoleak (N = 8) was performed due to progression of the
disease involving the aortic arch if secondary TEVAR was technic-
ally impossible. In most of these cases (N = 6), replacement of the
ascending aorta and aortic arch was performed by the ‘reverse’
frozen elephant technique, as described by Coselli et al. [18].
These patients showed superior outcome with no in-hospital mor-
tality or stroke, but with resulting permanent paraplegia in a single
case. Alternatively, if a type I endoleak persists despite repeated
procedures—similar to the case in the series—endostapling may be
considered [19].
Common risk factors for the development of any type of endo-
leaks are the LSA coverage, an increased aortic diameter (aneurysm)
and extensive aortic coverage with multiple stent grafts [16]. In 2
patients, persisting type II endoleak from the LSA was successfully
treated by endovascular coil embolization on postoperative day
(POD) #66 and #88 via percutaneous brachial artery access; how-
ever, 1 patient suffered a stroke. Therefore, our current manage-
ment strategy of patients with persistent endoleaks consists of early
treatment of type I and III endoleaks and a more conservative ‘wait
and watch’ strategy for detection of potential aneurysm progression
in patients with type II endoleaks [16, 20].
Secondary to endoleaks, stent graft infections and AOF/ABF
(3.5%; N = 13 out of 371) were found to develop early during
follow-up. Endovascular stent graft infection is reported to occur
with an incidence rate of 0.05–4% with medical treatment alone
resulting in a mortality rate of 100%. In our own experience [21],
the treatment strategy for infected stent grafts with or without
ﬁstula formation was surgical and comprised aggressive debride-
ment of the infected tissues and stent graft extirpation. Thoracic
Figure 3: (A) Aortogram after thoracic endovascular aortic repair (TEVAR) using two Valiant stent grafts (Medtronic) for aneurysm exclusion due to chronic type B aortic dis-
section. (B) Computed tomography scan on POD#1 after TEVAR showed an acute rupture at the level of the overlapping zone (endoleak type II) of both stent prostheses
(red arrow).
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endovascular aortic repair was not considered as a bridge to surgery
in these high-risk patients so as not to delay curative treatment.
Similar to our own observations, Cernohorsky et al. [22] reported a
short interval (within 3 months) between TEVAR and clinical signs of
stent graft infection, thereby emphasizing the important role of pro-
phylactic antibiotics during and after the intervention. The use of
rifampicin-soaked Dacron prostheses or autologous grafts (cryopre-
served) remains another treatment strategy for stent graft infection
with virulent organisms or frank purulence [23]. Extra-anatomical
bypass may also be considered as an alternative surgical solution in
patients with severe mediastinal infection.
The third most frequent indication for a secondary procedure was
malperfusion syndrome. In particular, intentional LSA coverage was
found to cause relevant malperfusion of the upper left limb or steal
syndrome of the left vertebral artery in 6 patients. Endovascular LSA
coverage has been shown to cause relevant subclavian steal syn-
drome, with stroke also being infrequently reported [24]. Therefore,
previous subclavian transposition or carotid-to-subclavian bypass
should be considered if intentional LSA coverage by elective TEVAR
is planned. In 3 other patients, end-organ malperfusion was success-
fully overcome by stenting of the respective aortic branch.
Paraplegia remains of concern in the treatment of after TEVAR
complications and was observed in 5.4% (3 out of 56 patients) of
the study group (open surgery 4.0% versus reintervention 6.4%;
P = 0.68). In one patient after open surgery, early paraplegia oc-
curred on POD#1 after extended thoraco-abdominal repair, due to
type II endoleak-associated aneurysm progression with complete
visceral debranching. The operation was performed under mild
hypothermia at 32°C with left heart bypass, CSF drainage and near-
infrared spectroscopy to monitor the paraspinous collateral
network to detect related spinal cord ischaemia [25]. All of the seg-
mental aortic arteries were sacriﬁced intraoperatively. However, the
patient suffered from severe haemorrhage postoperatively and
required massive transfusion. Improvement of neurological symp-
toms was achieved by medical therapy with dexamethasone, re-
duction of CSF pressure and an increase in mean arterial pressure,
but permanent motor deﬁcits of the lower extremities remained.
In the other two cases, immediate paraplegia occurred after
re-TEVAR and thoraco-abdominal segmental artery coil emboliza-
tion (type II endoleak). The ﬁrst patient underwent primary TEVAR
due to acute TBAD complicated by abdominal malperfusion.
Perioperative CSF drainage was utilized; however, the patient
experienced immediate paraplegia after extended stent grafting of
the thoraco-abdominal aorta. The second patient had undergone
primary TEVAR for chronic TBAD-associated large aortic aneurysm.
After TEVAR, a type II endoleak persisted for more than 3 months,
originating from thoracic and lumbar aortic segmental arteries. The
patient underwent complex coil embolization with closure of the
proximal entry tear as well as the thoracic and lumbar segmental ar-
teries. Shortly after the procedure, the patient developed the ﬁrst
signs of paraplegia. Despite the frequent use of CSF drainage and
maintenance of supranormal mean arterial pressures, improvement
of neurological symptoms was incomplete.
Other post-procedural complications were observed in both
groups and included sepsis (16 vs 3.2%; P = 0.09), renal insufﬁ-
ciency (16 vs 3.2%; P = 0.09), malperfusion (4.0 vs 3.2%; P = 0.82)
and reoperation as a tertiary procedure (8.0 vs 6.4%; P = 0.87).
Tertiary procedures were required in only 4 (7.1%) out of the
56 patients; however, the rate for more than one additional
operation/intervention may be as high as 42% [24]. Despite
being relevant, the incidence of these complications did not sig-
niﬁcantly differ between patients treated either surgically or
reinterventionally. However, respiratory insufﬁciency (12 vs 0%;
P = 0.04) only occurred after conventional surgical repair, and
therefore was found to be signiﬁcantly different between treat-
ment groups. The 3 patients who developed respiratory insufﬁ-
ciency were operated on via a left-sided thoracotomy for AOF
(n = 2) and large descending aortic aneurysm (n = 1), which is per
se associated with signiﬁcant pain and may have a negative
impact on postoperative pulmonary function. However, since
TEVAR was not feasible—due to stent graft infection (N = 2) and
lack of an adequate landing zone (N = 1)—no alternative treat-
ment strategy to open surgery existed in these 3 cases.
The results that were observed in this study show that secondary
procedures may be successfully performed with an acceptable
outcome. Except for respiratory failure, no statistically differences
were found regarding mortality and morbidity postoperatively as
well as during early and mid-term follow-up. However, after TEVAR
complications may occur with varying degrees of severity, thereby
demanding early diagnosis and individual planning by an interdis-
ciplinary team to treat each complication, for example stent graft
infections and aortic ﬁstulae, accordingly.
Limitations
The limitations of this study are inherent to the single-centre experi-
ence, the heterogeneity of the treated aortic pathologies and the
retrospective nature of the analysis. In many cases, the respective
endovascular reintervention strategy depended on the individual
experience of the endovascular surgeon/interventionalist on call
and our knowledge of published case reports. Currently, no treat-
ment algorithm or standardized protocol for secondary procedures
with regard to after TEVAR complications is deﬁned, necessitating
an interdisciplinary treatment strategy on an individual basis.
CONCLUSIONS
Complications after primary TEVAR seem to occur cumulatively
during follow-up and often require secondary procedures for deﬁn-
ite treatment. During early and mid-term follow-up, the predo-
minant complications after TEVAR comprised endoleaks (Type Ia),
malperfusion syndrome, stent graft infections, ﬁstula formation and
expanding aneurysm. Despite the high-risk nature of complications,
individually planned secondary open surgical and interventional pro-
cedures may be successfully performed with an acceptable outcome.
Owing to an increased incidence of early complications after TEVAR,
close surveillance during follow-up is strongly recommended.
Conﬂict of interest: none declared.
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APPENDIX. CONFERENCE DISCUSSION
Scan to your mobile or go to
http://www.oxfordjournals.org/page/6153/1
to search for the presentation on the EACTS library
Dr S. Folkmann (Vienna, Austria): This manuscript reports on a secondary inter-
vention rate after TEVAR. Within 10 years, a cohort of 370 patients with all
aortic pathologies were retrospectively recruited. 56 patients underwent sec-
ondary intervention, nearly half another endovascular treatment, and 44% had
an open surgical repair.
So that leads me to my ﬁrst question: How did you treat a type I endoleak?
How did you make the decision?
And the second question would be, in your manuscript you mentioned that
while the TEVAR procedure was done, the CSF drainage was used, I would like
to know which patients this was done in and if it was performed at the primary
or secondary intervention.
Dr M. Nozdrzykowski (Leipzig, Germany): Regarding the ﬁrst question, to the
best of our knowledge there is currently not any experience or any consensus
on how one should treat a type I endoleak. In our cohort, we have about 40%
of patients with type I endoleak, and it was the most common indication for
secondary interventions, especially type Ia endoleak which was the indication
for secondary intervention in approximately 27% of patients. Our current strat-
egy in case of a type Ia endoleak is: if the proximal landing zone is 20 mm or
more, and if we can place a new stent in the zone of 3 or 4, according to
Ishimaru classiﬁcations, we use as a ﬁrst choice approach for a second TEVAR
procedure. In contrast, in cases of steep aortic arch angulation and if the prox-
imal landing zone is shorter than expected, or if the aortic lesion is near or
involving the aortic arch, we used as primary therapy open secondary interven-
tion, I mean open surgical repair. Moreover, in young patients we use more fre-
quently open surgical repair, because of unclear durability of the stent grafts.
Relating to your second question, we didn’t commonly use cerebrospinal
ﬂuid drainage (CSF) in our patients. The use of CSF drainage was dependent on,
whether it was the primary, or the secondary intervention. In the primary inter-
vention we used CSF drainage only in patients who had previously thoracoab-
dominal aortic repair, because in these cases, the paraplegia rate is higher. Also
in cases of a second TEVAR, we use CSF drainage, if the extended thoracic or
thoracoabdominal aortic stent-graft placement was performed, for example, in
cases of a type Ib endoleak or endoleak type III, most frequently in patients
with DeBakey type III aneurysms.
To summarize, we used CSF drainage in elective cases and in approximately
40% of patients undergoing TEVAR a second time.
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Abstract
OBJECTIVES: Hybrid endovascular procedures are rapidly evolving and have recently been adopted for high-risk patients deemed un-
suitable for conventional aortic arch surgery. We describe here our initial experience with this technique, including the management of
2 patients who developed a retrograde type A aortic dissection post-de-branching.
METHODS: Between May 2010 and October 2012, 109 patients underwent conventional aortic arch repair at our institution. A further
9 high-risk patients with complex aortic arch pathology (median logistic EuroSCORE: 26, range: 11–41) were deemed unsuitable for
conventional total aortic arch replacement and therefore underwent hybrid aortic arch repair. Complete supra-aortic de-branching, fol-
lowed by endovascular stent-grafting (TEVAR) of the transverse arch and descending aorta, was performed in these high-risk patients.
RESULTS: In-hospital mortality was zero and no patient developed paraplegia/paraparesis due to spinal cord ischaemia. However, 2
patients (22%) developed retrograde type A aortic dissection on Days 10 and 12 post-TEVAR. Both patients had a dilated ascending
aorta and received a stent graft containing bare metal springs at the proximal end. Emergency ascending aortic replacement was per-
formed during moderate-to-mild hypothermia (28–34°C) and bilateral antegrade cerebral perfusion via cannulation of the de-branch-
ing prosthesis. A Hemashield prosthetic graft was anastomosed to the proximal stent graft in an elephant trunk technique. Both patients
suffered from minor non-debilitating stroke, with 1 being discharged home and 1 transferred to a neurological rehabilitation centre 2
and 3 weeks after reoperation, respectively.
CONCLUSIONS: Retrograde type A aortic dissection after hybrid endovascular treatment of the aortic arch represents a new—most
likely under-reported—pathology that may be successfully treated with open surgical repair. The use of stent grafts with protruding
proximal bare springs and the implementation of oversizing and post-deployment ballooning should be avoided in patients undergoing
hybrid arch procedures, particularly if the ascending aorta is dilated.
Keywords: Retrograde type A aortic dissection • Proximal landing zone • Ascending aorta • Hybrid aortic repair • TEVAR • Supra-aortic
de-branching/re-routing • Aortic arch
INTRODUCTION
Conventional open ‘two-stage’ surgery for extensive thoracic
aortic pathologies—including the aortic arch and the descending
aorta—remains challenging, with an associated morbidity and
mortality in the range of 13–36% [1–4]. Hybrid endovascular pro-
cedures are evolving and have recently been adopted for high-
risk patients deemed to be unsuitable for conventional aortic
arch surgery. Such procedures have been used to treat a wide
range of aortic disease involving the transverse aortic arch and
the descending thoracic aorta.
New less-invasive surgical strategies—involving off-pump partial
or complete surgical re-routing of the supra-aortic branches
followed by thoracic endovascular aortic repair (TEVAR)—have re-
cently been introduced into clinical practice to treat aortic arch
pathologies in high-risk patients with promising early results [5–7].
The main concept of ‘supra-aortic de-branching’ is the creation of
a proximal landing zone (Zones 0, 1, 2) to allow for safe second-
stage endovascular stent graft deployment to completely exclude
transverse and distal arch pathologies, e.g. aneurysms, penetrating
ulcers and dissections [8]. Although TEVAR has been developed as
†Presented at the 26th Annual Meeting of the European Association for
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a less-invasive approach for the treatment of aortic pathologies, it
is also associated with a dangerous and formerly unknown com-
plication: retrograde type A aortic dissection (rAAD) [5, 9].
The risk of rAAD during and after hybrid de-branching proce-
dures in the management of aortic arch pathologies remains
unknown. However, the occurrence of rAAD during TEVAR
seems to be multifactorial rather than directly related to intrao-
perative manipulation alone, particularly in the course of
delayed rAAD [5].
We describe here our early experience with aortic
de-branching procedures, with a particular focus on the diagno-
sis and management of patients who developed postoperative
rAAD.
PATIENTS AND METHODS
Between May 2010 and October 2012, 109 patients underwent
conventional aortic arch surgery at our institution. A further 9
high-risk patients with pathology of the aortic arch and descend-
ing aorta were deemed unsuitable for conventional surgery due
to signiﬁcant comorbidities (median logistic EuroSCORE: 26,
range: 11–41), and were therefore admitted for hybrid endovas-
cular aortic repair. Preoperative patient demographics and co-
morbidities are shown in Table 1.
Indications for hybrid treatment comprised extensive athero-
sclerotic arch aneurysm (n = 7) and arch aneurysm due to an ab-
errant subclavian artery (n = 2). Preoperative multislice computed
tomography (CT), with subsequent 3D reconstruction of the
entire aorta, was performed in order to identify an adequate
proximal landing zone (Ishimaru classiﬁcation) for endovascular
stent-grafting and to exclude any major occlusive vessel disease
of the supra-aortic and thoracoabdominal aortic branches [8]. To
allow for complete stent-grafting of the transverse arch, a prox-
imal landing zone of at least 2.0 cm in the distal ascending aorta
(Zone 0) was chosen in all patients. Preoperative coronary angi-
ography and echocardiography were performed in all patients.
Six operations were performed in a hybrid operation theatre
equipped with an angiographic C-arm system allowing for con-
comitant TEVAR, while the other 3 patients underwent a staged
procedure. The de-branching procedures were performed
without cardiopulmonary bypass (CPB) in 6 patients, and with
CPB in 1 patient who had a patent LIMA-LAD bypass graft
post-CABG. Concomitant off-pump coronary artery bypass graft-
ing (OPCAB) was performed in 2 patients. Later in the series, 2
patients with a dilated ascending aorta (diameter >40 mm)
underwent supracoronary ascending aortic replacement followed
by supra-aortic de-branching using a four-branched prosthetic
graft (Lupiae graft, Vascutek Terumo, Scotland, UK). The ascend-
ing aorta was replaced in these patients during CPB in order to
achieve an adequate proximal landing zone and to avoid the risk
of rAAD.
Endovascular stent-grafting of the distal ascending aorta, trans-
verse arch and proximal descending aorta was successfully per-
formed retrogradely via the femoral artery under ﬂuoroscopy
followed by completion angiography in all cases. The TEVAR pro-
cedure was performed during the same operation as the
de-branching procedure in 6 patients, and as a second-stage
completion repair 5–8 days later in 3 patients. A postoperative
routine follow-up CT scan was performed 1 week post-TEVAR in
all patients.
RESULTS
Open supra-aortic de-branching, with (n = 3) or without (n = 6)
the use of CPB was successfully performed in all patients.
Concomitant OPCAB surgery was performed in 2 patients. No
patient required intraoperative conversion to conventional open
repair with deep hypothermic circulatory arrest.
Retrograde stent graft deployment via the femoral artery was
successful in all 9 patients. Stent graft quantity depended on the
individual extend of aortic pathology to allow for complete
exclusion: 6 patients received three stent grafts (Valiant®,
Medtronic Vascular, Santa Rosa, CA, USA)—covering the trans-
verse arch and descending aorta up to the celiac trunk—and 2
were treated with one stent graft (Valiant®, Medtronic Vascular,
Santa Rosa, CA, USA). Only 1 patient underwent TEVAR with two
Zenith® (Cook, Inc., Bloomington, IN, USA) stent grafts.
Intraprocedural balloon dilatation of the aortic stent grafts was
necessary in 4 cases and depended on individual aortic arch
pathology and the occurrence of endoleaks immediately after
stent graft deployment. No endoleaks were detected during the
following clinical course.
Morbidity and mortality after hybrid arch repair
The median intensive care unit (ICU) stay and hospital stay were
11.3 ± 8.5 days (range 2–29 days) and 19.5 ± 12.1 days (range
7–42 days), respectively. In-hospital mortality was zero.
Perioperative stroke and transient postoperative delirium oc-
curred in 2 and 3 patients, respectively. No postoperative transi-
ent or permanent spinal cord ischaemia (i.e. paraplegia/
paraparesis) occurred, even in patients with coverage of the
entire descending aorta to the celiac axis.
Five patients developed respiratory insufﬁciency postopera-
tively, and 3—one with chronic obstructive pulmonary disease—
required percutaneous tracheostomy in order to be weaned
from the ventilator. One patient with chronic renal insufﬁciency
required temporary dialysis during the early postoperative
course. Reoperation was required in 3 patients because of post-
operative bleeding, acute innominate artery bypass occlusion
and sternum instability in 1 patient each.
Table 1: Patient demographics and preoperative
comorbidities
Age ± SD, range 76.4 ± 4.8 (67–82) years
Male, n (%) 9 (100)
Hypertension, n (%) 9 (100)
Obesity, n (%) 2 (22)
Hyperlipidaemia, n (%) 6 (67)
Coronary artery disease, n (%) 4 (44)
Previous myocardial infarction, n (%) 1 (11)
Chronic obstructive pulmonary disease, n (%) 2 (22)
Diabetes mellitus, n (%) 4 (44)
Chronic renal failure, n (%) 1 (11)
Chronic pancreatitis, n (%) 1 (11)
Liver cirrhosis, n (%) 1 (11)
Previous cardiac operation, n (%) 2 (22)
Previous major surgery (non-cardiac), n (%) 6 (67)
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Two patients developed retrograde type A dissection
post-TEVAR and are described in more detail below.
Case 1
At the beginning of the series, an 80-year old male patient pre-
sented with progressive back pain due to a large aneurysm of
the distal aortic arch and descending aorta (max. diameter 60
mm) post-type B aortic dissection. The patient also suffered
from several comorbidities including dyspnea at rest, obesity,
atrial ﬁbrillation, arterial hypertension, symptomatic hyperthy-
roidism and acute gastroenteritis. With regard to the medical
history and the actual condition, this patient was deemed frail
and high risk for open surgery.
He underwent off-pump supra-aortic de-branching and
TEVAR of the entire descending aorta using three stent grafts.
TEVAR coverage extended distally to the celiac axis, with good
perfusion of the celiac trunk on completion angiography.
The procedure was successful and the patient recovered
uneventfully. On the 10th postoperative day, however, he
developed chest pain and acute cardiac tamponade requiring
cardiopulmonary resuscitation. Emergency chest CT showed
acute rAAD in close proximity to the proximal end of the stent
graft and the anastomosed ‘de-branching’ graft (Fig. 1A and B).
Replacement of the supracoronary ascending aorta
was performed as an open emergency operation. Bilateral
antegrade selective cerebral perfusion (800 ml/min) was
performed via cannulation of the de-branching graft, during
moderate hypothermia (28°C) and distal circulatory arrest.
Intraoperatively, a dissection entry due to bare spring perfor-
ation of the enlarged ascending aorta (diameter 42 mm) was
conﬁrmed.
A Hemashield graft (32 mm) was anastomosed to the proximal
end of the stent graft in an elephant trunk technique achieving
good hemostasis (Fig. 1C and D). The right coronary sinus was
dissected but the aortic valve was still competent. In view of the
patient’s age and comorbidities, the decision was made to glue
together the layers of the right coronary sinus with ﬁbrin glue,
and the proximal anastomosis was completed thereafter. After
ﬁnishing the proximal anastomosis, the de-branching graft was
anastomosed end-to-side to the new ascending aortic graft.
Circulatory arrest time was 35 min, aortic cross-clamp time was
82 min and CPB time was 158 min.
Figure 1: CT 3D reconstruction of the thoracic aorta after supra-aortic de-branching and thoracic endovascular stent graft repair showing retrograde aortic type A
dissection (rAAD) due to proximal bare spring perforation (A and B). Intraoperative view of the proximal portion of the deployed stent graft after resection of the
ascending aorta (C). An ‘elephant trunk procedure’ was performed by suturing a Hemashield graft to the proximal end of the stent graft (D); the bare springs can
be cut off before or after completion of this anastomosis.
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A postoperative cranial CT scan showed multiple infarction
syndrome. Two weeks after reoperation for rAAD, the patient
was responsive and able to weakly move all extremities, and was
discharged to a neurological rehabilitation clinic.
Case 2
The second patient (age 67) had been admitted for an aberrant
right subclavian artery aneurysm with involvement of the distal
aortic arch, as well as signiﬁcant left main coronary artery
disease. The diameter of his native ascending aorta was 36 mm
and therefore he was thought to be at low risk for rAAD. The
medical history included arterial hypertension, diabetes mellitus,
smoking (>40 pack years) and previous visceral surgery. The
patient was deemed to be high risk for conventional open
surgery because of the challenging location of his aortic aneur-
ysm at the origin of the aberrant right subclavian artery (i.e.
Kommerell’s diverticulum).
The patient underwent supra-aortic de-branching and con-
comitant off-pump OPCAB surgery. TEVAR of the transverse
arch, using one stent graft (Valiant®), was performed as a
second-stage repair 1 week later. The postoperative course was
uneventful; however, routine predischarge surveillance CT
revealed an rAAD involving the non-coronary sinus and proximal
ascending aorta, without signs of acute cardiac tamponade.
Urgent supracoronary ascending replacement with a 30-mm
Hemashield prosthesis was performed. The de-branching pros-
thesis was cannulated in order to perform bilateral antegrade se-
lective cerebral perfusion during mild hypothermic (34°C) arrest.
Additional distal perfusion (2.5 l/min) of the lower body was per-
formed via a balloon occlusion catheter that was placed within
the arch stent graft, in order to lower the risk of ischaemic
damage to the spinal cord and visceral organs. The dissection
entry was located in the proximal ascending aorta directly adja-
cent to the bare metal springs of the stent graft. During ante-
grade cerebral and lower body (distal) perfusion, the ascending
aorta was resected and an ‘elephant trunk procedure’ with a
30-mm Hemashield prosthetic graft was performed as described
above. The aortic valve was competent and therefore the dis-
sected layers of the non-coronary sinus were re-approximated
with ﬁbrin glue. Circulatory arrest time was 25 min, aortic cross-
clamp time was 43 min and CPB time was 85 min.
The patient was extubated on the second postoperative day,
but required another reoperation for sternal instability 10 days
later. In addition, a right posterolateral cerebral infarction
(3.7 × 2.7 cm) was diagnosed via cranial CT scan after the patient
had developed left arm weakness. No further neurological deﬁ-
cits occurred and the patient was discharged home 6 weeks
after the initial de-branching operation.
DISCUSSION
rAAD has been recognized as an uncommon but frequently lethal
aortic disease in the era of transcutaneous thoracic aortic inter-
vention [5, 9]. Post-TEVAR rAAD was initially reported as single
case reports following the treatment of acute type B aortic dissec-
tion [10, 11]. In 2009, a multicentre study of the European Registry
on Endovascular Aortic Repair Complications reported on an inci-
dence of rAAD post-TEVAR for either acute or chronic type B
dissection of 1.33% (95% CI 0.75–2.40) [12]. Although rAAD
post-TEVAR is uncommon, its associated mortality is higher than
that observed in patients presenting with conventional type A
aortic dissection, being 50% if rAAD is diagnosed in-hospital and
70% if diagnosed during the TEVAR procedure [12].
Today, hybrid endovascular procedures are increasingly used
in high-risk patients deemed unsuitable for conventional aortic
arch surgery [5–7]. Most recently, the incidence of early rAAD
after partial (Zone 1 and 2) and complete (Zone 0) supra-aortic
re-routing followed by TEVAR of the aortic arch was reported to
be 1.9%, with a 30-day hospital mortality rate of 33% [9].
However, the incidence of rAAD after stent graft deployment in
the ascending aorta (Zone 0) with complete arch coverage was
even higher when compared with more distal endografting of
the aortic arch (Zone 1 or 2): 6.9 vs 1.4% [9]. Czerny et al.
reported an overall rAAD incidence of 8% in a multicentre study
of 66 patients with total arch de-branching and TEVAR (Zone 0),
with an early (<7 days postoperatively) and delayed (>7 days
postoperatively) incidence of 3 and 5%, respectively [5]. At our
institution, 2 (22%) of 9 patients who underwent hybrid arch
repair developed delayed rAAD. Even though emergency
surgery was successful with no in-hospital mortality, the high oc-
currence of rAAD and the accompanying stroke rate raises con-
cerns about the safety of complete supra-aortic de-branching
and TEVAR of the aortic arch.
Williams et al. reviewed their institutional database with regard
to supra-aortic de-branching and TEVAR of the aortic arch (Zones
0–2) and identiﬁed only 6 (1.9%) of 309 patients who developed
early rAAD [9]. Their patient analysis revealed an increased rAAD
incidence in patients with an aortic diameter of more than >40
mm and after stent graft deployment in the native ascending
aorta (Zone 0) of 4.8 and 6.9%, respectively. A combination of
increased ascending aortic diameter (>40 mm), a proximal landing
zone in the native aorta (Zone 0), and the existence of dissection
pathology increased the incidence of rAAD up to 25% [9]. All of
these potential risk factors applied to the ﬁrst patient of our series
who developed rAAD: ascending aortic diameter of 42 mm,
proximal landing zone in the native ascending aorta (Zone 0) and
pre-existing type B aortic dissection. In addition, it was noted at
the time of reoperation that the entry site was directly adjacent to
the proximal bare springs of the stent graft.
Other investigators have noted an association between prox-
imal bare springs and the occurrence of rAAD [12, 13].
However, a deﬁnite causation has not yet been established.
Czerny et al. identiﬁed several factors that may contribute to
the development of rAAD after surgical de-branching and com-
plete TEVAR of the arch: ascending aortic injury after partial
clamping for the proximal anastomosis, compliance mismatch
(rigidity of the stent graft vs highly compliant ascending aorta)
and blood ﬂow alterations after transposition [5]. Aortic injury
due to partial clamping of the ascending aorta was unlikely to
have been the cause of rAAD in our second patient, since he
underwent a repeat CT scan between his de-branching and
TEVAR procedures. This interval CT did not reveal any evidence
of rAAD, which was ﬁrst diagnosed after the TEVAR procedure.
Intraoperative examination again revealed an entry site that oc-
curred directly adjacent to the proximal bare metal springs that
may have caused the initial aortic wall injury. Kpodonu et al.
suggested that stent graft oversizing to >20% with regard to
aortic diameter may also be a potential risk factor for rAAD
[14]. Of note, 4 patients in our series (including both patients
with rAAD) required balloon expansion after stent graft deploy-
ment in the transverse arch.
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Another issue regarding rAAD after TEVAR is the resulting
neurological outcome after the reoperation. Both patients had
been treated successfully with supra-aortic de-branching and
TEVAR without any neurological complication postoperatively.
However, both required emergent ascending aortic replacement
with bilateral SCP—and ultimately suffered from stroke after reo-
peration. Clearly, any aortic operation bears a potential risk for
occurrence of the new neurological events. However, CPR was
required preoperatively in the ﬁrst case and may have predis-
posed the patient to signiﬁcant cerebral ischaemia. Avoiding
rAAD—and thereby an aortic reoperation—is of outmost import-
ance in these high-risk patients to lower the incidence of neuro-
logical complications and postoperative mortality.
The results of our study and others suggest that not every
‘high-risk’ patient deemed unsuitable for conventional aortic
arch repair is a good candidate for off-pump supra-aortic
de-branching and TEVAR of the aortic arch. When considering
hybrid or conventional surgery, it is important to always indi-
vidually estimate the patient’s history, actual clinical status and
anatomical variations. During a period of 29 months, we only
classiﬁed 9 of 118 patients (7.6%) requiring aortic arch surgery as
acceptable candidates for supra-aortic de-branching and TEVAR.
However, the fact that both patients with rAAD (22%; n = 2) were
successfully treated by emergent open surgery may even indi-
cate that conventional surgery could have been successfully per-
formed in the ﬁrst place despite these signiﬁcant comorbidities.
It is important for every surgeon to distinguish whether a
patient is dying from aortic pathology (i.e. dissection or aneur-
ysm) or with aortic pathology. Mack most recently described a
method of patient selection for transcutaneous aortic valve re-
placement with regard to frailty and reported the usefulness of
the ‘eyeball test’, grip strength and the 5-min walk test in order
to assess whether a patient is best suited for conventional
surgery, interventional treatment or conservative therapy [15].
Currently, there is no general consensus among the aortic
experts in classifying ‘ﬁtness for open surgery’, TEVAR or hybrid
procedures, and therefore patient estimation of being ‘too high
risk’ for open arch surgery depends on the surgeon’s individual
experience only!
Koullias and Wheatly suggested a new hybrid classiﬁcation
system for high-risk patients with regard to anatomy to allow for
better decision making when deciding to replace the transverse
arch surgically or to exclude the underlying aortic pathology by
TEVAR: hybrid type 1 vs hybrid type 2 [16] (Fig. 2). With regard
to their classiﬁcation, the frozen elephant trunk technique could
be used in patients requiring a hybrid type 1 repair, while
off-pump supra-aortic de-branching with TEVAR of the arch
would be indicated in a hybrid type 2 [16]. The Philadelphia
group published another classiﬁcation system (Type I–III) to
address the varying pathologies of the transverse arch [7] (Fig. 2).
They suggested the use of supra-aortic de-branching and TEVAR
of the transverse arch in the ‘classic’ saccular aneurysm (Type I),
while Type II and III have no suitable proximal landing zone
(and distal landing zone in Type III) and therefore require recon-
struction of Zone 0 by ascending aortic replacement [7]. In Type
II or III, TEVAR may be performed antegradely during the same
session (Type II, IIIa) or retrogradely via the femoral artery as a
second-stage repair (Type IIIb).
Perioperative diagnostics and imaging are of outmost import-
ance to diagnose post-TEVAR rAAD. Intraoperative transoesopha-
geal echocardiogram (TEE) allows for the detection of acute rAAD
during TEVAR, and therefore should be applied in every case [9].
A high degree of clinical suspicion should be used in the post-
operative period, particularly if sudden hypotension occurs. At
our institution, postoperative routine chest CT scan is performed
1 week post-TEVAR in order to exclude any procedure-related
complications (e.g. subacute rAAD, endoleaks etc.), and to verify
the therapeutic success (e.g. aneurysm exclusion).
Although our incidence of rAAD is worrisomely high in this
small patient cohort, it is possible that the true incidence of
post-TEVAR rAAD is under-reported in the current literature. We
strongly believe that routine predischarge CT scan examination
should be performed in all patients treated by TEVAR regardless
of symptoms or clinical suspection.
As a result of our high incidence of rAAD after hybrid aortic
de-branching and stent-grafting in patients (with extensive aortic
pathologies involving the arch and the descending aorta), we
now electively perform ascending aortic replacement with a
four-branched prefabricated graft in all patients with ascending
aortic ectasia (aortic diameter >4.0 cm) or aneurysm (hybrid
type 2/Type II and III as described above), in order to achieve an
extended proximal landing zone (3–4 cm in length) and to avoid
the potential risk of rAAD. Moreover, we also avoid the use of
conventional endovascular stent graft prostheses with protruding,
rigid proximal bare springs during all hybrid de-branching pro-
cedures, particularly in patients with a dilated ascending aorta or
distorted vascular anatomy. Finally, we are very selective when
identifying patients for hybrid therapy, with conventional aortic
arch surgery being our procedure of choice in the vast majority
of patients.
CONCLUSION
rAAD represents a new and possibly under-reported complica-
tion after hybrid endovascular treatment of the aortic arch. The
use of stent grafts with protruding proximal bare stents and the
implementation of oversizing and post-deployment ballooning
should be avoided in this high-risk cohort, particularly if the
ascending aorta is dilated. An expert consensus should attempt
to more accurately identify high-risk patients unsuitable for
Figure 2: Suggested classiﬁcation systems for hybrid aortic arch repair with
regard to arch pathology by Koullias et al. [16] and Milewski et al. [7].
Supra-aortic de-branching followed by TEVAR of the arch; TEVAR procedure is
primary (hybrid type 2/type I). Conventional hemiarch/arch replacement is
performed; TEVAR procedure is secondary (hybrid type 1/type II and III).
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conventional surgery who will beneﬁt most from hybrid arch
procedures.
Conﬂict of interest: none declared.
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Abstract
OBJECTIVES: Severe complications after thoracic endovascular aortic repair (TEVAR), such as secondary aorto-oesophageal (AOF) or aorto-
bronchial ﬁstulae (ABF), are most likely under-reported; however, once detected, emergent surgery becomes necessary.
METHODS: Between June 2002 and September 2013, 10 (2.6%) of 374 patients (8 males; mean age 68 years, range: 49–77) were admitted
with AOF (n = 8) or ABF (n = 2) post-TEVAR during follow-up (mean 12.9 months, range 0.2–48.1). The respective Ishimaru landing zones
were 0 (n = 1), 2 (n = 3), 3 (n = 4) and 4 (n = 2). Median interval between TEVAR and AOF/ABF formation was 18.1 months (range 0.1–65.1).
Symptoms on admission included haematemesis (n = 4), haemoptysis (n = 2), melena (n = 1), elevated C-reactive protein (n = 10), new-
onset fever (n = 3), positive blood cultures (n = 8), dysphagia (n = 1), chest pain (n = 4), previous syncope (n = 1) and vertigo (n = 1). In 6
patients with AOF, stent graft removal required ascending aortic (n = 1), aortic arch (n = 1), left hemiarch (n = 2) and descending aortic
(n = 6) replacement with concomitant oesophagectomy (n = 4) and cervical oesophagostomy (n = 1) or oesophageal repair (n = 2); another
patient with AOF underwent oesophagectomy and cervical oesophagostomy via posterolateral thoracotomy without stent graft removal as
a ﬁrst-stage operation. One patient with ABF was treated by stent graft removal, aortic arch and descending aortic replacement in combin-
ation with bronchial repair. Two patients were deemed inoperable and treated conservatively.
RESULTS: All patients survived the operation. Reoperation due to postoperative mediastinitis, haemorrhage, pericardial tamponade and
wound infection was required in 4 (50%, 95% conﬁdence interval [CI] [22, 78]) patients. In-hospital mortality was 25% (n = 2; 95% CI [7, 59])
due to mediastinitis with resulting multiorgan failure (n = 1) and aortic rupture with haemorrhagic shock (n = 1). One patient died due to
unknown cause on postoperative day 158. No neurological complications occurred postoperatively. Postoperative complications com-
prised acute renal failure with temporary dependence on haemodialysis (n = 2) and respiratory insufﬁciency (n = 4) requiring percutaneous
tracheostomy (n = 2). Both patients treated conservatively died after 4 and 81 days due to pulmonary haemorrhage and fulminant mediastini-
tis, respectively.
CONCLUSIONS: AOF and ABF represent uncommon but fatal complications—if treated conservatively—after TEVAR that may occur during
short- and mid-term follow-up. Surgery for AOF/ABF requires early diagnosis and should be performed promptly and in a radical fashion to
totally excise all infected tissues in these high-risk patients.
Keywords: Aorto-oesophageal ﬁstula • Aorto-bronchial ﬁstula • Thoracic endovascular aortic repair • Stent graft infection • Aortic erosion •
Postinterventional complication
INTRODUCTION
Thoracic endovascular aortic repair (TEVAR) has been clinically
introduced in the mid-90s and is now increasingly advocated by
many surgeons and interventionalists as the method of choice to
treat thoracic aortic disease [1]. However, despite a reported low
early postoperative mortality, stent grafts—if compared with open
aortic surgery—may result in a higher incidence of long-term
complications [2], potentially causing severe collateral damage
to adjacent mediastinal structures [3], while associated with an
equally increased risk of postoperative paraplegia [4].
Secondary aorto-oesophageal (AOF) and aorto-bronchial (ABF)
ﬁstulae have been known to be uncommon but fatal complica-
tions after open thoracic and thoracoabdominal aortic surgery [5].
†Presented at the 27th Annual Meeting of the European Association for Cardio-
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More recently, the incidence of AOF and ABF post-TEVAR has
been described to be 1.5–1.9% [5–7]. However, the incidence of
secondary AOF and ABF is most likely under-reported due to
patients that are lost during follow-up and might even increase in
the future, since TEVAR is nowadays not exclusively used in aortic
emergencies or elderly high-risk patients [2, 3].
Since secondary AOF and ABF are uncommon and optimal
treatment remains controversial, the purpose of this study was to
report on the incidence, clinical presentation and outcomes after
radical surgery in this high-risk cohort of post-TEVAR patients.
PATIENTS ANDMETHODS
A total of 374 patients underwent TEVAR at our institution
between June 2002 and September 2013. We retrospectively
identiﬁed 10 patients who were admitted either due to AOF
(n = 8) or due to ABF (n = 2). The mean patient age was 67.6 ± 8.1
years (range 49–77) and 8 (80%, 95% conﬁdence interval (CI)
[49, 94]) were males. Follow-up post-TEVAR was 100% complete
(mean 12.9 months; range 0.2–48.1). The patients’ demographics
and comorbidities are given in Table 1.
Endovascular procedures
The indications for TEVAR in the 10 patients were descending
aortic aneurysm (n = 5), chronic (n = 2) or acute (n = 1) type B
aortic dissection (TBAD), penetrating atherosclerotic ulcer (PAU;
n = 1) and aberrant right subclavian artery aneurysm with aortic
arch involvement (n = 1). Three different endovascular stent graft
systems were used: Valiant (Medtronic Vascular, Santa Rosa, CA,
USA) in 7 patients, Excluder (TAG; W.L. Gore and Associates, Inc.,
Flagstaff, AZ, USA) in 2 patients and Talent (Medtronic Vascular) in
1 patient. Retrograde stent graft deployment via the femoral
artery (n = 10) was performed in the ascending aorta after com-
plete supra-aortic debranching (n = 1), the aortic arch (n = 3) and
the descending aorta (n = 6); the respective Ishimaru landing
zones were 0 (n = 1), 2 (n = 3), 3 (n = 4) and 4 (n = 2). The single
patient with stent graft deployment in landing zone 0 had
received supra-aortic debranching prior to TEVAR. In 3 patients
with an Ishimaru landing zone 2, intentional left subclavian artery
(LSA) overstenting was performed; 1 of the 3 patients initially
received left common carotid to LSA bypass before TEVAR.
Another patient was initially treated with 1 stent graft for success-
ful exclusion of a large descending aortic aneurysm but he
required stent graft extension 5 years later due to aneurysmal pro-
gression of the distal landing zone. No endoleaks were noted
during post-procedural angiography; post-deployment ballooning
with stent graft oversizing of > 20%, 10–19% and 0–9% was per-
formed in 5, 2 and 3 patients, respectively.
Surgical procedures
All patients diagnosed with AOF or ABF were generally classiﬁed
as surgical emergencies. The optimal treatment strategy was dis-
cussed on an individual basis by an interdisciplinary team including
a cardiovascular surgeon, a general/visceral surgeon, a vascular
interventionalist and a radiologist. However, re-TEVAR was not con-
sidered as a potential treatment option in these patients due to the
underlying infectious process of the mediastinum with involvement
of the previously implanted endovascular prostheses. Two patients
were deemed inoperable and treated conservatively.
The details of our institutional surgical technique to address
secondary surgical procedures after TEVAR have been described
elsewhere [8, 9]. In brief, surgical access was achieved via a
left-sited posterolateral thoracotomy (n = 6) or in combination
with a full sternotomy (n = 2). Arterial cannulation for cardiopul-
monary bypass (CPB; n = 7) was performed via the femoral (n = 5),
the axillary artery (n = 1) or both (n = 1). The right axillary artery
was cannulated to allow selective cerebral perfusion (SCP) along
with direct cannulation of the right atrium for venous drainage
(n = 2). Median CPB time was 17 5 ± 77.7 min (range 117–220).
Hypothermic circulatory arrest (HCA) was induced at deep-
to-moderate hypothermia of 21–24°C (n = 4) by cross-clamping
the lower descending aortic segment. However, intraoperative
body core temperatures for hypothermic circulatory arrest (HCA)
have been gradually increased to mild hypothermic conditions
(30–33°C; n = 3) in the past few years. HCA without SCP was uti-
lized in 5 patients (mean HCA duration 13.5 min; range 3–22). The
head was packed externally in ice during HCA.
In all patients with aortic replacement—except 1 patient who
was operated on at deep-to-moderate HCA of 22°C in combin-
ation with SCP—moderate distal aortic perfusion (25–32°C; 3 l/
min) was performed retrogradely via the femoral artery (n = 6) for
adequate visceral and spinal cord protection during the entire
procedure. Perioperative cerebrospinal ﬂuid (CSF) drainage as an
additional measure to minimize the risk of paraplegia was used up
to 72 h postoperatively. Intraoperative perfusion data are sum-
marized in Table 1.
Table 1: Preoperative comorbidities and intraoperative
data
Characteristics Number of patients
(% [95% CI])
Overall 10
Age (years, mean ± SD) 67.6 ± 8.1
Gender (male) 9 (90 [60, 99.5])
Hypertension 9 (90 [60, 99.5])
Coronary artery disease 4 (40 [17, 69])
Cardiomyopathy (EF < 30%) 2 (20 [6, 51])
Chronic obstructive pulmonary disease (COPD) 3 (30 [11, 60])
Previous pneumonia 4 (40 [17, 69])
Renal insufficiency 3 (30 [11, 60])
Diabetes mellitus 6 (60 [31, 83])
Obesity 4 (40 [17, 69])
Hyperlipidaemia 3 (30 [11, 60])
Peripheral vascular disease 3 (30 [11, 60])
Previous cardiac surgery 2 (20 [6, 51])
Previous cerebral infarction 1 (10 [0.5, 40])
Intraoperative data; patients (n = 8)
CPB time, mean ± SD (range) 175 ± 77.7 min
(117–220)
Femoral artery cannulation, n (% [95% CI]) 7 (88 [53, 99.4])
Axillary artery cannulation, n (% [95% CI]) 2 (25 [7, 59])
SCP, n (% [95% CI]) 3 (38 [14, 69])
Distal aortic perfusion, n (% [95% CI]) 6 (75 [31, 83])
Overall HCA temperature, mean (range) 26.1°C (21–32)
Deep-to-moderate HCA, mean (range) 22.2°C (21–24)
Mild HCA, mean (range) 31.3°C (30–32)
HCA time, mean ± SD (range) 13.5 ± 6.3 min (3–22)
CPB: cardiopulmonary bypass; SCP: selective cerebral perfusion;
HCA: hypothermic circulatory arrest; CI: confidence interval.
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In 6 patients with AOF, stent graft removal required ascending
aortic (n = 1), aortic arch (n = 1), left hemiarch (n = 2) and descend-
ing aortic (n = 6) replacement with concomitant oesophagectomy
(n = 4) and cervical oesophagostomy (n = 1) or oesophageal repair
by suture (n = 2) (Fig. 1); 2 of the 6 patients underwent a staged
procedure: primary oesophagoectomy with cervical oesophagost-
omy via a left-sited posterolateral thoracotomy followed by aortic
replacement in a second procedure (n = 1) and vice versa (n = 1).
One patient with AOF—initially treated by supra-aortic debranching
prior to TEVAR—who had been diagnosed with severe mediastinitis
and several oesophageal abscesses underwent oesophagectomy
and cervical oesophagostomy via a left-sited posterolateral thora-
cotomy without stent graft removal as a ﬁrst-stage operation. Four
AOF patients also received a percutaneous endoscopic gastros-
tomy tube to allow enteral nutrition postoperatively. The single
patient with ABF underwent aortic arch and descending aortic re-
placement due to extensive aneurysm progression with bronchial
repair. Table 2 gives an overview of the performed operative pro-
cedures.
Smear tests of the mediastinum and the infected prostheses
were performed in all cases. All patients were treated either with
broad-spectrum antibiotics (institutional protocol) or calculated
antibiotic therapy with regard to previously isolated bacteria from
the individual patient’s blood cultures.
Study variables and deﬁnitions
The operative reports and clinical charts of all patients were retro-
spectively reviewed. The local ethics committee did not require
additional patient consent.
Deﬁnite diagnosis of AOF or ABF ﬁstula was deﬁned as docu-
mented imaging results by endoscopy, CT, oesophagography or
bronchioscopy.
HCA was deﬁned as time of complete circulatory arrest
(without SCP or distal aortic perfusion).
Renal failure was deﬁned as an increase in serum creatinine of
>1.5 mg/dl and temporary (resolved by the time of discharge) or
permanent need for haemodialysis. Respiratory insufﬁciency was
deﬁned as weaning failure from mechanical ventilation by means
of prolonged ventilation (>7 days) or requirement of reintubation
or tracheostomy. Hospital mortality was deﬁned according to
current guidelines as death in hospital prior to discharge or within
30 days of surgery (regardless of location).
Follow-up was 100% complete with a mean follow-up time
of 12.9 months (range 0.2–48.1). Follow-up was ascertained by
a mailed paper questionnaire or a phone call to the patient or
family members, or by contact with the family physician. It was
performed by study personnel and consisted of information on
patient vital status, symptomatology, and reoperations or hospita-
lisations. Supplemental information on CT or endoscopy ﬁndings
was obtained when possible.
Statistical methods
Categorical data are reported as frequencies (percentages) and
continuous variables as mean (range). 95% CIs were calculated fol-
lowing the method of Wilson by means of the R package binom.
RESULTS
Incidence and clinical presentation
Among the 374 patients treated by TEVAR between January 2002
and February 2013, the overall incidence of either AOF or ABF was
2.6% (n = 10); the respective incidence of AOF and ABF were 2.1%,
95% CI [1.1, 4.2]% (n = 8) and 0.5%, 95% CI [0.15, 1.9]% (n = 2).
Mean interval between TEVAR and development of AOF/ABF
was 18.1 ± 24.8 months (range 0.1–65.1). Clinical symptoms on ad-
mission included haematemesis (n = 4), melena (n = 1) or haem-
optysis (n = 2) with haemorrhagic shock (n = 4), new-onset fever
(n = 3), elevated inﬂammatory laboratory parameters (n = 10), dys-
phagia (n = 1), dyspnea (n = 1), chest pain (n = 4), vertigo (n = 1)
and previous syncope (n = 1).
At the time of admission, 8 (80%) patients were found to have
positive blood cultures with bacteria. Mediastinal smear tests were
positive in 6 cases. Antibiotics were continued for at least 3
months postoperatively. Table 3 gives an overview of the obtained
microbiological data.
The initial diagnosis of AOF/ABF was performed via endoscopy
(n = 7), CT (n = 4), bronchoscopy (n = 1) or oesophagography
(n = 1) (Fig. 2). However, all patients received a CT of the thoracic
and thoracoabdominal aorta (aortic protocol) prior to surgery; 1
patient had developed a type I endoleak and 4 patients were diag-
nosed with an endoleak type II fed by the LSA (n = 3) or a thoracic
aortic segmental artery (n = 1) prior to open surgery.
Clinical symptoms of all patients at the time of admission for
AOF/ABF are summarized in Table 4.
Hospital mortality and longevity
The respective in-hospital, 6-month mortality and 1-year mortal-
ity rates were 25% (n = 2), 37.5% (n = 3) and 37.5% (n = 3) for oper-
ated and 50% (n = 1), 100% (n = 2), 100% (n = 2) for conservatively
Figure 1: Intraoperative exposure of an aorto-oesophageal ﬁstula after stent
graft removal (A). Explanted endovascular stent graft; the prosthetic material
has been dissolved by the infectious process (B).
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Table 2: Aetiologies, procedures and complications
Patient,
age (yrs)
Aetiology Previous TEVAR
stent graft (n),
length (mm)
Prox. LZ/
oversizing
(%)
Type of fistula
(length)/
Incidence of
Endoleak
Operation
aortic replacement; AOF or ABF
repair
Postoperative
complications
Hospital
mortality
#1, 61 Acute
TBAD
Valiant (1),
28 × 157
Z3/21 AOF (5 cm)/yes DA replacement;
oesophagectomy
−/− No
#2, 71 DAA Talent (1),
42 × 114
Z2/0 AOF (1.5 × 1.5
cm)/yes
Asc Ao, AA, DA replacement;
oesophageal repair/staged
cervical oesophagostomy
Rethoracotomy:
mediastinitis, PE;
Pneumonia, temp.
dialysis, multi-organ
failure
Yes
#3, 75 DAA Valiant (1), 32–
36 × 150
Z4/11 AOF (3 × 4 cm)/
no
DA replacement;
oesophagectomy
Tracheostomy No
#4, 49 PAU Gore TAG (1),
31 × 100
Z2/26 AOF (5 × 2 cm)/
no
Left hemiarch, DA replacement;
oesophagectomy/staged
cervical oesophagostomy
Rethoracotomy:
haemorrhage, PE,
mediastinitis;
Resp. insufficiency,
wound infection
No
#5, 70 DAA Gore TAG (1),
34 × 200; Talent
(1) 34 × 114
Z4/21 AOF (0.5 cm)/no DA, upper TAA replacement;
oesophageal repair
Rethoracotomy:
wound infection;
Temp. dialysis
No
#6, 73 Aberrant
RSAA
Valiant (1),
38 × 200
Z0/21 AOF (2 cm)/yes -/Oesophagectomy and cervical
oesophagostomy
Rethoracotomy:
haemorrhage (x2)
Yes
#7, 66 Chronic
TBAD
Valiant (1),
46 × 150
Z2/9 ABF (N.A.)/no AA, DA replacement/bronchial
repair
Splenectomy No
#8, 74 DAA Valiant (1),
34 × 160
Z3/18 AOF (6 cm)/yes Oesophagectomy and cervical
oesophagostomy/staged left
hemiarch, DA replacement
Tracheostomy,
pneumonia
No
#9, 77 DAA Valiant (1),
44 × 200
Z3/21 AOF (5 cm)/no −/− −/− −/−
#10, 59 Chronic
TBAD
Valiant (1),
32 × 32 × 150
Z3/9 ABF (N.A.)/yes −/− −/− −/−
TEVAR: throacic endovascular arotic repair; LZ: landing zone; AOF: aorto-oesophageal fistula; ABF: aorto-bronchial fistula; TBAD: type B aortic dissection; DAA:
desecening aortic aneurysm; RSAA: right subclavian artery aneurysm; AscAo: ascending aorta; AA: aortic arch; DA: descending aorta; TAA: thoracoabdominal
aorta; PE: pericardial effusion; N.A.: not available.
Table 3: Laboratory and microbiological data
Patient C-reactive protein
(CRP) mg/l
Leucocytes per
microliter
New-onset
fever
Blood cultures Mediastinal smear test
#1 102 10200 Yes Staphylococcus aureus Staphylococcus aureus
#2 231 22200 Yes No growth No growth
#3 65 7080 No Citrobacter freundii (ESBL) Staphylococcus epidermidis, Proteus mirabilis,
Citrobacter freundii, Steptococcus mitis, Prevotella
oralis
#4 232 14400 Yes Staphylococcus aureus Staphylococcus aureus, Streptococcus mitis/oralis,
Prevotella oralis (Bacteroides oralis), Candida
albicans
#5 291 15100 No No growth Candida glabrata (Torulopsis glabrata),
Propionibacterium acnes
#6 198 6160 No Streptococcus anginosus Streptococcus anginosus
#7 40 9660 No Staphylococcus epidermidis No growth
#8 29 8550 No Staphylococcus anginosus,
Escherichia coli (ESBL)
Streptococcus anginosus, Escherichia coli (ESBL)
extended spectrum ß-lactamase
#9 404 9800 No Lactobacillus species –
#10 70 9660 No Salmonella enteritis,
Staphylococcus
epidermidis
–
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treated patients. Postoperative follow-up was available for all
patients and 100% complete. After a mean period of 12.9 months,
5 (62.5%) patients were still alive.
All initial open surgical procedures for stent graft removal and/
or oesophageal resection were technically successful. However, 2
patients died within 40 days, resulting in an in-hospital mortality
of 25%.
The ﬁrst patient had been admitted in septic shock due to ful-
minant mediastinitis caused by AOF 4 months post-TEVAR (Fig. 3).
He underwent oesophagectomy and cervical oesophagostomy via
left posterolateral thoracotomy and secondary aortic surgery was
planned after clinical stabilization. Six days later, he developed
right-sited haemothorax with acute rupture of the ascending
aorta and died as a result of hypovolemic shock in the operating
theatre.
The second patient had been admitted due to AOF and was
treated by aortic replacement with oesophageal repair and subse-
quent coverage by a pericardial patch. Postoperatively, the patient
required prolonged mechanical ventilation. On postoperative day
(POD) 14 the patient became septic and haemodynamically
instable. Chest CT revealed a pneumomediastinum and
reoccurrence of the AOF and pericardial effusion. After pericardial
drainage, the patient successfully underwent oesophagoectomy
with cervical oesophagostomy. However, the patient ultimately
developed multiorgan failure during the following clinical course
and died on POD 40.
Postoperative complications
Complications leading to rethoracotomy occurred in 4 (50%)
patients and were in detail: mediastinitis (n = 2), postoperative
haemorrhage (n = 2), pericardial tamponade (n = 2) and wound in-
fection (n = 2). Another patient with chronic TBAD required splee-
nectomy via a left-sited laparotomy due to preoperative infarction
of the spleen.
Four patients—including 2 individuals with chronic obstruc-
tive pulmonary disease—developed respiratory insufﬁciency.
Percutaneous tracheostomy was required in 1 patient with COPD
and 1 patient due to postoperative pneumonia in order to be
weaned from the ventilator. Temporary dialysis due to acute renal
failure occurred in 2 (25%) patients—with 1 of them developing
Figure 2: Diagnosis of aorto-oeophageal ﬁstulae by endoscopy (A), computed tomography (B) or oesophagography (white arrows) (C).
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multiorgan failure during his clinical course. No new neurological
complications occurred postoperatively.
Overall mean time to hospital discharge was 30 ± 21.4 days
(range 3–68). Postoperative complications are listed in Table 2.
Non-surgical treatment
Two patients with AOF (n = 1) and ABF (n = 1) were deemed inop-
erable at the time of diagnosis, and therefore were treated conser-
vatively.
The ﬁrst patient had successfully undergone emergency TEVAR
for chronic TBAD with covered aortic rupture. On POD 5 surveil-
lance CT of the chest revealed an endoleak type I that was treated
by intra-aortic angioplasty with ballooning at the proximal and
distal end of the prosthesis on the same day; postinterventional
angiography showed no persisting endoleak. However, on the
next day, he developed haemoptysis and was transferred to the
ICU due to haemodynamic instability. Chest CT revealed an ABF
of the left main bronchus (Fig. 4). On POD 7, he acutely developed
massive haemoptysis—including small parts of lung tissue—requir-
ing reintubation with a double lumen endotracheal tube and car-
diopulmonary resuscitation. However, the patient died shortly
after successful CPR due to signiﬁcant pulmonary bleeding and
subsequent haemorrhagic shock.
The second patient had been initially treated endovascularly for
acute rupture of her descending aortic aneurysm but returned 42
days post-TEVAR due to development of an AOF. Patient history
revealed chest pain and haematemesis prior to syncope. On
admission, the patient was already intubated and sedated.
Endoscopy revealed a large AOF (length: 5 cm) located in the mid-
oesophagus without an active bleeding source. Due to various
other comorbidities, including ongoing left-sited pneumonia and
urinary tract infection, the patient was treated medically and died
after 81 days due to fulminant mediastinitis.
DISCUSSION
Described for the ﬁrst time by Dubrueil in 1818 and Girardet in
1914, primary AOF and ABF have been known to be extremely
rare but lethal clinical entities [10, 11]. Secondary AOF/ABF after
open thoracic aortic surgery occur with an increased incidence in
up to 1.7% of patients following open thoracic aortic surgery [5].
Although long-term outcomes (>10 years) after stent grafting
of the thoracic aorta are still unknown, TEVAR is now being pro-
claimed by many interventionalists as the method of choice to
address thoracic aortic pathologies [2]. With increased use of
TEVAR, formerly unknown complications such as retrograde
aortic dissection [12] and other uncommon severe complica-
tions have been described [4, 6]. In this context, the clinical inci-
dence of secondary AOF and ABF post-TEVAR is currently
reported to be 1.5–1.9% [5–7].
We report an overall incidence of AOF/ABF of 2.6% in a con-
secutive patient cohort of 374 patients over a period of more than
10 years as a single-centre experience—with a respective inci-
dence of AOF and ABF of 2.1 and 0.5%.
The mean time interval between TEVAR and AOF/ABF develop-
ment was 18 months, with 7 (70%) patients being readmitted
within the ﬁrst year after treatment (< 12 months). In 2009, Chiesa
et al. reported a mean interval to AOF (68%), ABF (5%) or com-
bined AOF/ABF (26%) after thoracic stent grafting of 11 months
(10.9 ± 15.4 months). Most recently, data by the European Registry
of Endovascular Aortic Repair Complications (EuREC) showed a
median TEVAR-to-AOF time of 3 months (90 days) [6]. However,
the underlying mechanisms of secondary AOF and ABF develop-
ment post-TEVAR are still unknown.
Czerny et al. [6] hypothesized that AOF development may be
associated with the need for an emergency procedure and the
presence of mediastinal haematoma prior to TEVAR. Secondary
oesophageal ischaemia may be the result of elevated pressures
within the posterior mediastinum, ultimately leading to AOF for-
mation. Similarly, ABF may occur if the bronchial artery is com-
pletely excluded during TEVAR, resulting in bronchopulmonary
ischaemia [13]. Chronic inﬂammation—due to resorption of the
haematoma or aortic compression and erosion by the implanted
stent graft—is another theory of AOF/ABF development [5, 6].
Endoleaks after endovascular stent grafting during follow-up
have also been reported to represent a potential cause of AOF/
ABF development [7, 8]. In our series, 5 of 10 patients (50%) with
AOF/ABF developed an endoleak (type I: n = 1, type II: n = 4), in-
cluding 2 patients with intentional LSA coverage. Although inten-
tional LSA coverage may be performed safely to achieve an
adequate proximal landing zone, this strategy may increase the
risk of a persisting endoleak type II and possible AOF/ABF forma-
tion. LSA transposition, ligation with left common carotid artery to
LSA bypass or LSA embolization post-TEVAR could prevent poten-
tial type II endoleaks (risk for steal from the left vertebral artery) or
neurological complications in cases with a proximal Ishimaru
landing zone within the arch 0–2 [14]. Type II endoleak
post-TEVAR also occurred in 1 patient due to back bleeding from
a prominent thoracic aortic segmental artery; this represents
Table 4: Patient presentation and diagnostics
Incidence of AOF/ABF; patients (n = 10)
Overall, n (% [95% CI]) 10 (2.7 [1.5, 4.9])
AOF, n (% [95% CI]) 8 (2.1 [1.1, 4.2])
ABF, n (% [95% CI]) 2 (0.5 [0.15, 1.9])
Timing
Months since TEVAR, mean ± SD (range) 18.1 ± 24.8 (0.1–65.1)
Clinical symptoms
Elevated C-reactive protein, mg/ l ± SD
(range)
166.2 ± 118.3 (29–404)
New-onset fever, n (% [95% CI]) 3 (30 [11, 60])
Positive blood cultures, n (% [95% CI]) 8 (80 [49, 94])
Haematemesis, n (% [95% CI]) 4 (40 [17, 69])
Haemoptysis, n (% [95% CI]) 2 (20 [6, 51])
Melena, n (% [95% CI]) 1 (10 [0.5, 40])
Haemorrhagic shock, n (% [95% CI]) 4 (40 [17, 69])
Chest pain, n (% [95% CI]) 4 (40 [17, 69])
Dysphagia, n (% [95% CI]) 1 (10 [0.5, 40])
Dyspnoea, n (% [95% CI]) 1 (10 [0.5, 40])
Vertigo, n (% [95% CI]) 1 (10 [0.5, 40])
Syncope, n (% [95% CI]) 1 (10 [0.5, 40])
Exhaustion, n (% [95% CI]) 1 (10 [0.5, 40])
Evidentiary preoperative diagnostics
Computed tomography, n (% [95% CI]) 4 (40 [17, 69])
Endoscopy, n (% [95% CI]) 7 (70 [40, 89])
Oesophagography, n (% [95% CI]) 1 (10 [0.5, 40])
Bronchoscopy, n (% [95% CI]) 1 (10 [0.5, 40])
TEVAR: thoracic endovascular aortic repair; AOF: aorto-oesophageal
fistula; ABF: aorto-bronchial fistula; CI: confidence interval.
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Figure 3: Computed tomography after readmission showing mediastinits (asterisk) and an aorto-oesophageal ﬁstula (dark red arrow heads) after TEVAR at the level of
the transverse arch (A–D). Ectopic gas can be found within the mediastinum (red arrows).
Figure 4: Computed tomography of the chest showing an aorto-bronchial ﬁstula with a communication between the left main bronchus and the stent graft at the
level of the descending aorta (dark red arrow heads; A and B).
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another unsolved problem of TEVAR, especially after extensive
endovascular thoracic and thoracoabdominal aortic coverage.
New innovative strategies, such as segmental artery coil emboliza-
tion prior to TEVAR, are currently under investigation to address
this issue [15].
During stent graft deployment, oversizing may be necessary to
achieve an optimal result on post-procedural angiography.
However, oversizing may increase the risk of aortic wall deterior-
ation and ﬁstula formation [5, 12]. Stent graft oversizing was
performed in almost all patients of our series (n = 9; Table 2), in-
cluding 5 (50%) patients with an intra-procedural oversizing of
>20%. We can conclude that oversizing of more than 20% should
be avoided if possible during TEVAR [5].
Recently, the use of stent grafts with rigid, proximal bare springs
has also been noted to bare a potential risk of aortic intimal
erosion, retrograde aortic dissection, free rupture and/or aortic
penetration with damage to adjacent mediastinal structures
causing a state of chronic inﬂammation [3, 6, 12, 16]. We have
previously demonstrated that proximal bare springs may increase
the risk for aortic intimal damage—and potential AOF/ABF forma-
tion—in patients with an ectatic/dilated native thoracic aorta [12]
(Fig. 3).
Patients with AOF/ABF present with a variety of clinical
symptoms, which may lead to a signiﬁcant delay in diagnosis and
treatment. Patients frequently have a history of self-limited
haematemesis or haemoptysis (‘sentinel’ or ‘herald bleedings’,
Table 4) with no signiﬁcant decrease in haemoglobin [5, 7, 17]. At
the time of bleeding recurrence, patients often present with
haemorrhagic shock requiring emergent surgical treatment [8].
Therefore, a history of bleeding (haematemesis, haempotysis,
melena, etc.) should raise the suspicion of secondary ﬁstula for-
mation after TEVAR and further diagnostics such as CT, endoscopy
and/or bronchioscopy should be performed promptly.
Of note, only 3 patients in this series presented with new-onset
fever but all (n = 10; 100%) were found to have elevated inﬂamma-
tory laboratory parameters and positive blood cultures with bac-
teria (n = 8; 80%) at the time of AOF/ABF diagnosis. Intraoperative
mediastinal smear tests detected bacteria (n = 6; 75%) or fungi
(n = 2; 25%) in 6 of 8 patients (see Table 3).
One of our patients presented with nonspeciﬁc symptoms (i.e.
vertigo and chest pain) and the diagnosis of AOF was made only
after CT imaging (Fig. 2). Other nonspeciﬁc symptoms—such
as dyspnea, dysphagia, previous syncope, new onset fever or
exhaustion—were always accompanied by more deﬁnite symptoms
suggestive of AOF or ABF (i.e. haemoptysis or haematemesis).
We therefore suggest to closely follow all patients post-TEVAR
and to expect late complications after endovascular treatment even
if patients present with uncommon or unspeciﬁc clinical symptoms.
The optimal treatment for secondary AOF/ABF has been dis-
cussed controversially in the literature. Medical treatment alone is
known to be inadequate with a mortality rate of 100% [5–7, 18].
Re-TEVAR as a treatment option for AOF/ABF has been
reported by some investigators [19, 20], but seems very question-
able since the infected prosthesis remains in place and debride-
ment of infected tissue cannot be performed [20, 21]. Moreover,
life-long antibiotic therapy would be necessary in these high-risk
patients. We believe that emergency TEVAR for AOF should only
be used as a ‘bridge-to-surgery’ in haemodynamically unstable
patients [9, 22].
It has been suggested that open surgery offers the best
outcome in the treatment of primary and secondary AOF/ABF, but
no consensus about the optimal surgical strategy exists [6, 18].
Mortality after open repair for AOF/ABF has been reported to be
64% [5] with a 1-year survival between 16 and 57% [5, 6].
Extra-anatomic aortic bypass has been initially reported by
Yonago et al. [17] in 1969 and is still considered an alternative sur-
gical strategy to manage a primary or secondary AOF/ABF. An
omental ﬂap has been reported for patients with aorto-enteric
ﬁstula [23]. Most recently, Okita et al. presented their results for
open surgery of primary and secondary AOF (post-TEVAR patients:
n = 4) at the 27th EACTS Annual Meeting in Vienna and reported a
low hospital mortality rate of 26.7%. Their surgical strategy com-
prised simultaneous resection of the aorta and the oesophagus
followed by in situ reconstruction of the descending aorta using a
rifampicin-soaked Dacron graft with additional coverage of an
omental (or intercostal muscle) ﬂap [22].
Others investigators favour the use of cryopreserved aortic allo-
grafts (homografts) and have achieved similar results with an
equally low mortality rate of 27% [24]. However, homografts may
not always be available at a time and usually tend to be too short
and of a small diameter to allow aortic replacement in AOF/ABF
cases. A promising alternative could be the use of 2–3 self-made
pericardial tubes, e.g. by wrapping around a conventional 15 × 10
cm pericardial patch to get a 3.5 cm tube.
Canaud et al. [25] most recently reported on their results after
secondary open surgery in a heterogeneous post-TEVAR cohort of
14 of 236 patients and reported an extraordinary low hospital
mortality of 14.3% with a 2-year survival rate of 87.7%. However,
their surgical series of 14 patients included only 7 patients (50%)
with AOF (n = 1) and ABF (n = 6).
We are convinced that prompt and radical surgical therapy
represents the treatment of choice in patients with post-TEVAR
complications [8, 9]. In AOF patients, we perform a staged surgical
approach: oesophagectomy (with or without oesophagostomy)
with radical excision of all infected tissue, stent graft removal and
aortic replacement followed by second-stage oesophageal recon-
struction, e.g. gastric pull-up operation. For patients with ABF, we
perform a similar approach to the aorta/stent along with appro-
priate bronchial repair, e.g. ﬂap coverage or lobectomy.
CONCLUSIONS
AOF and ABF represent uncommon but fatal complications
after TEVAR that may occur during short- and mid-term follow-
up. Surgery for AOF/ABF requires detailed planning and should
be performed promptly and in a radical fashion to excise all
infected tissues. However, more data is required on the surgi-
cal outcome of patients with ﬁstula formation after TEVAR in
order to determine the optimal surgical strategy of these chal-
lenging patients.
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APPENDIX. CONFERENCE DISCUSSION
Dr M. Schepens (Brugge, Belgium): I just have a brief question. I didn’t notice
from your data that you use omentoplasty to treat this kind of severe problem.
Do you think it has any place in the treatment?
Dr Etz: I personally think this is an option if the patient presents with severe
mediastinitis. In this cohort there was only one patient in whom it was consid-
ered, but we would rather go for radical resection right now. Presently, data is
scarce and we do not utilize omentoplasty much in Leipzig. In this cohort there
was only one patient who had a pericardial patch but there was no one that
received an omentoplasty. Nevertheless, I think it is a valid option.
Dr Schepens: What is your opinion about complete resection of the aneurys-
mal wall, since the previous speaker really said that it was important to remove
the whole aneurysm?
Dr Etz: The way I was trained by Dr Griepp is to remove as much diseased an-
eurysmal tissue as possible, particularly when you are in doubt. If infection is
excluded, I think it’s okay to leave aneurysmal wall behind if you have a bleed-
ing issue as a major problem, for instance.
Dr Y. Okita (Kobe, Japan): I have two questions. This is a postop TEVAR
experience.
Dr Etz: Right.
Dr Okita: In Leipzig, how many had a primary aorto-oesophageal ﬁstula? If
you know, please tell us.
Dr Etz: A primary aneurysm?
Dr Okita: An aorto-oesophageal ﬁstula.
Dr Etz: So primary after TEVAR or primary -
Dr Okita: No, no, before.
Dr Etz: In Leipzig it is very rare that a patient comes with a primary untreated
aneurysm that’s eroding the oesophagus. The raw numbers do not tell us much
about the incidence because we neither know the true denominator nor the
number of patients that never reach the hospital because of an acute and fatal
haemorrhage after rupture.
Dr Okita: This is rare, right?
Dr Etz: It is rare.
Dr Okita: And the second question. You are comparing the results of
aorto-oesophageal and aortobronchial. Can you ﬁnd any difference regarding
the mortality between the two of them?
Dr Etz: With the small numbers we have, there is really no way to tell, particu-
larly with only two patients presenting with an aortobronchial ﬁstula. The way
these patients present is often quite dramatic as we all know, sometimes with
recurrent haematemesis or haemoptysis as direct heralds of imminent rupture.
This is one of the reasons why it’s probably an under-reported complication.
These patients die a sudden death and you don’t see them in the hospital.
Dr Okita: Did you do a lung resection as well?
Dr Etz: No, but if it’s necessary, if the aneurysm is eroding the lung for in-
stance, we would.
Dr C. Knosalla (Berlin, Germany): I have three questions. First, I would like to
know what your current strategy is when dealing with aorto-oesophageal
ﬁstula. In which cases do you try to repair the oesophagus? Or do you immedi-
ately resort to oesophagectomy to really eradicate it?
And my second question is, as I did my vascular training with Edouard Kieffer
in Paris, where do you see the value of allografts in this indication?
And thirdly, you did these operations over quite a period of time and you
said you have 100% follow-up in your hospital. So I would imagine that you can
give us some more details about recurrence rates after one year.
Dr Etz: Let’s start with the ﬁrst question, what I think about oesophageal
repair as opposed to a staged radical resection. In our experience, there was
only one patient that had an oesophageal repair, and his survival was poor. First
of all, it is always an individual decision, of course, and there is no large experi-
ence that we could base it on. But whenever you have a case that goes wrong
and you are in doubt whether oesophageal repair is feasible, then it is probably
better to perform radical resection, and since we had an experience with this
one case we are hesitant with regard to repair. If it is a very small lesion (and
possibly depending on who is on call), I would not categorically declare that it
would never undergo repair, but we do not generally recommend it.
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Regarding your second question, usually we have a number of proximal
homografts available and only a few thoracic homografts. If there’s availability
and we think that the inﬂammation is a major problem and that there may be
difﬁculties with the proximal anastomosis, for instance, then we would opt for a
homograft, if available, yes. And the last question was, again?
Dr Knosalla: The recurrence rate after one year, because these cases really
can have late reinfections, particularly if you use prosthetic grafts.
Dr Etz: I believe, and this is what I was taught by Dr Griepp, in reporting
one-year mortality as a measure of operative success: this is the true number;
reporting hospital mortality, 60-day, and whatever, is not. These are very exten-
sive surgeries and one-year survival is the true number. So that’s what we have
been reporting; in our series it was 62.5%. I think this is probably the best you
can get at this point with these desperate cases at one year.
And you’re absolutely right, the study is over a long time period and some of
the patients had been operated on before I joined the Leipzig team. Even so, I
think our data are resilient, because we have a lot of research personnel thor-
oughly questioning not only the patients themselves, but also calling the GPs,
and if there is any doubt, then the previous operating surgeon is contacted
as well.
Dr A. Apaydin (Izmir, Turkey): The homografts, they have a short-term risk of
rupture; I think it’s about 11%. So they are not very safe, you should keep it in
mind.
Dr J. Bachet (Paris, France): You said one thing that intrigues me. You say, ‘of
course homografts.’ These patients are completely unexpected patients, and I
suppose that you don’t have homografts on the shelf like we have valves.
Dr Etz: Exactly. What I said is, of course, we consider their use.
Dr Bachet: Well, you can consider everything you like.
Dr Etz: If we have homografts available (and Leipzig is a large institution so
we have a little more in stock probably than other institutions), yes, we would
consider using them. But I totally share your concern.
Dr Bachet: But I suppose they are not very often available, as you said.
Dr Etz: That’s right.
Dr Bachet: On the other hand, what do you think of what Thierry Carrel’s
group proposed, which is to use systemically preserved pericardium? They
have published very good results.
Dr Etz: It is also used, yes, of course. It’s a good option, I think.
Dr M. Borger (Leipzig, Germany): Just a comment to Dr Bachet. We only have
one descending thoracic aortic homograft at a time in our institution. The other
more important problem is that they tend to have quite a small diameter and
you can’t match the size of the homograft to the size of the native aorta, which
is usually dilated. Especially by the time you take out the stent, you are often
left with this long segment of dilated aorta that needs to be replaced, which is
difﬁcult with a homograft.
Until now, we have performed repair of aorto-oesophageal ﬁstula with a
standard prosthetic graft. However, we’ve used bovine pericardium, as you
are referring to, in patients with mycotic aneurysms where the area of
involved aortic pathology tends to be much shorter. Since we have been very
happy with pericardium for mycotic aneurysms, we will probably start using
this technique for oesophageal ﬁstulae. However, one would need to sew to-
gether three of these pericardial tubes, in order to achieve the correct length
and diameter. That is, you take a 15×10 cm pericardial patch, wrap it around
and sew the edges together in order to achieve a 3.5 cm diameter tube and
then sew enough of these tubes together in order to replace the affected
aorta.
Dr W. Harringer (Braunschweig, Germany): This is an excellent technical ex-
planation of how you do it, especially if you don’t have homografts of the ap-
propriate size available. I personally still prefer homografts. We also have some
of them on the shelf. But this is clearly an individual situation. If you don’t have
them, then either (as Professor Okita’s group) use soaked Dacron or use peri-
cardium as an alternative to prosthetic material. It’s not an invention by the
Bern group because it has been done before by others, years before, because
they didn’t have alternatives. But it seems to be an excellent choice if you don’t
have other material available in these infective situations.
But let me ask you one more thing. The one-year survival rate came down, of
course. How many of these patients died of infection or reinfection? What
were the reasons for death, do you know that?
Dr Etz: Two patients that died had been deemed to be inoperable. One was
already presenting with signs of infection, so in this case we know the cause.
The other one died after fulminant haemorrhage. However, once they are
home after surgery, the follow-up on the cause of death is very difﬁcult.
Dr M. Picichè (Rome, Italy): My question is about the interval between the
beginning of massive haemoptysis and the operation, because, of course, this
requires management. What do you do? Do you use a Carlens tube and
occlude one side in order to avoid blood ﬂooding into the other side of the
bronchus, in case of aorto-oesophageal ﬁstula?
Dr Etz: Fortunately, sentinel bleeding often occurs, which raises our suspi-
cions. We are very alert in these acute emergencies but we have not routinely
used a Sengstaken–Blakemore tube, although we used a bronchus blocker in
one case – whatever you need to get the patient alive to the OR suite. There is
no protocol as such.
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